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     CHAPTER I – SUMMARY 
In Saccharomyces cerevisiae (hereafter called yeast), three RNA polymerases synthesize the nuclear 
transcriptome. During the transcriptional cycle, RNA polymerase I, II and III (Pol I, II and III) are 
recruited to their respective promoter, elongate the nascent transcript in the context of chromatin 
and finally terminate transcription. Whereas the initation step is quite well understood, our 
knowledge about elongation and termination is very limited. Therefore, we developed an in vitro 
transcription system in which elongation and termination of RNA Pol I can be analyzed independent 
of promoter-specific initiation. The same transcription system allowed comparison of the three RNA 
polymerases regarding their behaviour, if barriers are encountered during elongation. In summary, 
the following questions were addressed: 
1) Several DNA cis elements and trans-acting factors are described to support RNA Pol I dependent 
transcription termination. Among the protein factors are the Reb1 homolog Ydr026c/Nsi1 which was 
recently found to be required for efficient Pol I termination in vivo, Reb1, which terminates 
transcription in vitro and the replication fork blocking protein Fob1. We further investigated the role 
of these factors in the termination process regarding i) the role of Nsi1 and other possible trans-
acting factors and ii) the influence of mutations in Pol I subunits in transcription termination. We 
found that Nsi1 imposed an elongation barrier for Pol I. Furthermore, we could show that presence 
of the 35S rDNA terminator-proximal Reb1 binding site was sufficient for Nsi1-dependent Pol I 
pausing/termination in vitro which was further enhanced by the T-rich 1 element. In addition, our 
data suggest that Nsi1 and Fob1 exhibit a cooperative effect in Pol I transcription termination in vitro. 
 
2) We further wanted to elucidate whether RNA Pol I, II and III deal differently with elongation 
obstacles in general. Thus, we comparatively analyzed Pol I, II and III transcription of templates 
complexed with the physiological elongation barriers Nsi1, Reb1 and Fob1 in vitro. Furthermore, the 
unphysiological bacterial strong DNA-binding proteins LexA and LacI as well as the mouse rDNA 
terminaton factor TTF-I were included in the analysis. We could show that Nsi1 and Reb1 were 
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specifically impairing Pol I transcription elongation. Contrary, LexA only imposed a road-block for Pol 
II. On the other hand, TTF-I was an elongation obstacle for all three RNA polymerases. 
 
3) In all eukaryotic cells, gene transcription occurs in the context of chromatin. Chromatin is a 
complex assembly of DNA and DNA bound proteins, with histone molecules forming the abundant, 
basic unit of chromatin, the nucleosome. It is of great importance to understand how the different 
RNA polymerases cope with the chromatin template. It has been suggested, that actively transcribed 
Pol I and III genes are devoid of nucleosomes, whereas Pol II genes are nucleosomal. To analyze 
whether the RNA polymerases have intrinsic activities to deal differently with the nucleosomal 
templates, we comparatively investigated Pol I, II and III transcription elongation on templates 
complexed with nucleosomes in vitro. Many studies employing in vitro assays have already analyzed 
chromatin transcription by the different RNA Pols. However, it is hard to compare the individual 
results, since the respective in vitro systems used for analysis often differ significantly in many 
aspects, whereas side-by-side comparison of Pol I, II and III is possible in our system. Furthermore, 
we used RNA Pol I mutants to elucidate the contribution of certain subunits to transcribe through 
nucleosomal templates. We observed that Pol I and III were able to transcribe a nucleosomal 
template in vitro, whereas in agreement with the literature a single nucleosome imposed a very 
strong barrier for Pol II elongation. Additionally, we could demonstrate that subunit A49 significantly 
contributes to Pol I’s ability to overcome the nucleosomal barrier. 
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     CHAPTER II – INTRODUCTION 
 
2.1  RNA polymerases – ubiquitous conserved enzymes 
 
2.1.1 Outline 
 
In 1869, nucleic acids were isolated by Friedrich Miescher for the first time. However, it took several 
decades to discover that the substance which was by then called nuclein was comprised of the two 
different nucleic acids DNA and RNA and to elucidate their chemical composition (reviewed in Allen 
1941). Several ribonucleotide (rNTP) -consuming enzymatic activities like polynucleotide 
phosphorylase (GRUNBERG-MANAGO et al. 1955) or the CCA-adding enzyme (Preiss et al. 1961), 
were described in the following years. Nonetheless it remained unclear until 1959/1960 how RNA 
was synthesized. Simultaneously, Jerard Hurwitz (Hurwitz et al. 1960), Sam Weiss (Weiss & Gladstone 
1959), Audrey Stevens (Stevens 1960) and James Bonner (Huang et al. 1960) reported RNA-
synthesizing activities which marked the discovery of DNA-dependent RNA polymerases (RNAP). 
While Weiss obtained a fraction exhibiting polymerase activity from rat liver tissue, Bonner worked 
with a pea extract and Stevens and Hurwitz fractionated E. coli lysates. Contrary to the view back 
then emanating from the hypothesis of the existence of one RNA polymerase, the world of RNA 
polymerases has significantly changed until today and still continues to evolve. Today we know that 
every organism contains at least one RNA polymerase and a multitude of viruses carry the genetic 
information for one. 
Chemically, DNA-dependent RNA polymerases are nucleotidyl transferases which catalyze 
polymerisation of rNTPs in 5’-3’ direction. Thereby, phosphodiester bonds are formed by a 
nucleophilic attack of the 3’-OH group of the last nucleotide in the RNA chain on the α-phosphorus of 
the incoming rNTP. Unlike DNA polymerases, RNA polymerases do not need a primer. The sequence 
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of the synthesized RNA is determined by the DNA template and equal to the sequence of the coding 
DNA strand albeit thymine is replaced by uracil. Therefore, RNA synthesis by RNA polymerases was 
called transcription.  
In vivo, the transcriptional cycle can be roughly dissected into the three main steps initiation, 
elongation and termination. Briefly, upon initiation the RNA polymerase is recruited to a specific 
recognition sequence upstream of the respective gene called promoter by initiation factors hence 
forming the closed complex. Unwinding of the transcription bubble marks the transition to the open 
complex state. Next, the first nucleotides are added. During elongation, the polymerase is released 
from the promoter and the RNA chain is further extended. Transcription termination is defined as 
polymerisation cessation and release of the transcript and the polymerase. The literature knows 
further subdivisions of these three steps, of which some are well-defined and constantly used and 
some depend on the view of the respective authors. Initiation is sometimes subdivided in the two 
steps pre-initiation complex (PIC) formation and actual recruitment of the polymerase including 
unwinding of the DNA helix. Promoter escape or clearance is defined as the point when the initiation 
factors break away from the polymerase and the RNAP has left the promoter behind. Sometimes this 
is referred to as a fourth step in the transcription cycle, albeit it is also seen as the first step of 
elongation. After promoter clearance, a phase of short transcript production and polymerase pausing 
and backtracking follows, known as the abortive transcription phase. RNA chain elongation itself is 
often termed as productive elongation. 
 
 
2.1.2 T7 RNA polymerase 
 
Within viral RNA polymerases, T7 RNA Pol, which was also used in this study, is the best 
characterized. It was discovered in 1970 upon infection of E. coli with T7 bacteriophages (Chamberlin 
et al. 1970). The T7 gene I is coding for this one-subunit polymerase with a molecular weight of 
98kDa (Davanloo et al. 1984). In the T7 genome 17 T7 RNA Pol promoters were identified (Dunn & 
Studier 1983). They consist of 23 highly conserved base pairs (TAATACGACTCACTATAG*GGAGA, * 
marks the TSS) which are recognized by the polymerase with high specificity (Davanloo et al. 1984). 
Upon binding of the polymerase to the promoter, the closed complex is formed. Subsequently, the 
promoter DNA is bent by the polymerase at an angle of 40°-60° in the region from -2 to +1 
referenced to the transcription start site (Újvári & Martin 2000) and the transcription bubble is 
opened. Promoter strand separation is driven by incorporation of nucleotide +2 (Stano et al. 2002). 
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Once a stable initiation complex has been formed upon incorporation of roughly 10nt, the 
polymerase switches to elongation mode and promoter clearance occurs (Liu & Martin 2002). Two 
termination signals for T7 RNA Pol were identified so far. (Dunn & Studier 1983) reported that the 
TΦ region in the late part of the T7 genome served as a transcription terminator. Upon transcription, 
the nascent RNA forms a hairpin structure which leads to termination in combination with a 
downstream T-rich region on the non-template strain. Furthermore it was demonstrated that the 
presence of a T-rich stretch alone leads to termination (Mead et al. 1986). Additionally, it was 
observed that T7 RNA Pol terminated at prokaryotic RNA polymerase terminators (Jeng et al. 1990). 
T7 RNA Pol shows homology to mitochondrial and chloroplast RNA polymerases in plants as well as 
to mitochondrial RNA polymerase in S. cerevisiae (Kelly et al. 1986). Based on studies indicating 
structural homologies, it was suggested that T7 RNA Pol is evolutionary related to DNA polymerases 
(Steitz et al. 1994). 
 
 
2.1.3 Bacterial RNA polymerase 
 
The bacterial RNA polymerase consists of 5 (core enzyme) or 6 (holoenzyme) subunits named with 
greek letters: αIαIIββ’σω with a total molecular weight of roughly 470kDa (Ebright 2000). The x-ray 
structure of RNA polymerase from T. aquaticus was solved in 1999 and revealed a claw-like shaped 
enzyme with a central cleft of roughly 25Å diameter harboring the catalytical Mg2+ ion (Zhang et al. 
1999). The catalytically active center is comprised of the two largest subunits β’ and β which 
resemble the two pincers of the claw and the bottom of the cleft. αI and αII are located distal of the 
cleft and interact with β and β’, respectively. Both α subunits contain an N-terminal domain (NTD) 
which is necessary for interactions with the β subunits and a C-terminal domain (CTD) which interacts 
with promoter DNA (Busby & Ebright 1994). The ω subunit is located at the β’ CTD and stabilizes the 
association of β’ with the αIαIIβ subassembly (Minakhin et al. 2001). The σ-subunit binds to β’ and is 
required for promoter-specific initiation. The core enzyme does not recognize promoters albeit it is 
catalytically active. Promoter recruitment requires presence of a σ-factor, of which 7 different coding 
sequences are found in the E. coli genome (Pérez-Rueda & Collado-Vides 2000). Usually, transcription 
is initiated by the housekeeping σ70 which was named after its molecular weight. Among others, 
specialized σ factors are activated upon nutrient depletion, transition to stationary phase, nitrogen 
shortage or heat shock (reviewed in Gruber & Gross 2003). A typical prokaryotic promoter 
recognized by σ70-associated RNAP consists of the Pribnow box (5’-TATAAT-3’) located at position -10 
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(compared to the TSS), the -35 region (5’-TTGACA-3’) and the UP element located further upstream. 
However, not all promoters contain all elements and the actual sequences often differ from the 
consensus. Promoters identified by alternative sigma factors can differ to great extent. σ factors are 
involved in all aspects of transcription initiation including locating the RNA polymerase to the 
promoter, DNA melting, initiation of RNA synthesis and promoter escape (Borukhov & Severinov 
2002). It has been believed for a long time that transition from initiation to elongation required the 
dissociation of the σ factor due to steric conflicts with the nascent RNA. Recently it was shown that 
in early stages of elongation σ can stay associated with the RNAP although the association to β’ is 
altered (Kapanidis et al. 2005). Two kinds of transcription terminators are found in the E. coli genome 
(reviewed in Uptain et al. 1997; Richardson 1993). Factor-independent terminators are comprised of 
GC-rich inverted repeats followed by a T-rich stretch comparable to the T7 RNA Pol terminator. They 
induce RNAP pausing and destabilization of the RNA-DNA hybrid due to the weak A-T interactions 
and thus release of the nascent RNA. The factor-dependent terminators do not share sequence 
homology but require the presence of the termination factors Rho (ρ), Tau (τ) or nusA (Banerjee et 
al. 2006) with Rho accounting for 50% of the factor-dependent terminators. Rho was discovered and 
purified by (Roberts 1969). It is a helicase (Brennan et al. 1987), translocase and ATPase. The 
mechanism of Rho-dependent termination is well understood. While the polymerase is stalled at the 
Rho pausing site (Kassavetis & Chamberlin 1981), Rho recognizes the Rho utilization site on the 
nascent RNA which has a low G but high C content (Morgan et al. 1985). Then Rho translocates along 
the RNA towards the polymerase thereby hydrolyzing ATP. Upon arrival, Rho unwinds the RNA-DNA 
hybrid and thus causes release of the transcript (Richardson 2002; Richardson 2003). 
 
 
2.1.4 Archaeal RNA polymerase 
 
Investigation of archaeal transcription started with the purification of RNA polymerase from 
Halobacterium cutirubrum (Louis & Fitt 1971). Early on it was evident that archaeal transcription 
occurs homologously to that in eukarya (reviewed in Reeve et al. 1997). Archaea contain one 13-
subunit RNAP which shares significant structural and mechanistic homology with the eukaryotic 
RNAPs but especially with Pol II (Huet et al. 1983; Prangishvilli et al. 1982). Recent publications 
revealing the x-ray structure of RNAP from S. solfataricus and S. shibatae confirmed this close 
relationship (Hirata et al. 2008; Korkhin et al. 2009) and the number of 13 subunits. Furthermore, 
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similarity of the Pol II and archaeal pre-initiation complexes (PIC) was demonstrated by x-ray 
crystallography (Kosa et al. 1997). 
Archaea possess homologues of the eukaryotic transcription factors TATA-binding protein (TBP) 
(Rowlands et al. 1994), the basal transcription factor TFIIB (Ouzounis & Sander 1992) (TFB or aTFA), 
TFIIS (TFS) (Hausner et al. 2000) and TFIIEα (TFE) (Bell et al. 1998). Interestingly, archaeal 
transcription regulators are related to the ones found in bacteria (reviewed in Geiduschek & 
Ouhammouch 2005). Archaeal promoters consist of the TATA box (Hausner et al. 1991) and a purine-
rich adjacent upstream sequence (TFB-responsive element, BRE). It was shown that archaeal RNAP, 
TFB and archaeal TBP are necessary and sufficient for promoter-dependent transcription in vitro 
(Hausner et al. 1996; Hethke et al. 1996). Upon initiation, both TBP and TFB bind to the promoter 
thus forming the PIC. Next, RNAP is recruited to the PIC (Hausner et al. 1996; Bell et al. 1999). 
Transition from closed to open complex occurs upon promoter opening which is mediated by the B-
linker region of TFB (Kostrewa et al. 2009). After open complex formation, RNAP scans the DNA in 
cooperation with the B-reader domain of TFB to identify the TSS (Kostrewa et al. 2009). TFE was 
shown to be necessary for initiation on weak promoters by enhancement of TATA-box recognition 
(Bell et al. 2001) and described as part of the elongation complex (Grünberg et al. 2007). The 
knowledge about archaeal RNAP elongation is very limited. It was shown that upon transition from 
initiation to elongation, subunit H exhibits a conformational change (Grünberg et al. 2010). 
Furthermore, it was demonstrated that TFS stimulates the intrinsic RNA cleavage activity of RNAP 
thus showing similarity to its homolog TFIIS (Hausner et al. 2000; Grünberg et al. 2010). There are 
indications that TFS-mediated cleavage activity is important for transcription fidelity (Thomas et al. 
1998), rescuing of stalled elongation complexes (Reines et al. 1993) and at pausing sites (Marr & 
Roberts 2000). However, TFS cleavage is apparently not linked to polymerase backtracking (Grünberg 
et al. 2010). Current knowledge suggests that termination of archaeal RNAP does not require 
additional factors. In contrast, arrest and termination are dependent on oligo dT stretches in the 
template DNA in analogy to RNA Pol III (Mūller et al. 1985; Thomm et al. 1993; Spitalny & Thomm 
2008). Most recent studies revealed that the trigger loop in the RNAP active center plays a role in 
correct transcription termination, since its deletion or mutation lead to increased pausing and 
termination (Fouqueau et al. 2013). In summary, the archaeal transcription machinery exhibits 
similarities with eukaryotic RNA Pol II and III as well as with the bacterial transcription regulation thus 
indicating common ancestry. 
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2.2  Eukaryotic RNA polymerases 
 
2.2.1 From one to five – an overview 
 
It took almost a decade from the discovery of the RNA polymerase until it was demonstrated that 
eukaryotes contain three different RNAPs which were distinctly located in the nucleolus or the 
nucleoplasm (Roeder & Rutter 1969; Roeder & Rutter 1970). Today it is common knowledge that 
eukaryotic RNAPs have distinct targets. With trypanosomes being the only described exception 
(Günzl et al. 2003), Pol I solely synthesizes the 35S (47S in higher eukaryotes) rRNA precursor. Pol II 
transcribes mRNA precursors, microRNAs (miRNA) (Lee et al. 2004) and a fraction of the small 
nuclear RNAs (snRNA). Pol III synthesizes the 5S rRNA (Szymanski et al. 1998), tRNAs (Sprinzl et al. 
1991) and other small noncoding RNAs including U3 and U6 snRNA and RNase P RNA (Gupta & Reddy 
1991). More recent studies revealed that two additional RNAPs named RNA Pol IV and V exist in 
plants which are structurally related to Pol II (reviewed in Haag & Pikaard 2011). Both Pol IV and V 
are involved in RNA directed DNA methylation (RdDM) mediated by siRNAs (Herr et al. 2005; 
Onodera et al. 2005). The primary transcript(s) of Pol IV were not identified so far whereas Pol V-
dependent RNAs were described in vivo (Wierzbicki et al. 2008). Enzymatic activity of Pol IV and V 
was not yet demonstrated in vitro. Furthermore, mitochondria and chloroplasts contain their own 
RNAPs (2.1.2).  
The evolutionary background for the existence of up to five RNA polymerases in eukaryotes remains 
unclear. One key feature of eukaryotic RNAPs is their spatial separation in different nuclear sub-
domains. However, it is evident that although all eukaryotic RNAPs are highly specialized, they share 
mechanistic and structural homologies.  
 
 
2.2.2 Structure and subunit composition of yeast RNA Pol I, II and III 
 
In yeast, RNA Pol I, II and III contain 14, 12 and 17 subunits, respectively. According to current 
nomenclature, the name of a subunit consists of a capital letter referring to the appearance in Pol I, II 
or three combined with a number indicating the molecular weight of the subunit in kDa. However, 
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also names in Rpxy format are used with x being a, b or c for the polymerase and y being the subunit 
number. An overview together with prokaryotic RNAPs is given in Table 2-1. 
Eukaryotes 
Archaea Bacteria subunit function 
subunit 
location Pol I Pol II Pol III 
A190 Rpb1 C160 A’+A’’ β’ catalytic core 
A135 Rpb2 C128 B (B’+B’’) β catalytic core 
AC40 Rpb3 AC40 D α  core 
AC19 Rpb11 AC19 L α  core 
ABC27 ABC27 (Rpb5) ABC27 H ω  core 
ABC23 ABC23 (Rpb6) ABC23 K   core 
ABC14.5 ABC14.5 (Rpb8) ABC14.5 -   core 
ABC10a ABC10a (Rpb10) ABC10a N   core 
ABC10b ABC10b (Rpb12) ABC10b P   core 
A12.2 Rpb9 C11 X  RNA cleavage core 
A14 Rpb4 C17 F  initiation complex 
formation 
stalk 
A43 Rpb7 C25 E  stalk 
A49 (Tfg1) C37   
initiation complex 
stabilization 
Pol I/III 
specific 
subcomplex 
A34.5 (Tfg2) C53   
  C82    Pol III 
specific 
subcomplex 
  C34    
  C31    
Table 2-1: Subunit composition of eukaryotic, archaeal and bacterial RNA polymerases. The table is adapted from (Vannini 
& Cramer 2012). Common subunits of Pol I, II and III are highlighted in blue, common subunits of Pol I and III are highlighted 
in green. Tfg1 and Tfg2 are not defined as Pol II subunits and thus given in brackets although they exhibit structural 
homology to A49/A34.5 and C53/C37. 
By now, crystal structures of the 10-subunit core Pol II are available at a resolution of 2.8Å (Cramer et 
al. 2000; Cramer et al. 2001) and at 3.8Å for the complete Pol II (Armache et al. 2005). Pol I structure 
was extensively studied with cryo-EM and immuno EM (Schultz et al. 1993; Klinger et al. 1996; 
Bischler et al. 2002; De Carlo et al. 2003; Kuhn et al. 2007). Up to now, only one cryo-EM based 
structure of Pol III is available (Vannini et al. 2010). However, no crystal structures are published for 
either Pol I or Pol III to date apart from subcomplexes. Nonetheless, homology modeling of Pol I and 
III subunits into the cryo-EM structure by means of the Pol II crystal structure further consolidated 
analogies between the structures of the three polymerases (reviewed in Vannini & Cramer 2012). As 
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outlined in 2.1.3 and 2.1.4, crystal structures of bacterial and archaeal RNAP are available which 
share significant structural homology to their eukaryotic counterparts. 
         
Fig. 2-1: Conserved core topology of transcription initiation complexes. Initiation complex models are based on a minimal 
Pol II initiation complex model containing closed promoter DNA, Pol II, TBP, and TFIIB (Kostrewa et al., 2009). The X-ray 
structure of the complete Pol II (Armache et al., 2005) and the Pol II-based homology models for the Pol I and Pol III core 
(Kuhn et al., 2007 and Jasiak et al., 2006) are represented as gray molecular surfaces. TBP and Rrn3 (Blattner et al., 2011) 
are shown as pink and red molecular surfaces, respectively. TFIIB, TFIIE, TFIIF, and related factors are depicted as molecular 
surfaces, (Chen et al., 2010, Vannini et al., 2010 and Blattner et al., 2011) (Patrick Cramer,unpublished data). The presumed 
location of TFIIE, based on crosslinking data, is indicated with semitransparent filled circles (Chen et al., 2007). The locations 
of C82 and C34 were determined by electron microscopy (Vannini et al., 2010), and the location of the A49 tandem WH 
domain was inferred by crosslinking (Patrick Cramer, unpublished data). For each of the three models, two orthogonal 
views are shown. Adapted from (Vannini & Cramer 2012) 
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Pol I, II and III share a homologous 10 subunit core (reviewed in Vannini & Cramer 2012). From the 
Pol II structure, it is evident that the two large subunits Rpb1 and Rpb2 form the central mass with a 
cleft between them harboring the catalytically active metal ion.The Rpb1-Rpb2 complex is anchored 
via a subassembly of Rpb3, Rpb10, Rpb11 and Rpb12. The core polymerase is completed by Rpb5, 6 
and 9. In Pol I and III one subunit of the core is not only structurally related to the Pol II counterpart 
Rpb9 but also to the Pol II transcription factor TFIIS (Ruan et al. 2011). A protruding stalk is formed by 
heterodimeric complexes consisting of A43/A14 in Pol I, Rpb4/7 in Pol II and C25/C17 in Pol III 
(Armache et al. 2005; Peyroche et al. 2002; Jasiak et al. 2006; Hu et al. 2002). From this point, the 
three polymerases contain different numbers of subunits. However, subcomplexes of Pol I and III 
subunits exhibit partial structural homologies to general transcription factors of Pol II. The 
heterodimers A49 (N-terminal domain)/A34.5 and C53/C37 (Kassavetis et al. 2010; Landrieux et al. 
2006) are related to the TFIIF subunits Tfg1 and Tfg2. Furthermore, C82 and C34 are proposed to be 
homologs to the TFIIE subunits TFIIEα and TFIIEβ (Wang & Roeder 1997). Structural similarities were 
also detected between the C-terminal domain of A49 and TFIIEβ. Structural homology studies can be 
extended beyond polymerase subunits to further transcription factors (reviewed in Vannini & Cramer 
2012). 
 
 
2.2.3 Cellular localization and spatial organization of the rRNA genes 
 
The rDNA locus constitutes the nucleolus, a subcompartment of the nucleus in which RNA Pol I 
transcription takes place. On electron microscopic images the nucleolus can be morphologically 
dissected into three categories, which are called fibrillar centers (FC), dense fibrillar centers (DFC) 
and the granular component (GC) (Schwarzacher & Wachtler 1993). The rDNA is located in the FCs 
which are found close to the nuclear envelope. They are surrounded by the DFCs which are 
constituted of the Pol I transcripts (Cmarko et al. 2000) hence suggesting that Pol I transcription 
occurs at the interphase between FCs and DFCs. The granular components eventually contain 
maturing pre-ribosomes (Léger-Silvestre et al. 1999). 
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Fig. 2-2: The electron micrograph depicts the morphology of a yeast nucleus after cryofixation and freeze-substitution. 
The nucleus is seen to be outlined by a double envelope with pores (asterisks). In the nucleolus, three distinct 
morphological compartments are identified: the fibrillar centres (FC) are detected near the nuclear envelope, surrounded 
by a dense fibrillar component (DFC) that extends as a network throughout the nucleolar volume. A granular component 
(GC) is dispersed throughout the rest of the nucleolus. Bar represents 200nm. (from Léger-Silvestre et al., 1999) 
 
2.2.4 The only yeast Pol I target in vivo: The rDNA locus  
 
The rDNA locus in S. cerevisiae differs significantly from other genomic loci as it is present in an 
average of 150-200 copies per cell which are situated on the right arm of chromosome XII. This 
number is not fixed but variable due to recombination events in the cell. One rDNA copy was defined 
as the SmaI restriction fragment of the locus (Cramer et al. 1977; Cramer & Rownd 1980). The copies 
are arranged as repetitive tandem elements with a length of 9.1kb each in a head to tail 
conformation (Petes 1979). Each repeat harbours the Pol I-transcribed 35S rDNA gene and the 5S 
rDNA gene which is transcribed in the opposite direction by Pol III (Philippsen et al. 1978). Only about 
50% of the rDNA copies are transcriptionally active and thus nucleosome depleted (open), whereas 
the other half is assembled into nucleosomes and transcriptionally inactive (closed) (Dammann et al. 
1993). The 35S rDNA contains the sequences for the mature 18S, 5.8S and 25S rRNAs separated by 
the internal transcribed spacers 1 and 2 (ITS 1 & 2) (Kressler et al. 1999). Two external transcribed 
spacers (ETS 1 & 2) flank the 35S rDNA at the 5’ and 3’ end. Two rDNA regions were described to be 
involved in regulation of 35S rRNA transcription, the Pol I promoter (2.3.1) and the enhancer / 
terminator region (2.3.3). Originally declared as an enhancer for the next downstream 35S gene 
(Elion & Warner 1986), it was demonstrated to be dispensable for rDNA transcription in vivo (Wai et 
al. 2001) and implicated in Pol I termination (Lang et al. 1994; van der Sande et al. 1989). Several 
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other cis-regulatory elements are present in the two intergenic spacers (IGS1 & 2). Among those is an 
autonomous replication sequence (rARS) from which bi-directional replication of the locus is started 
during s-phase (Linskens & Huberman 1988). This enables the possibility of simultaneous 
transcription and replication. A replication fork barrier (RFB) is located at the 3’ end of the terminator 
region which prevents collisions between the replication and the transcription machineries. The 
replication fork can progress through the RFB towards the 35S rDNA but not in the opposite direction 
(Brewer & Fangman 1988; Brewer et al. 1992; Kobayashi et al. 1992). The RFB provides a binding 
platform for the replication fork binding protein Fob1, which is required for RFB activity (Kobayashi & 
Horiuchi 1996). Recent studies revealed two binding sites for Fob1 named RFB1 and 3. A model of 
Fob1 binding proposes that the RFB is wrapped around Fob1 and thereby contacting both binding 
sites (Kobayashi 2003). Furthermore, Fob1 plays a role in expansion and compaction of the rDNA 
locus which is achieved by homologous recombination. 
 
Figure 2-3: Schematic representation of the rRNA gene locus of S. cerevisiae. The position of the rDNA repeat cluster on 
chromosome XII with respect to the centromere (CEN) and telomeres (T) is shown. Each 9.1kb large rDNA repeat consists of 
the Pol I-transcribed 35S rRNA gene (precursor for the 18S, 5.8S and 25S rRNAs), the RNA Pol III-transcribed 5S rRNA gene 
and two intergenic spacer regions IGS1 and IGS2. Arrows mark transcription start sites and direction. The positions of 
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several DNA elements are indicated. The upstream element (UE) and core element (CE) constitute the Pol I promoter (P). 
Termination occurs at the terminator (T) which is located within a region called the enhancer (E). The autonomous 
replication sequence (ARS), the bidirectional Pol II promoter E-Pro and the replication fork barrier (RFB) are depicted. 
(modified from Goetze et al., 2010) 
Recombination events require double strand breaks which are induced by pausing of the DNA 
replication machinery (Burkhalter & Sogo 2004; Kobayashi et al. 1998). Deletion of Fob1 leads to a 
50% reduction of rDNA copies (Kobayashi et al. 1998). Another region required for repeat expansion 
(EXP) is located further downstream but in close proximity to the RFB (Kobayashi et al. 2001). It 
contains a bi-directional Pol II promoter (E-Pro) which marks the transcription start for non-coding 
RNAs (Ganley et al. 2005). It is suggested that these non-coding transcripts interfere with cohesin 
association to the rDNA locus during mitosis. Since cohesin association is believed to facilitate sister 
chromatid fixation and thus prevention of crossovers and dissimilar recombination events, cohesin 
loss may lead to changes in rDNA repeat number (Kobayashi & Ganley 2005; Kobayashi et al. 2004). 
 
 
2.3  The transcriptional cycles of yeast RNA Pol I, II and III 
 
Studies on eukaryotic transcription were carried out in many model organisms. As chapter 2.3 
focuses on yeast RNA polymerases, mostly data from this organism are reviewed. However, in case 
of homologous factors in yeast and higher eukaryotes, also results obtained from such studies were 
included to support the yeast data or to provide ideas how respective homologous factors could 
function in yeast. 
 
 
2.3.1 Transcription initiation 
 
A) Pol I 
 
The Pol I promoter is located upstream of the 35S rDNA gene and consists of the core element (CE) 
and the upstream element (UE). CE is located between position -28 and +8 with respect to the TSS 
whereas UE spans from -146 to -51 (Kulkens et al. 1991; Musters et al. 1989). It was demonstrated 
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that CE is essential for initiation and sufficient for a basal transcription level, whereas elevated levels 
of transcription require UE (Keener et al. 1998; Musters et al. 1989; Steffan et al. 1998). Upon 
transcription initiation, both CE and UE are recognized and bound by the respectively named core 
factor (CF) (Keys et al. 1994; Lalo et al. 1996) and upstream activating factor (UAF) (Keys et al. 1996). 
Together with TBP and Rrn3 they comprise the four described Pol I initiation factors. CF is a 
multiprotein complex consisting of the three subunits Rrn6, Rrn7 and Rrn11 (Keys et al. 1994; Lalo et 
al. 1996). UAF is comprised of the six proteins Rrn5, Rrn9, Rrn10, Uaf30 and the histones H3 and H4 
(Keener et al. 1997; Keys et al. 1996; Siddiqi et al. 2001). Recruitment of UAF to UE is mediated by 
subunit Uaf30 (Steffan et al. 1998; Hontz et al. 2008; Goetze et al. 2010). UAF seems to function as a 
key player in rDNA transcription since its deletion results in reorganization of the promoter 
chromatin (Goetze et al. 2010). It was demonstrated that deletion of Rrn5, Rrn9 or Rrn11 prevents 
Pol I transcription of the 35S rDNA which is then performed by Pol II from a cyptic promoter situated 
in the UE (Vu et al. 1999). Additionally, in a uaf30 ∆ strain, the 35S rDNA is transcribed by Pol I and II. 
Furthermore, UAF plays a role in Sir2-mediated rDNA silencing since it could be shown that Uaf30 is 
required for Sir2 recruitment (Goetze et al. 2010; Bryk et al. 1997; Cesarini et al. 2010; Fritze et al. 
1997; Smith & Boeke 1997). It was shown that TBP binds to UAF and CF in vitro, thus suggesting a 
bridging function (Steffan et al. 1996). The fourth initiation factor Rrn3 interacts directly with the Pol 
I subunit A43 independently of the template and with the CF subunit Rrn6 (Yamamoto et al. 1996; 
Peyroche et al. 2000). Only about 2% of the Pol I complexes are associated with Rrn3 in vivo and thus 
in an initiation-competent state (Milkereit & Tschochner 1998). Currently, two models for 
transcription initiation are under discussion. Since it was demonstrated that UAF stably associates 
with the UE (Vogelauer et al. 1998), it is accepted that PIC formation starts with binding of UAF. Next, 
TBP binds to UAF and stabilizes the CF-DNA interaction or recruits CF to the DNA to complete the PIC. 
However it remains unclear, whether UAF, CF and TBP remain stably associated with the promoter 
DNA (Keys et al. 1996) or whether CF and the Pol I-Rrn3 complex re-initiate to start a new 
transcription cycle (Aprikian et al. 2001; Bordi et al. 2001). Recent data further support the hierarchy 
of events suggested by Keys and co-workers (Goetze et al. 2010). In both models, finally Pol I-Rrn3 is 
recruited to the PIC. Interestingly Rrn3 is dispensable for Pol I recruitment but the resulting complex 
is not transcriptionally active (Aprikian et al. 2001). Furthermore, the two subunits A49 and A34.5 
seem to exhibit an influence on Rrn3 recruitment to the promoter and its dissociation from the 
polymerase upon transition to elongation and are required for high Pol I loading rates (Beckouet et 
al. 2008; Albert et al. 2011). 
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B) Pol II 
 
Due to the multiplicity of Pol II-transcribed genes, many variants of Pol II promoters exist. In general, 
the regulatory DNA elements can be divided into two fractions: The core promoter which is 
necessary for basal levels of transcription in vitro and PIC assembly (Smale & Kadonaga 2003) and 
upstream activating (UAS) or repressing sequences (URS) located 5’ of the core promoter in yeast 
(Errede et al. 1984; Mellor 2006; Gray & Fassler 1996). A variety of functional sequence elements is 
known from metazoan Pol II core promoters of which the TATA element is the only clearly conserved 
one in yeast (Sugihara et al. 2011; Basehoar et al. 2004). Several general Pol II transcription factors 
exist in yeast, of which TBP, TFIIA, TFIIB and TFIIF are required for formation and stabilization of the 
PIC on the core promoter. However the designation of TFIIA as a general transcription factor is 
currently under discussion (Høiby et al. 2007). It is generally accepted that PIC formation is nucleated 
by recruitment of TBP to the core promoter. The TBP-TATA complex is then recognized by TFIIB. A 
further main function of TFIIB is to position Pol II correctly over the TSS (Kostrewa et al. 2009; Miller 
& Hahn 2006; Hahn 2004; Thomas & Chiang 2006). The TFIIB-TBP-TATA complex then serves as a 
platform which is recognized by the Pol II-TFIIF complex. It was demonstrated that TFIIF functions in 
stabilization of Pol II in the PIC, selection of the TSS and stabilization of the RNA-DNA hybrid in early 
steps of transcription (Hahn 2004; Thomas & Chiang 2006). Open complex formation requires the 
ATPase and helicase activity of TFIIH which is recruited by TFIIE (Revyakin et al. 2004; Schaeffer et al. 
1993; Schaeffer et al. 1994; Flores et al. 1992). 
Pol II transcription initiation in yeast is regulated to great extent by transcription coactivators as the 
multiprotein complexes SAGA, TFIID, Mediator, NuA4 and at least 169 transcription factors (Teixeira 
et al. 2006; reviewed in Hahn & Young 2011). Roughly 90% of yeast Pol II promoters are TFIID-
dependent and it is speculated that TFIID recognition sites are present in the respective promoters 
(Shen et al. 2003; Huisinga & Pugh 2004). TFIID-dependent promoters were found to be normally 
constitutively active and did not contain the TATA element. TATA-containing promoters (19% of all 
yeast Pol II promoters) on the other hand are partially (50%) dependent on the transcription 
activator SAGA (Huisinga & Pugh 2004). TFIID is composed of TBP and several TBP activating factors 
(TAFs). TBP delivery by SAGA is controlled by its subunits Spt3, Spt8 and TAFIIS (Belotserkovskaya et 
al. 2000). Besides the core initiation mechanism, TFIID and SAGA are transcription coactivators 
necessary for initiation at gene-class specific promoters (Vannini & Cramer 2012). In these gene-
specific pathways, either TFIID or SAGA contact the UAS via interaction of the activating factors  and 
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hence help to recruit TBP to the core promoter (Kuras et al. 2000; Bryant & Ptashne 2003; Qiu et al. 
2004; Li et al. 2000). 
 
C) Pol III 
 
Pol III promoters are fundamentally different from their Pol I and Pol II counterparts as some of their 
functional elements are located within the transcribed regions. Among others, there are two major 
sorts of Pol III promoters named type 1 and type 2 in yeast. Typically, tRNA genes contain type 2 
promoters which are comprised of two cis elements called A and B boxes, which are located 12-20bp 
or 42-80bp downstream of the TSS, respectively (Dieci et al. 2002; Marck et al. 2006; Sharp et al. 
1985; Pavesi et al. 1994). The type 1 promoter occurs at the 5S rRNA gene and is composed of the A 
box, an intermediate element and a C box (Challice & Segall 1989). Type 2 promoters are directly 
recognized by the transcription factor IIIC. Contrary, at type 1 promoters the C-box is first bound by 
TFIIIA which subsequently recruits TFIIIC. At both promoter types, the TBP-containing transcription 
factor IIIB (Hernandez 1993) is recruited next to a region located roughly 50bp upstream of the TSS 
(Geiduschek & Kassavetis 2001). In yeast and plants, TATA elements were identified in the region of 
TFIIIB recruitment, thus establishing them as promoter core elements (Dieci et al. 2000; Yukawa et al. 
2000; Hamada et al. 2001). Once it was recruited, TFIIIB serves as a platform for Pol III association 
and thus PIC formation. In TATA-containing promoters, the TSS is located 28-30bp downstream of 
the 5’ end of the TATA element (Joazeiro et al. 1996; Dieci et al. 2006). 
 
 
2.3.2 Transcription elongation 
 
A) Pol I 
 
Until recently, elongation of Pol I was poorly studied and still our knowledge is very limited (reviewed 
in Schneider 2012). However, evidence is emanating linking the elongation step with overall control 
of the rRNA synthesis rate and rRNA processing (Schneider et al. 2007; V. Stefanovsky et al. 2006; Y. 
Zhang et al. 2010; Koš & Tollervey 2010; Osheim et al. 2004; Dragon et al. 2002). Recent studies 
suggested that the subunit A12.2 and the A49/A34.5 dimer were providing Pol I with an intrinsic 
ability to overcome elongation obstacles (Kuhn et al. 2007; Geiger et al. 2010). It was demonstrated 
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that Pol I is able to cleave the nascent transcript in an arrested elongation complex. This cleavage 
activity is promoted by subunit A12.2 (Kuhn et al. 2007) which allows Pol I to escape from an arrest 
on its own. Concerning A49 and A34.5, determination of crystal structures revealed that parts of 
subunit A49 and A34.5 are homologous to the Pol II elongation factor TFIIF subunits Tfg1 and 2 
(Geiger et al. 2010). As TFIIF was (amongst other functions) characterized as an elongation factor for 
Pol II (Conaway et al. 2000; Dvir et al. 2001) in vitro and in vivo, a similar role for A49 and A34.5 was 
suggested. Both subunits are not essential, but absence or mutations lead to severe growth defects 
(Liljelund et al. 1992; Gadal et al. 1997). Polymerases lacking the dimer were shown to be less 
elongation competent than WT Pol I in vitro and this effect could be rescued by addition of 
recombinant A49 (Kuhn et al. 2007). Although not involved in clearing of barriers during elongation, 
it was reported that the aspartate residue 784 in subunit A135 was crucial for optimal elongation 
rates in vivo and in vitro (Schneider et al. 2007). D784 is located in the funnel and thus might play a 
role in NTP loading. When D784 is substituted for glycine, the Pol I elongation rate in vitro was shown 
to be reduced 10-fold compared to the WT (Schneider et al. 2007). 
Apart from its intrinsic capabilities to deal with elongation barriers, several trans-acting elongation 
factors have been described for Pol I. Early on, it was demonstrated that the Spt4/Spt5 heterodimer 
influences Pol II transcription (Wada et al. 1998; Swanson & Winston 1992). In yeast, Spt4 and Spt5 
can be co-purified with Pol I (Schneider et al. 2006). Whereas Spt5 is an essential gene, a ∆spt4 
mutant exhibits a Pol I elongation aberration (Schneider et al. 2006) manifesting itself in increased 
rRNA levels. Thus it was concluded that Spt4 and Spt5 are negative regulators of Pol I transcription 
elongation. Contrary to these observations, there is evidence that Spt4 and Spt5 positively influence 
Pol I elongation (Anderson et al. 2011). In a comparative approach, binding of Spt5 to Pol I and Pol II 
was assessed in vitro (Viktorovskaya et al. 2011). It was shown that recombinantly expressed 
domains of Spt5 interacted with Pol II and Pol I subunits A135, A49 and A34.5. 
The Paf1 complex (Paf1C) is described as a positive trans-acting effector of Pol I transcription 
elongation (Mueller & Jaehning 2002; Squazzo et al. 2002; Zhang et al. 2009; A. P. P. Zhang et al. 
2010). It is comprised of five subunits (Mueller & Jaehning 2002), of which none is essential in yeast. 
However, ∆paf1 or ∆ctr9 mutants exhibit severe growth defects due to decreased levels of rRNA 
synthesis and negative effects on rRNA processing (Zhang et al. 2009). Nonetheless, the polymerase 
density on the 35S rDNA is equal to a WT strain. Direct interaction of Paf1C with an RNAP has only 
been documented for Pol II (Krogan et al. 2002; Mueller et al. 2004; Squazzo et al. 2002), however it 
was demonstrated that Paf1C is associated with the rDNA. A positive influence of Paf1C on Pol I 
elongation rates was demonstrated in vitro (Y. Zhang et al. 2010) and thus proposed in vivo. 
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The HMG-box protein UBF was described as a Pol I transcription factor. It exists in mammalian cells 
and its function was addressed by many studies. Since it has a homolog in yeast called Hmo1 (Gadal 
et al. 2002), some UBF functions will be discussed here. UBF was first described as a Pol I 
transcription activator in human cells (Jantzen et al. 1990). It was assigned a role in the initiation step 
and several studies proposed mechanistic explanations (Bell et al. 1988; Tuan et al. 1999; Kihm et al. 
1998; Kwon & Green 1994; Voit et al. 1992; McStay et al. 1991; Jantzen et al. 1990). However, recent 
publications have challenged this UBF function. In addition, it was demonstrated that UBF inhibits Pol 
I transcription in vivo and in vitro (V. Stefanovsky et al. 2006). However this negative effect was not 
due to decreased loading of Pol I onto the 45S rDNA and thus not an initiation defect. Hence, a role 
for UBF in elongation might be envisioned, which is supported by the fact that UBF is associated with 
the coding region of the 45S rDNA in mammals (O’Sullivan et al. 2002) and its homolog Hmo1 is 
associated with actively transcribed rDNA repeats in yeast (Merz et al. 2008). Two studies provided 
different explanations for the role of UBF. In (V. Y. Stefanovsky et al. 2006) it was suggested that 
association of UBF with the rDNA leads to a nucleosome-like structure which is influential on 
elongating Pol I. On the other hand, it was proposed that UBF increases the promoter clearance rate 
of Pol I in vitro. In yeast, it was demonstrated that Hmo1 is required for regulation of ribosomal 
protein transcription via the TOR pathway (Berger et al. 2007). Furthermore, it was shown that Hmo1 
is stabilizing the nucleosome-free state of the 35S rDNA which may help to maintain a nucleosome-
depleted chromatin environment for elongating Pol I (Wittner et al. 2011). Thus, there is significant 
evidence that UBF and Hmo1 play a crucial role in chromatin structure formation or maintenance, 
however the actual mechanism remains elusive. 
 
B) Pol II 
 
Besides its function in Pol II initiation, TFIIF stimulates Pol II elongation rates and decreases 
elongation pausing (Flores et al. 1989; Price et al. 1989; Bengal et al. 1991; Izban & Luse 1992; Tan et 
al. 1994). ChIP assays have documented that TFIIF is localized predominantly near the promoter 
region (Krogan et al. 2002; Pokholok et al. 2002). Mechanistically it was proposed that TFIIF 
recognizes paused elongation complexes, re-associates with them and alters Pol II conformation to a 
elongation-competent state (Zawel et al. 1995). However, TFIIF does not stay associated with 
elongating Pol II. Furthermore, TFIIF is directly interacting with the elongation factors Spt5 
(Lindstrom et al. 2003), components of the Paf1C (Shi et al. 1997) and influences TFIIS-mediated RNA 
cleavage (Elmendorf et al. 2001; Zhang et al. 2003). 
32  CHAPTER II – INTRODUCTION 
__________________________________________________________________________________ 
Upon transcriptional arrest triggered by polymerase pausing and subsequent backtracking, TFIIS 
enables further Pol II readthrough by promoting cleavage of the nascent RNA (Fish & Kane 2002; 
Conaway et al. 2003). In general, TFIIS reduces Pol II pausing and thus stimulates transcription 
elongation (Rappaport et al. 1987; Reinberg & Roeder 1987; Sluder et al. 1989; Bengal et al. 1991). It 
was demonstrated that TFIIS enhances the intrinsic RNA cleavage activity of Pol II (Rudd et al. 1994; 
Orlova et al. 1995) although the exact mechanism remains unknown. Recent structural studies of a 
Pol II-TFIIS complex revealed significant changes in Pol II conformation upon binding of TFIIS 
(Kettenberger et al. 2003). The structure supports the assumption that the nascent RNA and the DNA 
template are re-aligned correctly and Pol II conformation changes to an elongation mode. 
Another factor influencing Pol II transcription elongation is the DSIF (DRB sensitivity inducing factor) 
complex. It was named after its ability to make an in vitro transcription reaction susceptible to DRB 
(5,6-dichloro-1-β-D-ribofuranosylbenzimidazole) (Wada et al. 1998). DSIF is a heterodimeric complex 
consisting of the human homologs of yeast Spt4 and 5. First designated as an inhibitory effector of 
Pol II transcription (Wada et al. 1998), DSIF was later described as an elongation stimulator 
(Yamaguchi et al. 1999). In vitro transcription studies revealed that hSpt4 alone has a stimulatory 
effect on elongation (Rondón et al. 2004). Furthermore, genetic and physical interactions of DSIF 
with TFIIS, Paf1C, Spt6 and Pol II were demonstrated (reviewed in Sims et al. 2004). 
Like for Pol I, Paf1C was shown to positively effect Pol II elongation (Rondón et al. 2004). Additionally, 
Pol II transcription elongation depends on the phosphorylation state of the polymerase CTD 
(reviewed in Sims et al. 2004; Saunders et al. 2006). Apart from trans-acting factors which influence 
polymerase fidelity and processivity, elongation is also regulated at the chromatin template level 
(2.4).  
Besides the discussed examples, a vast amount of Pol II elongation factors was identified in mammals 
(reviewed in Sims et al. 2004; Saunders et al. 2006). Among those are NELF, CSB, P-TEFb, ELL, the 
elongins and many others which are outside the scope of this study. 
 
 
C) Pol III 
 
Concerning trans-acting Pol III elongation factors, no data are available so far. The only exception is 
concerning how Pol III handles nucleosomal templates which will be discussed later. Nonetheless, the 
structural homology of Pol III subunits to Pol II transcription factors (2.2.2) led to the hypothesis that 
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Pol III is permanently associated with some of its transcription factors (Carter & Drouin 2010). In 
analogy to the Pol II situation, subunit C11, the partial structural homolog to TFIIS was reported to 
promote transcript cleavage during transcriptional arrest (Chédin et al. 1998). 
 
 
2.3.3 Transcription termination 
 
A) Pol I (reviewed in Nemeth et al. 2013) 
 
In yeast, the intergenic spacer 1 (IGS1) of an rDNA repeat (2.2.4) harbors the Pol I termination region 
which was previously described as an enhancer for Pol I transcription (Elion & Warner 1986). In the 
early 1990s, a minimal model that supported Pol I transcription termination in vitro was established 
in the Reeder laboratory. The system was based on an initiation-independent approach using tailed 
templates (Dedrick & Chamberlin 1985; Kane & Chamberlin 1985). For efficient termination, purified 
Pol I, the DNA-binding protein Reb1 and a template containing the 11bp long Reb1 binding site (Reb1 
BS) and the 10-15bp long T-rich stretch located 10-20bp upstream of the Reb1 BS were required 
(Lang et al. 1994; Lang & Reeder 1995; Reeder & Lang 1994). Mechanistically, it was proposed that 
Pol I is paused by Reb1 and in cooperation with the T-rich stretch destabilizes the elongation 
complex. Taken together this leads to transcript and polymerase release from the template. 
However, the termination efficiency in vitro was rather low (70%-20%). In vivo, the role of Reb1 is 
less well defined. It was demonstrated that Reb1 is also associated with a number of regulatory 
regions upstream of Pol II transcribed genes (Ju et al. 1990; Morrow et al. 1993; Pinskaya et al. 2009). 
Since Reb1 is an essential protein in yeast, only depletion studies could be carried out, of which none 
revealed significant influences on Pol I termination (Braglia et al. 2011; Kawauchi et al. 2008). 
Interestingly, Reb1 association to its binding site in the terminator region could not be observed in 
vivo above background levels (Kawauchi et al. 2008; Goetze et al. 2010; Reiter et al. 2012). 
Concerning the cis-elements, it was demonstrated that the Reb1 binding site and the T-rich stretch 
were required for efficient termination in vivo (Reeder et al. 1999). In a recent study, a homolog of 
Reb1 was shown to interact with the terminator-proximal Reb1 BS in vivo (Reiter et al. 2012). It 
contains three Myb-like DNA-binding domains as Reb1 and was named Nsi1 (NTS1 silencing protein) 
according to its described function in nucleolar Pol II silencing (Ha et al. 2012). Furthermore, Fob1, 
which is associated with the replication fork barrier (RFB) was shown to support Pol I termination 
(Braglia et al. 2011). Apart from that, further factors involved in co-transcriptional rRNA processing 
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were assigned roles in Pol I termination in vivo. Among those are the 5’-> 3’ exonuclease Rat1, the 
RNase III-like endonuclease Rnt1, the helicase Sen1 and the polynucleotide kinase Grc3 (Elela et al. 
1996; Braglia et al. 2011; Braglia et al. 2010; Kawauchi et al. 2008; El Hage et al. 2008). Additionally, 
nucleosome remodeling factors like Chd1, Isw1 and Isw2 were discussed as influential on Pol I 
termination (Jones et al. 2007).  
Currently, two mechanisms of Pol I transcription termination are discussed. The first model 
originates from the in vitro analyses by the Reeder group as outlined above. A DNA-bound trans-
acting factor induces polymerase pausing and cooperates with the upstream T-rich element thus 
promoting release of transcript and polymerase. This model is supported by a recent publication 
(Reiter et al. 2012) in which a novel in vivo system to assess transcription termination was 
established. In this approach, all rDNA repeats were modified such that the Pol I terminator region 
spanning from the T-rich element to the RFB (322bp) was inserted into the internal transcribed 
spacer 1 (ITS1) between 18S and 5.8S rDNA. This resulted in a reduced growth phenotype due to 
premature termination. It was demonstrated that Pol I occupancy was lower downstream of the 
ITS1. Efficient termination was dependent on presence of Nsi1 and further supported by the T-rich 
element. 
On the other hand, it was proposed that co-transcriptional rRNA processing and 35S rRNA 3’ end 
formation is directly linked to Pol I termination (Braglia et al. 2011; Kawauchi et al. 2008; El Hage et 
al. 2008). It was demonstrated that deletion of Rnt1, Rat1, Sen1 or Grc3 gives rise to Pol I transcripts 
which are extended into the IGS1. Mutations in Rat1 or Sen1 lead to enhanced Pol I occupancy 
downstream or the terminator region as assayed by ChIP. All the above factors were shown to be 
associated with the terminator region (Braglia et al. 2010; Braglia et al. 2011; Kawauchi et al. 2008; El 
Hage et al. 2008). In summary this led to a hypothesis similar to the described torpedo model for Pol 
II. In a first and well understood step, the RNaseIII-like endonuclease cleaves the nascent 35S rRNA at 
a stem-loop structure in the ETS2 (Elela et al. 1996; Allmang & Tollervey 1998; Henras et al. 2004; 
Kufel et al. 1999). It was proposed that the resulting 5’ end is a target for the polynucleotide kinase 
Grc3, however the actual mechanism remains elusive. The phosphorylated 5’ end then is recognized 
by the exonuclease Rat1 and subsequently degraded in cooperation with the helicase Sen1. When 
Rat1 reaches the elongating polymerase, it is proposed to act like a torpedo and disrupt the Pol I-
RNA-DNA ternary complex. According to the model, the complexed Reb1 BS serves as a pausing or 
speed reducing element to allow Rat1 to catch up with the polymerase (Reeder et al. 1999; Braglia et 
al. 2011). Moreover, the Reb1 BS was proclaimed being part of a failsafe termination mechanism in 
case of deletion of Rnt1 or the Rnt1 cleavage site (Braglia et al. 2011). In this putative secondary way, 
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the RNA is cleaved at the T-rich stretch by an unknown endonuclease hence forming an alternative 5’ 
RNA end recognized by Rat1 (Braglia et al. 2011). 
 
Fig. 2-4: Two models for yeast RNA Pol I termination. (A) Model of yeast Pol I termination in vitro. Transcription in vitro can 
be efficiently terminated by purified Pol I in the presence of purified DNA-bound Reb1, and a T-rich element upstream of 
the Reb1 binding site. A promoter-independent transcription assay is used. (B) Model of yeast Pol I termination in vivo. Pol I 
transcription termination in vivo is accompanied/supported by processing of the nascent transcript. Factors which were 
suggested to be involved in pre-rRNA processing and termination are the endo- and exonuclease Rnt1 and Rat1, the 
helicase Sen1 and the RNA/DNA kinase Grc3. Factors required for efficient termination which interact with cis elements of 
the termination region are the NTS1-silencing protein Nsi1 and the replication fork barrier binding protein Fob1. Possible 
mechanisms of termination and consequences of leaky termination are discussed in the text. Note: a reduced level of 
premature termination can be observed, if the termination element without the described co-transcriptional cleavage sites 
(Rnt1 and T1) is inserted within ITS1. (Németh et al. 2013) 
However, many questions remain concerning which mechanism is happening in vivo or if elements of 
both models can be fit into one. Furthermore, none of the models provides a satisfying explanation 
for the apparent leakiness of Pol I termination. Both in vitro (70%) and in vivo (80%) termination 
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efficiencies below 100% were observed at the main terminator (T-rich and Reb1 BS) (Lang et al. 1994; 
Reeder et al. 1999). Studies using an artificial construct containing the promoter-proximal Reb1 BS 
which has a stronger affinity to Reb1 resulted in a minimal readthrough of 10% (Reeder et al. 1999). 
Those transcripts were further elongated until a second T-rich stretch (T2, also named a failsafe 
terminator) located roughly 250bp downstream of the 3’ end of the 25S rDNA or until the RFB 
(~300bp downstream of 25S) (Reeder et al. 1999; El Hage et al. 2008; Prescott et al. 2004). 
In mouse, the Pol I terminator region is also located in the 5’ part of the IGS1 but differs significantly 
from its yeast counterpart. It contains 10 repetitions of the actual terminator element, of which each 
is a binding site for TTF-I (Gurney 1985; Grummt et al. 1985). A mouse terminator element was 
defined as an 18bp sequence containing a restriction site for SalI and thus named Sal box (Grummt, 
Rosenbauer, et al. 1986). TTF-I (transcription termination factor 1) can be roughly dissected in three 
functional parts (Evers et al. 1995; Evers & Grummt 1995). Whereas the N-terminal section inhibits 
DNA binding and is involved in TTF-I oligomerization, the C-terminal part harbours two Myb-like 
domains which mediate DNA binding activity. The central part is promoting transcription 
termination. Pol I termination occurs just upstream of the first terminator element (T1) and is 
dependent on TTF-I (Gurney 1985; Grummt et al. 1985). Mutations in the terminator element which 
inhibit binding of TTF-I negatively influence transcription termination (Grummt, Kuhn, et al. 1986; 
Kermekchiev & Grummt 1987; Grummt, Rosenbauer, et al. 1986; Bartsch et al. 1988). Transcription 
termination by TTF-I depends on correct orientation of the terminator element (Smid et al. 1992; 
Kuhn et al. 1990; Grummt, Rosenbauer, et al. 1986). As in yeast, a T-rich stretch is located upstream 
of T1, however it was shown not to be required for efficient termination (Kuhn et al. 1988). 
Mechanistically, it is suggested that Pol I is stopped when encountering a bent DNA structure due to 
TTF-I (Smid et al. 1992). The Pol I transcript release factor (PTRF) subsequently promotes the 
dissociation of the ternary complex via direct interaction with Pol I (Mason et al. 1997; Jansa et al. 
1998; Jansa et al. 2001). There has been no evidence for a torpedo-like Pol I termination mechanism 
in higher eukaryotes. Furthermore, it is not clear, how 3’ end formation of the 45S rRNA occurs and if 
it is linked to termination (Parker & Bond 1989; Miwa et al. 1987). It has been further suggested that 
oligomerization of TTF-I leads to bridging between terminator (T1 – T10) and promoter (T0) and thus 
establishment of an rDNA loop at actively transcribed repeats (Sander & Grummt 1997; Denissov et 
al. 2011). 
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B) Pol II 
 
For Pol II, a poly-A site (PAS) dependent and a Sen1 dependent pathway were described as the two 
major mechanisms of termination (reviewed in Kuehner et al. 2011; Mischo & Proudfoot 2013). It is 
proposed that termination at most protein-coding genes follows the poly-A way. This process is 
tightly coupled to 3’ end formation of the nascent mRNA and can be dissected in two steps. After 
transcription of the poly-A site, Pol II is stalled and the nascent RNA is cleaved by an endonuclease. 
Next, the pre-mRNA gets polyadenylated and the downstream RNA is degraded (Logan et al. 1987; 
Whitelaw & Proudfoot 1986). Creation and processing of the 3’ end of the pre-mRNA is highly 
complex and involves about 20 proteins in yeast (Mandel et al. 2008; Millevoi & Vagner 2010). 
Hereby, the Rpb1 CTD serves as an anchor for the recruitment of the first processing factors. It is 
suggested that factor binding leads to conformational changes which in turn trigger polymerase 
pausing. Subsequently, a paused state of Pol II is necessary for further association of processing 
factors and termination stimulation (Glover-Cutter et al. 2008). Two main effectors in this pathway 
are the multiprotein complexes cleavage and polyadenylation factor (CPF) and the cleavage factor 
(CF) which bind to the nascent RNA when the poly-A site (PAS) has been transcribed. In yeast, the 
PAS consists of an adenine-rich efficiency element, an A-rich positioning element and a U-rich 
element spanning the actual cleavage site (Guo & Sherman 1996; Bardwell et al. 1991; Dichtl & Keller 
2001; Zaret & Sherman 1982; Valentini et al. 1999). Subcomponents of both CPF and CF interact with 
the Pol II CTD and subsequently promote cleavage of the nascent RNA. Nonetheless, it was proposed 
that efficient release of Pol II from the template requires Rat1 which recognizes the new 5’ end and 
torpedoes Pol II as outlined for Pol I (Teixeira et al. 2004; Ghazal et al. 2009; Rondón et al. 2009; 
Nabavi & Nazar 2010). However, it was demonstrated that Rat1 –promoted degradation of the RNA 
was not sufficient by itself for polymerase release in vitro (Dengl & Cramer 2009).  
For most non-coding RNAs transcribed by Pol II, 3’ end formation occurs via endonuclease cleavage 
and/or via action of the exosome-TRAMP complex (Houseley & Tollervey 2009). The three main 
factors involved in this pathway are the helicase Sen1 and the RNA binding proteins Nrd1 and Nab3 
(Kim et al. 1999; Steinmetz & Brow 1996; Steinmetz et al. 2001; Steinmetz et al. 2006). The exact 
mechanism remains unknown but it is proposed that interaction of the three factors with the Rpb1 
CTD leads to conformational changes in Pol II which facilitate termination (Carroll et al. 2007). 
Instead of Rat1 which torpedoes the polymerase, the actual termination event is postulated to occur 
as Sen1 unwinds the RNA-DNA hybrid. 
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C) Pol III 
 
RNA Pol III transcription is terminated after synthesis of a poly-U stretch, corresponding to a poly-T 
sequence on the non-template DNA strand (Matsuzaki et al. 1994; Bogenhagen & Brown 1981). It 
was proposed that no other trans-acting factors or RNA secondary structures were involved in Pol III 
termination. The actual mechanism remained unclear, however it was suggested that the weak A-U 
basepairing thermodynamically destabilizes the RNA-DNA hybrid and thus leads to RNA and DNA 
release (Yager & Von Hippel 1991). A very recent study challenged this hypothesis (Nielsen et al. 
2013). Nielsen and co-workers demonstrated that transcription of an immobilized artificial template 
containing a poly-T stretch resulted in RNAs that remained associated with the elongation complex. 
They concluded that the T-stretch rather served as a pausing signal for Pol III than a release element. 
From this, the hypothesis was established that an RNA secondary structure like a hairpin in close 
proximity to the poly-T stretch was involved in transcript release in analogy to bacterial transcription 
termination. However, termination mechanisms like forward translocation (Santangelo & Roberts 
2004) and RNA-DNA shearing could be excluded (Larson et al. 2008). It is proposed, that termination 
occurs via allosteric destruction of the Pol III elongation complex by the hairpin formation (Epshtein 
et al. 2007). 
Pol III transcription termination is also influenced by polymerase subunits. For the TFIIF and 
A49/A34.5 – homolog C53/C37 a role in slowing down Pol III on the T-stretch of the SUP4 tRNA gene 
was reported (Landrieux et al. 2006). The TFIIS-like domain of subunit C11 promotes intrinsic RNA 
cleavage by Pol III that occurs during elongation pausing, proofreading, and termination (Rijal & 
Maraia 2013; Alic et al. 2007; Iben et al. 2011). In a recent study, two separate mechanisms for Pol III 
transcription termination were proposed, depending on the subunit composition of the enzyme 
(Arimbasseri & Maraia 2013). However, the actual mechanistic contribution of C53, C37 and C11 are 
still not sufficiently clarified.  
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2.4  Transcription of nucleosomal templates by Pol I, II and III 
 
The natural template of RNA polymerases is not naked DNA but chromatin, a complex assembly of 
DNA, associated proteins and non-coding RNAs. The main structural unit of chromatin, most 
abundant component and first level of DNA compaction is the nucleosome. Core nucleosomes are 
comprised of two histones H2A, H2B, H3 and H4 each (Kornberg 1974; Kornberg & Thomas 1974). 
The nucleosomal proteins are arranged in two substructural complexes, a (H3/H4)2 central tetramer 
surrounded by two H2A/H2B dimers. In yeast, 147bp of DNA are wrapped around the histone 
octamer in 1.65 turns. The DNA-histone complex is stabilized by hydrogen bonds, hydrophobic and 
ionic interactions. Chromatin structure is highly dynamic and its conformational changes are coupled 
to the cell cycle and processes like transcription. Concerning transcription, it is believed that the 
three RNA polymerases encounter different chromatin states at their target genes in vivo.  
 
Fig. 2-5: The atomic structure of the nucleosome core particle. 147 bp of DNA (colored in different shades of blue) are 
wrapped around the histone octamer in 1.7 turns. The histone octamer is composed of two copies of each histone H2A 
(red), H2B (pink), H3 (green) and H4 (yellow) and forms the nucleosome core particle. Histone tails protrude from the 
nucleosome core particle (modified from Khorasanizadeh 2004) 
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A) Pol I 
 
Early biochemical studies suggested that transcriptionally active rDNA repeats are associated with 
nucleosomes (Matsui & Busch 1977; Higashinakagawa et al. 1977; Weintraub & Groudine 1976). 
However, data obtained by EM analysis of chromatin Miller spreads (Miller & Beatty 1969) showed 
that transcribed rDNA repeats were depleted of nucleosomes. Furthermore, the mentioned study 
revealed the existence of two distinct chromatin states, with 50% of the repeats being 
transcriptionally active (open) and 50% being silenced (closed). It was demonstrated that 
transcriptional activity correlated with distinct chromatin states by psoralen photocrosslinking 
(Conconi et al. 1989). rDNA which was relatively resistant to psoralen crosslinking and representing 
the inactive state was shown to be associated with nucleosomes. Contrary, heavily psoralen 
crosslinked repeats were lacking nucleosomal arrays and associated with nascent RNA (Dammann et 
al. 1993). Combination of psoralen crosslinking with chromatin endogenous cleavage (ChEC) (Schmid 
et al. 2004) further revealed that open copies were minimally associated with histones (and thus 
putatively nucleosomes) but instead with Hmo1, whereas the opposite was true for closed copies 
(Merz et al. 2008). However, there is evidence for a dynamic nucleosomal arrangement in yeast 
(French et al. 2003). Active and inactive repeats in mammals can also be distinguished by different 
nucleosome positioning at the promoter (Längst et al. 1998), the DNA methylation pattern and the 
N-terminal histone tail modifications (Santoro et al. 2002; Németh et al. 2008). Little is known about 
how Pol I deals with a nucleosomal template. There are lines of evidence suggesting that chromatin 
transcription of mammalian Pol I requires the histone chaperones nucleolin and nucleophosmin 
(Angelov et al. 2006; Rickards et al. 2007; Okuwaki et al. 2001; Murano et al. 2008). Furthermore, it 
was demonstrated that nucleosome remodelers Chd1, Isw1 and Isw2 are associated with rDNA 
repeats (Jones et al. 2007). In a recent study, it was demonstrated that human Pol I was able to 
transcribe through a nucleosomal template in vitro with 10% efficiency compared to naked DNA 
(Birch et al. 2009). However, the histone chaperone FACT (facilitates chromatin transcription) was co-
purified with the polymerase. In vivo, FACT is was suggested to be associated with active rDNA genes 
and downregulation of FACT expression leads to reduced cellular rDNA levels (Birch et al. 2009). Thus 
it was proposed that FACT helps Pol I to overcome nucleosomal barriers in vivo. Nonetheless, the 
exact mechanism of chromatin transcription by Pol I remains unclear as well as the general necessity 
for it in closed copy opening. 
Futhermore, there is evidence that beyond Pol I transcription termination, TTF-I is also a key 
regulator regarding the epigenetic state of the rDNA locus in mouse and human (reviewed in 
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Grummt & Längst 2013). It was demonstrated that binding of TTF-I to a recognition site (T0) 
upstream of the Pol I promoter moderates nucleosome remodeling which is necessary for efficient 
rDNA transcription (Längst et al. 1998; Längst et al. 1997). Activation of transcription by TTF-I occurs 
via recruitment of the ATPase CSB (Cockayne Syndrome protein B) which in turn serves as an anchor 
for the histone methyltransferase G9a (Yuan et al. 2007). Additionally, TTF-I functions in rDNA 
silencing. It was shown that T0-bound TTF-I interacts with the NoRC (Nucleolar Remodeling Complex) 
subunit TIP5 (TTF-I interacting protein 5) (Németh et al. 2004). Subsequently, TIP5 directs DNA 
methyltransferases and histone deacetylases to the rDNA promoter and hence contributes to 
establishment of a heterochromatin state (Zhou et al. 2002; Santoro et al. 2002). It was suggested 
that NoRC function requires the association of TIP5 with a non-coding transcript named pRNA 
(promoter RNA) which is originating from a promoter situated in the IGS1 region (Tsp) (Mayer et al. 
2006; Santoro et al. 2010). Recent studies proposed that the pRNA forms a transient triplex structure 
with the T0 DNA which leads to dissociation of TTF-I and recruitment of the methyltransferase 
Dnmt3b (Schmitz et al. 2010). Methylation of a certain CpG residue by Dnmt3b in turn prevents 
initiation complex formation. 
 
Fig. 2-6: Electron micrographs of actively transcribed Pol I, II and III genes. (Pol I) Representative electron micrograph of 
one rDNA repeat after chromatin spreading. The long arrow indicates direction of Pol I transcription of the 35S rRNA gene. 
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The short arrow indicates the structure frequently seen at the position of the 5S rRNA gene. Bar represents 400nm (Pol II) 
Spreaded embryonic chromatin of D. melanogaster with protruding nascent transcripts of a non-ribosomal gene. Small dots 
along the DNA represent nucleosomes. Bar represents 1µm. (Pol III) Identification of active S. cerevisiae 5S rRNA genes in 
rDNA intergenic spacers. Elongated dot represents Pol III complexes. (all adapted from French et al. 2003; French et al. 
2008; Laird & Chooi 1976) 
 
B) Pol II 
 
Pol II transcription in the context of chromatin was addressed in genome-wide studies as well as 
single locus analyses. Genome-wide studies indicate that the average nucleosome density on the 
yeast chromosomes is relatively constant with a median spacing of 23bp (Yuan et al. 2005; Mavrich 
et al. 2008; Albert et al. 2007; Brogaard et al. 2012). However, it was demonstrated that the coding 
regions of nearly all Pol II target genes are occupied by nucleosomes, whereas regulatory regions of 
actively transcribed genes are often nucleosome-free (Yuan et al. 2005; Knezetic & Luse 1986; Izban 
& Luse 1991; Lorch et al. 1987). Apart from genome-wide studies, a few single gene loci were 
analyzed regarding their nucleosomal state, including PHO5, HIS3, CHA1, MFA2 and the centromere 
of chromosome III and the (Moreira & Holmberg 1998; Saunders et al. 1990; Teng et al. 2001). Both 
genome-wide approaches and single locus analyses revealed a consensus pattern of nucleosomal 
organization at promoter regions is observed in the S. cerevisiae genome. It is well established, that 
the region from -300bp to -150bp relative to the TSS can be occupied by a nucleosome (named -1) 
and hence regulate the accessibility of the promoter cis-elements. Transition from repressed to 
active state is proposed to be accompanied by histone tail modification and eventually nucleosome 
eviction. The next nucleosome downstream of the TSS (designated +1) is very tightly positioned 
(Mavrich et al. 2008) and often contains histone variants and histone tail modifications (Kouzarides 
2007; Cosgrove & Wolberger 2005; Malik & Henikoff 2003). The following downstream nucleosomes 
exhibit less consensus spacing, histone variant incorporation and histone tail modifications with 
growing distance from the +1 nucleosome (Li et al. 2007; Lieb & Clarke 2005).  
A nucleosome imposes a strong barrier for elongating Pol II in vitro (Kireeva et al. 2005) with its 
polymerase stalling potency being dependent on the strength of the actual histone-DNA interactions 
(Bondarenko et al. 2006). Single molecule transcription experiments using an optical trap confirmed 
the nucleosomal barrier to Pol II, which in this case was insuperable depending on the reaction 
conditions (Hodges et al. 2009). However, if respective nucleosome positioning sequences are 
inserted in the genome, transcription is not greatly affected (Gaykalova et al. 2011). This led to the 
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assumption that in vivo Pol II can overcome nucleosomal barriers with the help of additional 
effectors.  
It was demonstrated that spontaneous release of the first 20bp which are wrapped around the 
nucleosome occurs with a frequency of roughly 250ms (Li et al. 2005). Furthermore, it is known that 
nucleosome disassembly occurs via eviction of an H2A/H2B dimer from the octamer (Gansen et al. 
2009; Böhm et al. 2011). Taken together, this leads to the mechanistic hypothesis that Pol II can gain 
access to nucleosomal DNA and then Pol II traversal is facilitated by loss of a H2A/H2B dimer. This 
model is supported by publications reporting that Pol II can remove an H2A/H2B dimer from the 
nucleosome upon single round transcription in vitro (Bintu et al. 2011; Kireeva et al. 2002). It was 
further reported that loss of the H2A/H2B dimer favored Pol II traversal through the remaining 
histone hexamer (Bintu et al. 2011; Kireeva et al. 2002). In single molecule optical trap experiments it 
was determined that Pol II was able to elongate roughly 30bp into the wrapped DNA before it 
encountered the first barrier (Hodges et al. 2009). This barrier was due to the strong interactions 
between DNA and the H2A/H2B dimer.  
Nonetheless, several trans-acting factors influence Pol II transcription of nucleosomal templates. 
Among those are chromatin remodelers which can translocate nucleosomes along the DNA, 
exchange or evict histones or evict the complete nucleosome from the DNA via ATP hydrolysis 
(Clapier & Cairns 2009; Hota & Bartholomew 2011). Chromatin remodelers are divided in the four 
subfamilies switch/sucrose nonfermentable (SWI/SNF), imitation switch (ISWI), chromodomain-
helicase-DNA-binding protein (CHD) and inositol-requiring 80 (INO80). SWI/SNF were detected at Pol 
II gene promoters and open reading frames in yeast and it was suggested that they travel with the 
elongating polymerase (Schwabish & Struhl 2007; Shivaswamy & Iyer 2008). It is believed that 
SWI/SNF act by eviction of histone octamers and play a role in transcription activation upon change 
of environmental conditions (Lorch et al. 1999; Bruno et al. 2003; Dechassa et al. 2010). Both ISWI 
and the CHD family have been assigned a role in transcription elongation. It was shown that ISWI 
family members can exchange histones and lower the nucleosomal barrier to Pol II transcription in 
vitro (Bruno et al. 2003; Gaykalova et al. 2011). CHD-like factors were found to colocalize with Pol II 
in vivo. Furthermore, Chd1 interactions with the histone chaperone FACT and the Pol II elongation 
factors DSIF and Spt4/5 were demonstrated (Simic et al. 2003; Srinivasan et al. 2005). Both CHD and 
ISWI are reportedly sliding nucleosomes along the DNA hence forming ordered nucleosomal arrays. 
In yeast, ISWI facilitates nucleosome positioning on the edge of the 5’ and 3’ nucleosome-free 
regions (Lusser et al. 2005; Whitehouse et al. 2007; Gkikopoulos et al. 2011). Among other functions, 
INO80 family members promote exchange of H2A against its variant H2AZ and vice versa. 
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Not only chromatin remodelers are involved in transcription of nucleosomal DNA but also a 
multitude of histone chaperones. Unlike the remodelers, chaperones do not consume ATP but 
exhibit strong affinities to surfaces of the histone octamer and thus are able to disrupt nucleosomes 
or to promote histone exchange (Das et al. 2010). Disruption of an H2A/H2B dimer from the octamer 
upon passage of Pol II is facilitated by Nap1 and FACT. Thereby Nap1 cooperates with nucleosome 
remodeling factors like Chd1 and the RSC complex (Lorch et al. 2006; Walfridsson et al. 2007). It is 
proposed that Nap1 in general controls the H2A/H2B density on coding regions and hence influences 
Pol II transcription elongation (Andrews et al. 2008). The histone chaperone FACT promotes the 
elongation of Pol II on nucleosomal templates in vitro (Orphanides et al. 1998). In vivo, FACT is 
associated with elongating Pol II and physically interacts with Pol II elongation factors including Chd1, 
DSIF, Spt6, Paf1 and Nap1 (Saunders et al. 2003; Mason & Struhl 2003). FACT activity is stimulated by 
ubiquitinylation of lysine 123 in H2B (H2BK123) in vitro (Pavri et al. 2006). It remains unknown, 
whether Nap1 and FACT act cooperatively or separately and whether the main in vivo contribution to 
Pol II elongation comes from H2A/H2B dimer eviction or nucleosome reassembly upstream of the 
elongating polymerase (Schwabish & Struhl 2004; Rosario & Pemberton 2008). Asf1 (anti silencing 
factor 1) and Spt6 (suppressor of ty homolog 6) are chaperones of the H3/H4 tetramer. It was 
demonstrated that Asf1 is associated with Pol II transcribed genes and promotes loss and re-
deposition of H3 (Schwabish & Struhl 2004). Spt6 is associated with Pol II (Andrulis et al. 2000) and 
facilitates chromatin transcription in vivo by enhancing Pol II’s elongation rate (Ardehali et al. 2009). 
It is suggested that Spt6 plays a role in depositioning of H3 after polymerase readthrough since loss 
of Spt6 function results in a generally lowered H3 density at transcribed genes (Ivanovska et al. 
2011). However, it cannot be judged by now whether the stimulatory effect of Spt6 on chromatin 
transcription by Pol II is promoted by re- or disassembly of H3 (Kaplan et al. 2003). 
Obviously, histone post-translational modifications and use of non-canonical histones are involved in 
transcription regulation and nucleosome traversal of RNA polymerase (reviewed in Petesch & Lis 
2012). 
 
C) Pol III 
 
Concerning Pol III, it is suggested that the respective actively transcribed genes are devoid of 
nucleosomes in vivo (Wittig & Wittig 1982; Morse et al. 1992) proposing that Pol III possesses the 
ability to transcribe a mono-nucleosomal template in vitro without additional factors (Studitsky et al. 
1997). A recent study implicates action of FACT in Pol III transcription in vivo hence proclaiming FACT 
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a general chromatin transcription factor for all eukaryotic RNA polymerases (Birch et al. 2009). 
Additionally, several studies showed that chromatin remodeling and histone modifications were 
necessary for Pol III elongation through nucleosomal arrays in vitro (Englander et al. 1993; Ura et al. 
1997; Tse et al. 1998; Ng et al. 2002; Arimbasseri & Bhargava 2008). 
 
 
2.5  Objectives 
 
A first main focus of this study was laid on transcription termination of Pol I. A recent publication 
from our group (Reiter et al. 2012) proposed Nsi1 as a novel Pol I termination factor in vivo. We 
wanted to take another approach and assess Pol I termination in an initiation-independent in vitro 
transcription system. It is still unclear how the actual mechanism of Pol I transcription termination 
works and none of the currently discussed models includes Nsi1. Since Nsi1 but not Reb1 was 
detected at the terminator-proximal Reb1 BS in vivo, we wanted to elucidate, if Nsi1 could fulfill 
Reb1 functions in an in vitro termination assay. We further wanted to investigate which terminator 
cis elements and trans-acting factors are necessary and sufficient for Pol I termination in vitro and to 
determine their respective influence. An additional task was to investigate possible cooperative 
effects in Pol I termination between the three main factors of interest Reb1, Nsi1 and Fob1. 
Furthermore, we sought to elucidate the contribution and/or necessity of Pol I subunits for 
termination in vitro. By inclusion of Pol I mutants in the analysis, we hoped to get further 
mechanistical insight in the termination event. 
Second, we wanted to compare yeast Pol I, II and III regarding to their behaviour, if barriers are 
encountered during transcription in general. To determine polymerase-inherent differences and 
similarities during elongation, an in vitro approach independent of initiation was the first choice for 
reasons of comparability. The study includes physiological barriers like Reb1, Nsi1 and Fob1 as well as 
the strong DNA binding proteins LexA (A. P. P. Zhang et al. 2010; Butala et al. 2009; Butala et al. 
2007), the Lac repressor (LacI)(Müller-Hill 1975) and the mouse Pol I termination factor TTF-I. 
Finally, a side-by-side comparison of Pol I, II and III regarding their ability to transcribe nucleosomal 
templates was a major goal. Although transcription of nucleosomal templates was extensively 
studied (2.4), a comparative in vitro study including all three polymerases was never conducted. First 
we aimed at polymerase-inherent differences in the ability to transcribe chromatin templates. Next, 
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we wanted to determine whether polymerase subunits or respective homologous transcription 
factors influenced elongation on a nucleosomal template in vitro. 
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     CHAPTER III – MATERIAL & METHODS 
 
3.1 Material  
 
 
3.1.1  Chemicals 
 
All chemicals and solvents used in this work were purchased at the highest available purity from 
Sigma-Aldrich, Merck, Fluka, Roth, Serva or J.T.Baker, except agarose electrophoresis grade 
(Invitrogen), G418/Geneticin (Gibco), milk powder (Sukofin), Nonidet P-40 substitute (NP40) (USB 
Corporation), Tris ultrapure (USB Corporation). Restriction enzymes, chemicals and other enzymes 
needed for standard manipulation of DNA (3.2.1) were purchased from New England Biolabs. 
Ingredients for growth media were purchased from BD Biosciences (Bacto Agar, Bacto Peptone, 
Bacto Tryptone and Bacto Yeast Extract). Water was always purified with an Elga Purelab Ultra device 
prior to use. If a certain supplier was crucial, this is indicated in the method description. 
 
 
3.1.2 Media 
 
Water for media preparation had a resistivity of 18.2MΩ. All media were autoclaved for 20min at 
110°C and stored at 4°C. If antibiotics were to be added, this was done after the medium 
temperature fell below approximately 50°C. For casting of plates, 2% agar was added to the solution 
prior to autoclaving. For SF21 insect cell cultivation, SFII 900 SFM medium was purchased from Life 
Technologies. 
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medium ingredients concentration/percentage 
lysogeny broth (LB) 
(Sambrook et al. 1989) 
tryptone 
yeast extract 
NaCl 
(agar) 
10g/l 
5g/l 
10g/l 
(20g/l) 
LBAmp 
LB 
Ampicillin 
(agar) 
 
100µg/ml 
(20g/l) 
LBAmp Tetra Genta IPTG 
LB 
ampicillin 
tetracycline 
genatmycin 
IPTG 
(agar) 
 
100µg/ml 
10µg/ml 
10µg/ml 
0.5mM 
(20g/l) 
LBAmp Tetra Genta IPTG X-GAL 
LB 
ampicillin 
tetracycline 
gentamycin 
IPTG 
X-GAL 
(agar) 
 
100µg/ml 
10µg/ml 
10µg/ml 
0.5mM 
50mg/ml 
(20g/l) 
super optimal broth (SOB) 
(Hanahan 1983) 
tryptone 
yeast extract 
NaCl 
KCl 
MgCl2 (after autoclaving) 
MgSO4 (after autoclaving) 
20g/l 
5g/l 
0.6g/l 
0.2g/l 
10mM 
10mM 
YPD 
yeast extract 
peptone 
glucose 
(agar) 
10g/l 
20g/l 
20g/l 
(20g/l) 
YPDGeneticin 
YPD 
geneticin 
 
 
400mg/l 
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YPG 
yeast extract 
peptone 
galactose 
(agar) 
10g/l 
20g/l 
20g/l 
(20g/l) 
Table 3-1: Media. 
 
 
3.1.3 Buffers 
 
All buffers were prepared with purified water with a resistivity of 18.2MΩ. The pH values were 
adjusted with a standard pH meter at RT with 37% HCl or 10M NaOH if not indicated otherwise. 
Specifications provided as percentages are mass per volume (m/v) for solids and volume per volume 
(v/v) for fluids. Protease inhibitors, dithiothreitol (DTT) and β-mercaptoethanol were added freshly 
prior to use. 
 
A) General buffers 
 
buffer ingredients concentration/percentage 
TE buffer Tris/HCl, pH 8 
EDTA 
10mM 
1mM 
AE buffer Tris/HCl, pH 9 
EDTA 
10mM 
0.5mM 
EB buffer Tris/HCl, pH 8 10mM 
5x TBE buffer 
Tris/HCl 
boric acid 
EDTA 
450mM 
450mM 
10mM 
loading buffer AGE 
Tris/HCl pH 8.0 
EDTA 
bromophenol blue 
xylene cyanol 
glycerol 
10mM 
1mM 
0.01% 
0.01% 
33.3% 
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10x oligo annealing buffer 
Tris/HCl pH 7.5 
NaCl 
EDTA 
100mM 
1M 
10mM 
4x upper Tris buffer 
Tris/HCl, pH 6.8 
SDS 
bromophenol blue 
1.5M 
0.4% 
4x lower Tris buffer Tris/HCl 
SDS 
1.5M 
0.4% 
10x SDS PAGE electrophoresis 
buffer 
Tris/HCl 
Glycine 
SDS 
0.5M 
1.9M 
1% 
loading buffer SDS PAGE 
Tris/HCl, pH 6.8 
Glycerol 
SDS 
β-mercaptoethanol 
Bromophenol blue 
0.25M 
40% 
8.4% 
0.57M 
transfer buffer (Western blot) 
Tris/HCl 
glycine 
methanol 
25mM 
192mM 
20% 
Ponceau staining solution HOAc 
Ponceau S 
5% 
0.1% 
10x PBS 
NaCl 
KCl 
KH2PO4 
1.37M 
27mM 
20mM 
PBST PBS 
Tween 20 
1x 
0.05% 
TELit 
LiOAc 
Tris/HCl pH 8 (HOAc) 
EDTA pH 8 
100mM 
10mM 
1mM 
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LitSORB 
LiOAc 
Tris/HCl pH 8 (HOAc) 
EDTA pH 8 
Sorbitol 
sterile filtered 
100mM 
10mM 
1mM 
1M 
LitPEG 
LiOAc 
Tris/HCl pH 8 (HOAc) 
EDTA pH 8 
polyethylene glycol 3350 
sterile filtered 
100mM 
10mM 
1mM 
40% 
Tfb 1 
KOAc 
MnCl2 
KCl 
Glycerol 
pH 5.8 with HOAc 
sterile filtered 
30mM 
50mM 
100mM 
15% 
Tfb 2 
MOPS 
CaCl2 
KCl 
Glycerol 
pH 7 
sterile filtered 
10mM 
75mM 
10mM 
15% 
100x Protease inhibitors (PIs) 
benzamidine 
phenylmethylsulfonylflouride 
(PMSF) 
33mg/ml 
17mg/ml 
Solution I 
Tris/HCl pH 8 
EDTA 
RNase A 
15mM 
10mM 
100µg/ml 
Solution II NaOH 
SDS 
0.2M 
1% 
Table 3-2: General buffers. 
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B) Solutions for Coomassie and silver staining 
 
buffer ingredients concentration/percentage 
Coomassie staining solution 
water 
methanol 
glacial acetic acid 
Coomassie blue 
50% 
40% 
10% 
destaining solution for protein 
polyacrylamide gel 
water 
methanol 
glacial acetic acid 
50% 
40% 
10% 
fixation solution 
MeOH 
HOAc 
formaldehyde 
50% 
12% 
0.02% 
washing solution EtOH 50% 
pre-treatment solution Na2S2O3 0.8mM 
staining solution AgNO3 
formaldehyde 
0.2% 
0.075% 
developer 
Na2CO3 
formaldehyde 
pre-treatment solution 
6% 
0.05% 
2.5% 
stop solution HOAc 1% 
Table 3-3: Solutions for Coomassie and silver staining. 
 
C) Buffers for RNA polymerase/transcription factor IIF (TFIIF) purification 
 
buffer ingredients concentration/percentage 
P1 KOAc KOAc 
Hepes pH 7.8 
200mM 
20mM 
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MgCl2 
glycerol 
PIs 
1mM 
20% 
1x 
P2 KOAc 
KOAc 
Hepes pH 7.8 
MgCl2 
glycerol 
NP40 
(PIs) 
200mM 
20mM 
1mM 
20% 
0.1% 
(1x) 
P1 KCl 200/300/500 
KCl 
Tris/HCl pH 8 
MgAc 
glycerol 
PIs 
200/300/500mM 
20mM 
5mM 
20% 
1x 
P2 KCl 200/300/500 
KCl 
Tris/HCl pH 8 
MgAc 
glycerol 
NP40 
(PIs) 
200/300/500mM 
20mM 
5mM 
20% 
0.1% 
(1x) 
C1 
Hepes pH 8 
NaCl 
MgCl2 
DTT 
CaCl2 
imidazole 
20mM 
50mM 
10mM 
2.5mM 
2mM 
1mM 
C2 C1 
NaCl 
1x 
50mM 
Table 3-4: Buffers for RNA polymerase and TFIIF purification. 
 
D) Buffers for purification of recombinant proteins via the FLAG tag 
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buffer ingredients concentration/percentage 
TAP 100 
NaCl 
Tris/HCl pH 7.5 
MgCl2 
NP40 
DTT 
PIs 
100mM 
50mM 
5mM 
0.15% 
1mM 
1x 
TAP 300 
NaCl 
Tris/HCl pH 7.5 
MgCl2 
NP40 
DTT 
PIs 
300mM 
50mM 
5mM 
0.15% 
1mM 
1x 
Table 3-5: Buffers for FLAG tag purification. 
 
E) Buffers for purification of recombinant Reb1-His6 and Hmo1-His6 
 
buffer ingredients concentration/percentage 
resuspension buffer 1 
Tris/HCl pH 8 
EDTA 
β-mercaptoethanol 
PIs 
10mM 
1mM 
5mM 
1x 
resuspension buffer 2 
Tris/HCl pH 7 
EDTA 
β-mercaptoethanol 
PIs 
10mM 
1mM 
5mM 
1x 
washing buffer 1 
Tris/HCl pH 7 
NaCl 
imidazole 
PIs 
50mM 
1M 
2mM 
1x 
washing buffer 2 Tris/HCl pH 7 50mM 
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NaCl 
imidazole 
PIs 
1M 
2mM 
1x 
elution buffer 
Tris/HCl pH 8 
NaCl 
imidazole 
50mM 
300mM 
1x 
Table 3-6: Buffers for purification of Hmo1-His6 and Reb1-His6. 
 
F) Buffers for purification of the recombinant A49-His6/A34.5 dimer 
 
buffer ingredients concentration/percentage 
buffer A Tris pH 7.5 
β-mercaptoethanol 
50mM 
5mM 
buffer B 
Tris pH 7.5 
NaCl 
β-mercaptoethanol 
PIs 
50mM 
300mM 
5mM 
1x 
buffer C 
Tris pH 7.5 
NaCl 
β-mercaptoethanol 
PIs 
50mM 
1M 
5mM 
1x 
buffer D 
Tris pH 7.5 
NaCl 
imidazole 
β-mercaptoethanol 
PIs 
50mM 
300mM 
10mM 
5mM 
1x 
buffer E 
Tris pH 7.5 
NaCl 
imidazole 
β-mercaptoethanol 
50mM 
300mM 
200mM 
5mM 
Table 3-7: Buffers for purification of the A49-His6/A34.5 dimer. 
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G) Buffers for chromatin assembly 
 
buffer ingredients concentration/percentage 
high salt buffer 
Tris pH 7.6 
NaCl 
EDTA 
NP40 
β-mercaptoethanol 
10mM 
2M 
1mM 
0.05% 
1mM 
20x low salt buffer 
Tris pH 7.6 
NaCl 
EDTA 
NP40 
β-mercaptoethanol 
200mM 
1M 
20mM 
1% 
20mM 
6x loading buffer Glycerol 
orange g 
60% 
 
Table 3-8: Solutions for chromatin assembly. 
 
H) Buffers for in vitro transcription 
 
buffer ingredients concentration/percentage 
10x T7 RNA polymerase buffer 
Tris/HCl pH 7.9 
MgCl2 
spermidine 
DTT 
400mM 
60mM 
20mM 
100mM 
10x new transcription buffer 
(NTB) 
Hepes pH 8 
MgCl2 
EDTA 
EGTA 
DTT 
200mM 
100mM 
50mM 
0.5mM 
25mM 
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Proteinase K storage buffer 
Tris/HCl pH 7.5 
CaCl2 
glycerol 
20mM 
1mM 
50% 
Proteinase K buffer 
NaCl 
Tris/HCl pH 7.5 
EDTA 
SDS 
300mM 
10mM 
5mM 
0.6% 
Proteinase K mix (20 reactions) 
Proteinase K 
Proteinase K buffer 
110µl 
4.7ml 
denaturing RNA loading buffer 
formamide de-ionized 
TBE 
bromophenol blue 
xylene cyanole 
80% 
0.5x 
 
 
Table 3-9: Buffers for in vitro transcription experiments. 
 
 
3.1.4 Nucleic acids 
 
A) Nucleotides 
 
For polymerase chain reaction (PCR) deoxynucleotides were purchased from New England Biolabs 
(dNTPmix, 10mM each). Nucleotides for in vitro transcription were bought from GE Healthcare in 
separate vials (rNTP set, 100mM each). Radiolabeled [α−32P]-CTP was purchased from Hartmann 
Analytic GmbH at a concentration of 10μCi/μl and a specific activity of 400 Ci/mmol. 
 
B) Oligonucleotides 
 
Oligonucleotides were purchased from Eurofins MWG Operon. For cloning purposes, standard 
purification was chosen, modified oligos were ordered HPLC purified. 
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# name seqence 
gene/ 
locus 
function 
- T7 terminator TATGCTAGTTATTGCTCAG 
 
sequencing 
- M13 rev AACAGCTATGACCATG 
 
sequencing 
723 M13 
GTCAGACTGTGTCAACGGT
GTAGAT  
sequencing 
2038 Bla_rev 
AGCAAAAACAGGAAGGCAA
A  
sequencing 
2479 rDNA4 Th fo 
CTTGTCTCAAAGATTAAGCC
ATGC 
rDNA qPCR 
2480 rDNA4 Th re 
ACCACAGTTATACCATGTAG
TAAAGGAACT 
rDNA qPCR 
2551 5' for A135 seq 
TGT TGG TGG TAA TGA 
AAC AA 
A135 sequencing A135 with #2552 
2552 
3' rev A135 
seq 
GTT TTA AAA CCT AAG AGT 
CA 
A135 sequencing A135 with #2551 
2553 5' for B150 seq 
TAT CGC GAA ATT AAA TCA 
TA 
B150 Sequencing B150 with #2554 
2554 
3' rev B150 
seq 
TTC GTT TTA AAA CCT AAG 
AG 
B150 sequencing B150 with #2553 
2555 5' for C128 seq 
ATG GGC TAT AGT GGT 
TGG TG 
C128 sequencing C128 with #2556 
2556 
3' rev C128 
seq 
TCG TTT TAA AAC CTA AGA 
GT 
C128 sequencing C128 with #2555 
2557 
B150 H7 PA 
for II 
CAT TAC ACC ACG TTT ATA 
TAC CGA TCG TTC GAG 
AGA TTT T 
B150 
tagging of B150 with 7x His and 
ProtA 
2558 
C128 H7 PA 
for II 
CAT AGC CCC AAG ATT AAG 
ATT GGA AGA TAT CTT CCA 
GCA G 
C128 
tagging of C128 with 7x His and 
ProtA 
2559 Reb1 inv up 
TTA AGA ATT CTA TGA TTT 
TTT ACC CGG CAT GTA TTG 
TAT ATA TCT ATT A 
rDNA 
Reb1 binding site inverted for 
annealing with #2560 
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2560 Reb1 inv down 
TAA TAG ATA TAT ACA ATA 
CAT GCC GGG TAA AAA 
ATC ATA GAA TTC 
rDNA 
Reb1 binding site inverted for 
annealing with #2559 
2561 TFG1 fwd 
GAT GGT ACC AAA AAT TGT 
GTC GAA AGG TTG GCA 
ATG ACC ACA TGG AAT TAA 
AGA AAG AGC GTA CGC 
TGC AGG TCG AC 
TFG1 TFG1 tagging ProtA 
2562 TFG1 rev 
GAC CTC GAG AAA GAA 
CGA AAA CTA AAT AAC CTA 
TTA AGT ACA TAA CAT TAT 
AAA CTA ACA TCG ATG AAT 
TCG AGC TCG 
TFG1 TFG1 tagging Prot A 
2563 
5' for mut 
HpaI 
TAT CTA TTA TAA TAT ACG 
ATG AGG ATG ATA GTG 
TGT AAG AGT TAA CCA TTT 
ACT AAT GTA TGT AAG 
rDNA 
primer to introduce a mutation in 
the Reb1 binding site 
2564 3' rev AvaI Ydr 
CGT TCG CTC GAG ATT GAT 
TTG TTC CAA CAA TG 
Ydr026c 
primer for amplification of 
Ydr026c introducing a AvaI site 
2592 
3'_rev_SacI_F
OB1 
CTAGTGAGCTCTTACAATTC
CATTGATGTGC 
FOB1 
amplification of FOB1 and 
introduction of BamHI/SacI sites 
for insertion into pFL Flag TEV 
2593 
3'_rev_SacI_H
MO1 
CTAGTGAGCTCTCAAATAGA
AGAGTTGGATT 
HMO1 
amplification of HMO1 and 
introduction of BamHI/SacI sites 
for insertion into pFL Flag TEV 
2594 
3'_rev_SacI_m
TTF1 
TAGTGAGCTCTCACTGCACA
TCAGAGGCGC 
TTF1 
amplification of TTF1 and 
introduction of BamHI/SacI sites 
for insertion into pFL Flag TEV 
2595 
3'_rev_SacI_P
AF1 
TAGTGAGCTCCTATTCTTCTT
GTAAAGTTT 
PAF1 
amplification of PAF1 and 
introduction of BamHI/SacI sites 
for insertion into pFL Flag TEV 
2596 
3'_rev_SacI_R
EB1 
TAGTGAGCTCTTAATTTTCT
GTTTTCATTG 
REB1 
amplification of REB1 and 
introduction of BamHI/SacI sites 
for insertion into pFL Flag TEV 
2597 3'_rev_SacI_Y TAGTGAGCTCTTAATTGATT YDR026c amplification of YDR026c and 
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DR026c TGTTCCAACA introduction of BamHI/SacI sites 
for insertion into pFL Flag TEV 
2598 
5'_for_BamHI_
FOB1 
CTAAGGATCCATGACGAAA
CCGCGTTACAA 
FOB1 
amplification of FOB1 and 
introduction of BamHI/SacI sites 
for insertion into pFL Flag TEV 
2599 
5'_for_BamHI_
HMO1 
CTAAGGATCCATGACTACAG
ATCCTTCTGT 
HMO1 
amplification of HMO1 and 
introduction of BamHI/SacI sites 
for insertion into pFL Flag TEV 
2600 
5'_for_BamHI_
mTTF1 
CTAAGGATCCATGAAAGGG
GGCACAAGCAA 
TTF1 
amplification of TTF1 and 
introduction of BamHI/SacI sites 
for insertion into pFL Flag TEV 
2601 
5'_for_BamHI_
PAF1 
CTAAGGATCCATGTCCAAAA
AACAGGAATA 
PAF1 
amplification of PAF1 and 
introduction of BamHI/SacI sites 
for insertion into pFL Flag TEV 
2602 
5'_for_BamHI_
REB1 
CTAAGGATCCATGCCTTCAG
GTCATAACGA 
REB1 
amplification of REB1 and 
introduction of BamHI/SacI sites 
for insertion into pFL Flag TEV 
2603 
5'_for_BamHI_
YDR026c 
CTAAGGATCCATGGACAGC
GTGTCAAACCT 
YDR026c 
amplification of YDR026c and 
introduction of BamHI/SacI sites 
for insertion into pFL Flag TEV 
2604 
5'_for_YDR_ne
w 
TGTCTGCGTCAAGAAGAAA
GA 
YDR026c 
amplification of YDR026c and 
introduction of BamHI/SacI sites 
for insertion into pFL Flag TEV 
(newly designed primers) 
2605 
3'_rev_YDR_n
ew 
TGTTTGGGAAAGTAACCCTT
C 
YDR026c 
amplification of YDR026c and 
introduction of BamHI/SacI sites 
for insertion into pFL Flag TEV 
(new designed primers) 
2606 5'_for_cDNA CATTCCCTACAATTCTACTT 
 
generation of cDNA from the tail 
g- 5xTTF1 transcript 
2607 3'_rev_cDNA CTGGCACGACAGGTTTCCCG 
 
generation of cDNA from the tail 
g- 5xTTF1 transcript 
2608 5'_for_EMSA 
ATCACCTTACCCTATACTTAC
TCGC  
generation of EMSA templates 
possible on all pUC19 tail g- 
vectors 
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2609 3'_rev_EMSA CTGGCACGACAGGTTTCCC 
 
generation of EMSA templates 
possible on all pUC19 tail g- 
vectors 
2610 LexA shift up 
AACGAATTCCATGGTGCTGT
ATATAAAACCAGTGGTTATA
TGTACAGTAG 
 
small fragment for EMSA with 
one LexA binding site for 
annealing 
2611 
LexA shift 
down 
CTACTGTACATATAACCACT
GGTTTTATATACAGCACCAT
GGAATTCGTT 
 
small fragment for EMSA with 
one LexA binding site for 
annealing 
2612 top Ala tRNA 
ATGAATTCGGGCACATGGC
GCAGTTGGTAGCGCGCTTCC
CTTGCAAGGAAGAGGTCAT
CGGTTCGATTCCGGTTGCGT
CCAAAGCTTATAT 
tRNA Ala 
annealing oligo for insertion of 
the alanine tRNA via EcoRI 
/HindIII into pUC19 tail g- 
constructs 
2613 
down Ala 
tRNA 
ATATAAGCTTTGGACGCAAC
CGGAATCGAACCGATGACC
TCTTCCTTGCAAGGGAAGCG
CGCTACCAACTGCGCCATGT
GCCCGAATTCAT 
tRNA Ala 
annealing oligo for insertion of 
the alanine tRNA via EcoRI 
/HindIII into pUC19 tail g- 
constructs 
2614 
5'_for_BamHI_
LacI 
ACTGGATCCGTGAAACCAGT
AACGTTATAC 
LACI 
amplification of LACI from pGEX 
4T1 and insertion of BamHI site 
2615 
3'_rev_NotI_L
acI 
GATAAGCGGCCGCGTTTTTC
TTTTCACCAGTGA 
LACI 
amplification of LACI from pGEX 
4T1 and insertion of NotI site 
TRUNCATED! 
2616 3'_rev_LacI_2 
TAATGCGGCCGCTCACTGCC
CGCTTTCCAGT 
LACI 
amplification of LACI from pGEX 
4T1 and insertion of NotI site 
FULL Length 
2617 T7 Promoter TAATACGACTCACTATAGGG 
 
sequencing 
2618 SP6 Promoter CTATTTAGGTGACACTATAG 
 
sequencing 
2619 top 2xLacR 
CTTGTGGATCCTTAAGTGTG
GAATTGTGAGCGGATAACA
ATTTCACAAATTGTGAGCGG
ATAACAATTCTTAACTGCAG
TTCAG 
LacO 
top strand annealing oligo for 
insertion of 2 LacI binding sites 
via BamHI/PstI in pUC19 tail g- 
Enh 
2620 bottom 2xLacR CTGAACTGCAGTTAAGAATT LacO bottom strand annealing oligo 
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GTTATCCGCTCACAATTTGT
GAAATTGTTATCCGCTCACA
ATTCCACACTTAAGGATCCA
CAAG 
for insertion of 2 LacI binding 
sites via BamHI/PstI in pUC19 tail 
g- Enh 
2621 top 1xLacR 
CTTGTGGATCCTGTGGAATT
GTGAGCGGATAACAATTTCA
CACTGCAGTTCAG 
LacO 
top strand annealing oligo for 
insertion of 1 LacI binding site via 
BamHI/PstI in pUC19 tail g- Enh 
2622 
bottom 1x 
LacR 
CTGAACTGCAGTGTGAAATT
GTTATCCGCTCACAATTCCA
CAGGATCCACAAG 
LacO 
bottom strand annealing oligo 
for insertion of 1 LacI binding site 
via BamHI/PstI in pUC19 tail g- 
Enh 
2623 top LacO 
GTCCTGAATTCGGCGGCTCG
TATGTTGTGTGGAATTGTGA
GCGGATAACAATTTCACACA
GGAAACAGCCAAGCTTGGC
GA 
LacO 
top strand annealing oligo for 
insertion of the Lac Operator via 
EcoRI/ HindIII into pUC19 tail g- 
3xLexA 
2624 bottom LacO 
TCGCCAAGCTTGGCTGTTTC
CTGTGTGAAATTGTTATCCG
CTCACAATTCCACACAACAT
ACGAGCCGCCGAATTCAGG
AC 
LacO 
bottom strand annealing oligo 
for insertion of the Lac Operator 
via EcoRI/ HindIII into pUC19 tail 
g- 3xLexA 
2625 1xLacI E/H up 
GATGAATTCTGTGGAATTGT
GAGCGGATAACAATTTCACA
AAGCTTGATG 
LacO 
top strand annealing oligo for 
creation of pUC19 tail g- 1xLacI ; 
insertion via EcoRI/ Hind III 
2626 
1x LacI E/H 
down 
CATCAAGCTTTGTGAAATTG
TTATCCGCTCACAATTCCAC
AGAATTCATC 
LAcO 
bottom strand annealing oligo 
for creation of pUC19 tail g- 
1xLacI ; insertion via EcoRI/ Hind 
III 
3050 5’ for TER SacI 
GAGGGAGCTCTCTCTATAAA
TTTTATTTGT 
rDNA 
amplification of Pol I terminator 
introducing SacI site 
3051 
3’ rev TER 
BamHI 
GATGGATCCACTATAGGAA
ATGAGCTTTTC 
rDNA 
amplification of Pol I terminator 
introducing BamHI site 
3052 
5’ for Rnt TER 
SacI 
GAGGGAGCTCGCCTTTGTT
GTCTGATTTGT 
rDNA 
amplification of Pol I terminator 
plus Rnt1 site introducing SacI 
site 
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3053 
5’ for SOE SacI 
rDNA 
AAGGATTGACAGATTGAGA
GTTCTTTCTTG 
rDNA 
SOE primer eliminating the SacI 
site in the yeast rDNA with #3056 
3054 
3’ rev SOE SacI 
rDNA 
CCCACAAAATCAAGAAAGA
ACTCTCAATCT 
rDNA 
SOE primer eliminating the SacI 
site in the yeast rDNA with #3055 
3055 
5’ for SacI 
rDNA 
TTCGAGCTCGAGTAGGCTTG
TCGTTCGTT 
rDNA 
outer primer for rDNA SOE PCR 
introducing a SacI site with #3054 
3056 
3’ rev BamHI 
rDNA 
TCTGGATCCCACCATATCTT
CATAACCTG 
rDNA 
outer primer for rDNA SOE PCR 
introducing a BamHI site with 
#3053  
3057 
3' EMSA rev 
Cy5 
CTGGCACGACAGGTTTCCC 
 
universal reverse primer for 
amplification of all IVT constructs 
together with 5' EMSA for 
labeled with Cy5 
3094 
3' rev XhoI 
REB1 
GCACTCGAGTTAATTTTCTG
TTTTCATTG 
REB1 
introduction of Xho1 site 3' of 
REB1 ORF 
3095 pGEX 3' 
CCGGGAGCTGCATGTGTCA
GAGG  
sequencing 
3096 
3' rev NotI 
YDR026c 
ATATGCGGCCGCTTAATTGA
TTTGTTCCAACA 
YDR026c 
introduction of Not1 site 3' of 
YDR026c ORF 
3097 
3' rev NotI 
HMO1 
ATATGCGGCCGCTCAAATAG
AAGAGTTGGATT 
HMO1 
introduction of Not1 site 3' of 
HMO1 ORF 
3098 
3' rev NotI 
REB1 
ATATGCGGCCGCTTAATTTT
CTGTTTTCATTG 
REB1 
introduction of Not1 site 3' of 
REB1 ORF 
3099 
3' rev NotI 
PAF1 
ATATGCGGCCGCCTATTCTT
CTTGTAAAGTTT 
PAF1 
introduction of Not1 site 3' of 
PAF1 ORF 
3100 
3' rev NotI 
FOB1 
ATATGCGGCCGCTTACAATT
CCATTGATGTGC 
FOB1 
introduction of Not1 site 3' of 
FOB1 ORF 
3101 
3' rev NotI 
mTTF1 
ATATGCGGCCGCTCACTGCA
CATCAGAGGCGC 
TTF1 
introduction of Not1 site 3' of 
TTF1 ORF 
3102 pGEX 5' 
GGGCTGGCAAGCCACGTTT
GGTG  
sequencing 
3103 5' for bluescr CGCCTCCATCCAGTCTATTA 
 
amplification of 758bp from 
bluescript for elongation of IVT 
templates 
3104 3' rev bluescr GCACTTTTCGGGGAAATGT
 
amplification of 758bp from 
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G bluescript for elongation of IVT 
templates 
3105 3' rev blue seq CAATGATGAGCACTTTTAAA 
 
sequencing 
3106 
shift fragment 
5' TER 
ATAAATTTTATTTGTCTTAAG
AATTCTATGATCCGGGTAAA
AACATGTATTGTATATATC 
rDNA 
for EMSA / NanoTemper, 
together with shift fragment 3' 
TER 
3107 
shift fragment 
TTFI 
CCATTTTTTCCCCCCCAACTT
CGGAGGTCGACCAGTACTC
CGGGCGACACTTTGT 
rDNA 
EMSA and Nanotemper studies, 
anneal with reverse complement 
3108 
shift fragment 
TTFI rc 
ACAAAGTGTCGCCCGGAGT
ACTGGTCGACCTCCGAAGTT
GGGGGGGAAAAAATGG 
rDNA 
EMSA and Nanotemper studies, 
anneal with reverse complement, 
5' Cy5 
3109 
shift fragment 
TER 
ATAAATTTTATTTGTCTTAAG
AATTCTATGATCCGGGTAAA
AACATGTATTGTATATATC 
rDNA 
EMSA and Nanotemper studies, 
anneal with reverse complement 
3110 
shift fragment 
TER rc 
GATATATACAATACATGTTT
TTACCCGGATCATAGAATTC
TTAAGACAAATAAAATTTAT 
rDNA 
EMSA and Nanotemper studies, 
anneal with reverse complement, 
5' Cy5 
3111 
shift fragment 
w/o BS 
CCAATTCAACACAAGGGTG
AAAAGAGTTTGGAAACGAA
TTAGCTTGGCGTAATCA 
 
EMSA and Nanotemper studies, 
anneal with reverse complement 
3112 
shift fragment 
w/o BS rc 
TGATTACGCCAAGCTAATTC
GTTTCCAAACTCTTTTCACCC
TTGTGTTGAATTGG 
 
EMSA and Nanotemper studies, 
anneal with reverse complement, 
5' Cy3 
3113 
shift fragment 
ENH 
AAAAGAGTTTGGAAACGAA
TTCTATGATCCGGGTAAAAA
CATGTATTGTATATATC 
rDNA 
EMSA and Nanotemper studies, 
anneal with reverse complement 
3114 
shift fragment 
ENH rc 
GATATATACAATACATGTTT
TTACCCGGATCATAGAATTC
GTTTCCAAACTCTTTT 
rDNA 
EMSA and Nanotemper studies, 
anneal with reverse complement, 
5' Cy5 
3115 
LexA shift 
fragment 
AACGAATTCCATGGTGCTGT
ATATAAAACCAGTGGTTATA
TGTACAGTAG 
 
EMSA and Nanotemper studies, 
anneal with reverse complement 
3116 
LexA shift 
fragment rc 
CTACTGTACATATAACCACT
GGTTTTATATACAGCACCAT  
EMSA and Nanotemper studies, 
anneal with reverse complement, 
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GGAATTCGTT 5' Cy5 
3117 5' for g-less 
ATACCAAACCAATTCAACAC
AAGGG  
sequencing 
3118 
tail 
complement 
FAM 
UGCAUUUCACCUUACCCUA
UACUUACUCG  
5' FAM labeled RNA for 
hybridisation to a tailed template 
according to P.Cramer as a 
primer RNA 
3119 TspRI linker up 
GACCGGCACTGGGTTTACG
C  
introducing a TspRI site via blunt 
end cloning, 5' phosphorylated 
with #3120  
3120 
TspRI linker 
down 
GCGTAAACCCAGTGCCGGT
C  
introducing a TspRI site via blunt 
end cloning, 5' phosphorylated, 
rc with #3119 
3121 NDS59 
ACTTACAGCCATCGAGAGG
GACACGGCGAAAAGCCAAC
CCAAGCGACACCGGCACTG
GG 
 
non template strand for 
Studitsky IVT templates, 5' 
biotinylated 
3122 TDS50 
GGTGTCGCTTGGGTTGGCTT
TTCGGGCTGTCCCTCTCGAT
GGCTGTAAGT 
 
template strand for Studitsky IVT 
templates 
3123 RNA9 AUCGAGAGGG 
 
primer RNA for Studitsky IVT 
templates 
3476 TER 3' 
GATATATACAATACATGTTT
TTACCCGGATCATAGAATTC
TTAAGACAAATAAAATTTAT 
rDNA 
for EMSA / NanoTemper, 
together with TER 5' shift 
fragment 
3477 ENH 3' 
GATATATACAATACATGTTT
TTACCCGGATCATAGAATTC
GTTTCCAAACTCTTTT 
rDNA 
for EMSA / NanoTemper, 
together with ENH 5' shift 
fragment 
3478 RFB3 up Cy5 
CATGCAAGCTTAAGAGAAG
GGCTTTCACAAAGGGATCC
GAGTCGG 
rDNA 
for EMSA/ NanoTemper, RFB3 
site, for annealing 
3479 RFB3 up 
CATGCAAGCTTAAGAGAAG
GGCTTTCACAAAGGGATCC
GAGTCGG 
rDNA 
for EMSA/ NanoTemper, RFB3 
site, for annealing 
3480 RFB3 down CCGACTCGGATCCCTTTGTG rDNA for EMSA/ NanoTemper, RFB3 
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AAAGCCCTTCTCTTAAGCTT
GCATG 
site, for annealing 
3481 RFB1 up Cy5 
CATGCAAGCTTATGAGTGCT
TGTATAAGTTTGGATCCGAG
TCGG 
rDNA 
for EMSA/ NanoTemper, RFB1 
site, for annealing 
3482 RFB1 up 
CATGCAAGCTTATGAGTGCT
TGTATAAGTTTGGATCCGAG
TCGG 
rDNA 
for EMSA/ NanoTemper, RFB1 
site, for annealing with #3483 
3483 RFB1 down 
CCGACTCGGATCCAAACTTA
TACAAGCACTCATAAGCTTG
CATG 
rDNA 
for EMSA/ NanoTemper, 
RFB1site, for annealing with 
#3482 
3484 
5' forRFB 
compl Cy5 
CGTTGCAAAGATGGGTTGA
AAGAGAAGGGC 
rDNA 
primer for amplification of the 
RFB, 5’ Cy5 labeled 
3485 
5' for RFB 
compl 
CGTTGCAAAGATGGGTTGA
AAGAGAAGGGC 
rDNA 
primer for amplification of the 
RFB 
3486 
5' for TER SacI 
Cy5 
GAGGGAGCTCTCTCTATAAA
TTTTATTTGT 
rDNA 
primer for amplification of the 
rDNA terminator, 5’ Cy5 labeled 
3792 
5‘ for AflII 
Rebinv 
ATTTGTCTTAAGAATTCTAT
GAATTTTTACCCGGCATGTA
TTGTATATATCTATTATAATA
TAC 
rDNA 
PCR primer for introduction of an 
inverted Reb1 BS in pUC19 tail g- 
TER elong with 2105 
3793 
5‘ for AflII 
noReb 
ATTTGTCTTAAGAATTCTAT
GATCATGTATTGTATATATC
TATTAT 
rDNA 
PCR primer for deletionof the 
Reb1 BS in pUC19 tail g- TER 
elong with 2105 
3794 
5‘ for AflII 
LexA 
ATTTGTCTTAAGCATGGTGC
TGTATATAAA 
 
PCR primer for exchange of the 
Reb1 BS in pUC19tailg- TER elong 
with a LexA BS together with 
#3795 
3795 
3‘ rev BamHI 
LexA new 
GATCGGATCCAACGTACTAC
TGTACATATAACCACTG 
 
PCR primer for exchange of the 
Reb1 BS in pUC19tailg- TER elong 
with a LexA BS together with 
#3794 
3796 
5‘ for pUC19 
compl 
TGAGGATGATAGTGTGTAA
GAGTGTACC 
 
PCR primer for amplification of 
pUC19 tail g- TER elong and 
introduction of a PsiI site in the 
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Abf1 binding site via introduction 
of a point mutation with #3797 
3797 
3‘ rev pUC19 
compl 
TCGTATATTATAATAGATAT
ATACAATACATGTTTTTAC 
 
PCR primer for amplification of 
pUC19 tail g- TER elong and 
introduction of a PsiI site in the 
Abf1 binding site via introduction 
of a point mutation with #3796 
3798 
5‘ for elong 
EcoRI 
GATCGGAATTCCTTGTCTCA
AAGATTAAGCCATG 
 
PCR primer for amplification of 
the PCR product obtained with 
#2479 and #2480 with 
introduction of a KpnI and EcoRI 
site for cloning into pUC19 tail g- 
601 together with # 3799 
3799 
3‘ rev elong 
KpnI 
GATCTGGTACCCCACAGTTA
TACCATGTAGTAAAGGAAC 
 
PCR primer for amplification of 
the PCR product obtained with 
#2479 and #2480 with 
introduction of a KpnI and EcoRI 
site for cloning into pUC19 tail g- 
601 together with # 3798 
3800 
3‘ rev EMSA 
biotin 
CTGGCACGACAGGTTTCCC  
PCR primer for amplification with 
#2608 biotinylated 
3801 
3‘ rev M13 
FAM 
AACAGCTATGACCATG  PCR primer M13 rev FAM label 
Table 3-10: Oligonucleotides. 
 
C) Plasmids 
 
# name description cloning function origin 
1 pBluescript
KS(+/-) 
T3 und T7 Promoter 
M13-20, T7, und SK 
Primer 
 cloning Stratage
ne 
44 pYM 9 module for TEV-ProA-
7His-tag kanMX6 
 yeast 
tagging 
(Knop et 
al. 1999) 
45 pYM 10 module for TEV-ProA-  yeast (Knop et 
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7His-tag HISMX6 tagging al. 1999) 
190 pNOY373 rDNA mit Promoter, 
Start bei -206 mit 
XhoI-NotI flanked 
enhancer 
  (Wai et 
al. 2000) 
375 pT11 Constuct for 
propagation approach 
in delta rdn yeast 
strains.  
L/RS/rDNA/lexA/RS/L/
R (RS: recombination 
side, lexA: lexA binding 
side) 
  Griesen
beck, 
Joachim 
1245 pRS316 
SIRT G-less 
SIRT fragment and G-
less cassette 
unknown, beware of sequence 
mistakes!!!! 
in vitro 
transcripti
on 
template 
Philipp 
Merkl/
Max 
Felle/ 
Axel 
Berger 
1247 pUC19 PIP 
G- 601 
contains Pol I 
promoter dependent 
601 template for in 
vitro transcription 
EcoRI/EcoRV digested 
amplicon from pRS316 SIRT G-
less with 2107/2108 into KasI, 
blunted/EcoRI digested pUC19 
601 
in vitro 
transcripti
on 
template 
Philipp 
Merkl 
1248 pUC19 PIP 
G- 3xLexA 
contains Pol I 
promoter dependent 
3xLexA template for in 
vitro transcription 
EcoRI/HindIII digested 
amplicon from pT11 with 
2109/2110 into same digested 
pUC19 PIP G-601 
in vitro 
transcripti
on 
template 
Philipp 
Merkl 
1249 pUC19 PIP 
G- 5xTTF1 
contains Pol I 
promoter dependent 
5xTTF1 template for in 
vitro transcription 
EcoRI/HindIII digested 
amplicon from pMrEnIL9T5 
with 2111/2112 into same 
digested pUC19 PIP G-601 
in vitro 
transcripti
on 
template 
Philipp 
Merkl 
1250 pUC19 PIP 
G- 5xTTF1 
inv 
contains Pol I 
promoter dependent 
5xTTF1 inv template 
EcoRI/HindIII digested 
amplicon from pMrEnIL9T5 
with 2113/2114 into same 
in vitro 
transcripti
on 
Philipp 
Merkl 
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for in vitro 
transcription 
digested pUC19 PIP G-601 template 
1251 pUC19 PIP 
G- Enh 
contains Pol I 
promoter dependent 
Enh template for in 
vitro transcription 
EcoRI/BamHI digested 
amplicon from pRS316 SIRT G-
less with 2105/2106 into same 
digested pUC19 PIP G-601 
in vitro 
transcripti
on 
template 
Philipp 
Merkl 
1252 pUC19 PIP 
G- 12x601 
contains Pol I 
promoter dependent 
12x601 template for in 
vitro transcription 
EcoRI/HindIII digested 
fragment from pUC18 12x601 
into same digested pUC19 PIP 
G-601 
in vitro 
transcripti
on 
template 
Philipp 
Merkl 
1253 pUC19 tail 
G- 601 
contains tailed 
template 601 for in 
vitro transcription 
KasI/EcoRI digested amplicon 
from pRS316 SIRT G-less with 
2115/2107 into same digested 
pUC19 601 
in vitro 
transcripti
on 
template 
Philipp 
Merkl 
1254 pUC19 tail 
G- 3xLexA 
contains tailed 
template 3xLexA for in 
vitro transcription 
EcoRI/HindIII digested 
amplicon from pT11 with 
2109/2110 into same digested 
pUC19 tail G-601 
in vitro 
transcripti
on 
template 
Philipp 
Merkl 
1255 pUC19 tail 
G- 5xTTF1 
contains tailed 
template 5xTTF1 for in 
vitro transcription 
EcoRI/HindIII digested 
amplicon from pMrEnIL9T5 
with 2111/2112 into same 
digested pUC19 tail G-601 
in vitro 
transcripti
on 
template 
Philipp 
Merkl 
1256 pUC19 tail 
G- 5xTTF1 
inv 
contains tailed 
template 5xTTF1 inv 
for in vitro 
transcription 
EcoRI/HindIII digested 
amplicon from pMrEnIL9T5 
with 2113/2114 into same 
digested pUC19 tail G-601 
in vitro 
transcripti
on 
template 
Philipp 
Merkl 
1257 pUC19 tail 
G- Enh 
contains tailed 
template Enh for in 
vitro transcription 
EcoRI/BamHI digested 
amplicon from pRS316 SIRT G-
less with 2105/2106 into same 
digested pUC19 tail G-601 
in vitro 
transcripti
on 
template 
Philipp 
Merkl 
1258 pUC19 tail 
G- 12x601 
contains tailed 
template 12x601 for in 
vitro transcription 
EcoRI/HindIII digested 
fragment from pUC18 12x601 
into same digested pUC19 PIP 
G-601 
in vitro 
transcripti
on 
template 
Philipp 
Merkl 
1275 pET21a vector for expression AvaI/BamHI insertion of REB1 Expressio Philipp 
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REB1 of Reb1p with a C 
terminal His tag 
ORF amplified from genomic 
yeast DNA 
n of 
Reb1p 
with a C 
terminal 
His tag 
Merkl 
1561 pUC19 tail 
g- 1xLacR 
contains tailed 
template with 1 Lac 
repressor binding site 
for in vitro 
transcription 
EcoRI/ HindIII fragment of 
annealed oligos 2625/2626 
into EcoRI/ HindIII cut pUC19 
tail g- 3xLexA 
in vitro 
transcripti
on 
Philipp 
Merkl 
1562 pUC19 PIP 
g- 1xLacR 
contains Pol I 
promoter template 
with 1 Lac repressor 
binding site for in vitro 
transcription 
EcoRI/ HindIII fragment of 
annealed oligos 2625/2626 
into EcoRI/ HindIII cut pUC19 
PIP g- 3xLexA 
in vitro 
transcripti
on 
Philipp 
Merkl 
1563 pUC19 tail 
g- 2xLacR 
contains tailed 
template with 2 Lac 
repressor binding sites 
for in vitro 
transcription 
EcoRI/ BamHI fragment of 
annealed 2xLacR up and down 
oligos (Alarich) into EcoRI/ 
BamHI cut pUC19 tail g- Enh 
in vitro 
transcripti
on 
Philipp 
Merkl 
1564 pUC19 PIP 
g- 2xLacR 
contains Pol I 
promoter template 
with 2 Lac repressor 
binding sites for in 
vitro transcription 
EcoRI/ BamHI fragment of 
annealed 2xLacR up and down 
oligos (Alarich) into EcoRI/ 
BamHI cut pUC19 PIP g- Enh 
in vitro 
transcripti
on 
Philipp 
Merkl 
1565 pFL FLAG 
TEV REB1 
Acceptor vector for 
Multibac system with 
REB1 ORF 
ORF from yeast genomic DNA 
with primers 2596/2602, 
restricted with BamHI/ SacI 
into BamHI/SacI cut pFL FLAG 
TEV 
SF21 
expressio
n 
Philipp 
Merkl 
1566 pFL FLAG 
TEV PAF1 
Acceptor vector for 
Multibac system with 
PAF1 ORF 
ORF from yeast genomic DNA 
with primers 2595/2601, 
restricted with BamHI/ SacI 
into BamHI/SacI cut pFL FLAG 
TEV 
SF21 
expressio
n 
Philipp 
Merkl 
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1567 pFL FLAG 
TEV HMO1 
Acceptor vector for 
Multibac system with 
HMO1 ORF 
ORF from yeast genomic DNA 
with primers 2593/2599, 
restricted with BamHI/ SacI 
into BamHI/SacI cut pFL FLAG 
TEV 
SF21 
expressio
n 
Philipp 
Merkl 
1568 pFL FLAG 
TEV FOB1 
Acceptor vector for 
Multibac system with 
FOB1 ORF 
ORF from yeast genomic DNA 
with primers 2592/2598, 
restricted with BamHI/ SacI 
into BamHI/SacI cut pFL FLAG 
TEV 
SF21 
expressio
n 
Philipp 
Merkl 
1569 pFL FLAG 
TEV 
YDR026c 
Acceptor vector for 
Multibac system with 
YDR026c ORF 
ORF from yeast genomic DNA 
with primers 2604/2605, 
restricted with BamHI/ SacI 
into BamHI/SacI cut pFL FLAG 
TEV 
SF21 
expressio
n 
Philipp 
Merkl 
1570 pFL FLAG 
TEV mTTF1 
Acceptor vector for 
Multibac system with 
mTTF1 ORF 
ORF from yeast genomic DNA 
with primers 2594/2600, 
restricted with BamHI/ SacI 
into BamHI/SacI cut pFL FLAG 
TEV 
SF21 
expressio
n 
Philipp 
Merkl 
1571 pUC19 tail 
g- Enh 
2xLacR 
contains tailed 
template with 2 Lac 
repressor binding sites 
after the rDNA 
Enhancer for in vitro 
transcription 
BamHI/ PstI fragment of 
annealed oligos 2619/2620 
into BamHI / PstI cut pUC19 
tail g- Enh 
in vitro 
transcripti
on 
Philipp 
Merkl 
1572 pUC19 tail 
g- LacO 
contains tailed 
template with the Lac 
Operator for in vitro 
transcription 
EcoRI/ HindIII fragment of 
annealed oligos 2623/2624 
into EcoRI/ Hind III cut pUC19 
tail g- 3x LexA 
in vitro 
transcripti
on 
Philipp 
Merkl 
1573 pUC19 tail 
g- 
contains tailed 
template without any 
binding sites for in 
vitro transcription 
EcoRI /Hind III cut pUC19 tail 
g- 3xLexA blunted and re-
ligated 
in vitro 
transcripti
on 
Philipp 
Merkl 
1574 pUC19 tail contains tailed EcoRI/ HindIII fragment of in vitro Philipp 
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g- tRNA Ala template with the 
yeast alanine tRNA for 
in vitro transcription 
annealed oligos 2612/2613 
into EcoRI/ Hind III cut pUC19 
tail g- 3x LexA 
transcripti
on 
Merkl 
1575 pGST 4T1 
LACI 
expression of LacI as 
an N terminal GST 
fusion 
ORF from pGST 4T1 with 
primers 2614/2616 restricted 
with BamHI /NotI into BamHI/ 
NotI cut pGST 4T1 
E. coli 
expressio
n 
Philipp 
Merkl 
1576 pGST LEXA expression of LexA as 
an N terminal GST 
fusion 
 E. coli 
expressio
n 
Griesen
beck, 
Joachim 
1959 pUC19 PIP 
g- w/o BS 
contains Pol I 
promoter template 
with no protein 
binding site for in vitro 
transcription 
cut #1248 with EcoRI/HindIII, 
blunt, re-ligate 
in vitro 
txn 
Philipp 
Merkl 
1960 pUC19 tail 
g- TER 
contains tailed 
template with rDNA 
terminator including 
T1 T-rich element for 
in vitro transcription 
SacI/BamHI cut terminator 
region amplified with primers 
#3050/3051 was cloned into 
SacI/BamHI cut vector #1253 
in vitro 
txn 
Philipp 
Merkl 
1961 pUC19 PIP 
g- TER 
contains Pol I 
promoter template 
with rDNA terminator 
including T1 T-rich 
element for in vitro 
transcription 
SacI/BamHI cut terminator 
region amplified with primers 
#3050/3051 was cloned into 
SacI/BamHI cut vector #1247 
in vitro 
txn 
Philipp 
Merkl 
1962 pUC19 tail 
g- Rnt TER 
contains tailed 
template with rDNA 
terminator including 
T1 T-rich element and 
Rnt1 cleavage site for 
in vitro transcription 
SacI/BamHI cut terminator 
region amplified with primers 
#3052/3051 was cloned into 
SacI/BamHI cut vector #1253 
in vitro 
txn 
Philipp 
Merkl 
1963 pUC19 PIP 
g- Rnt TER 
contains Pol I 
promoter template 
with rDNA terminator 
SacI/BamHI cut terminator 
region amplified with primers 
#3052/3051 was cloned into 
in vitro 
txn 
Philipp 
Merkl 
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including T1 T-rich 
element and Rnt1 
cleavage site for in 
vitro transcription 
SacI/BamHI cut vector #1247 
1964 pUC19 tail 
g- rDNA 
BamHI SacI 
frag 
contains tailed 
template with the 
BamHI SacI fragment 
of the rDNA, for 
further cloning 
SacI/BamHI rDNA fragment 
from pNOY373 was inserted 
into SacI/BamHI cut vector 
#1253 
in vitro 
txn 
Philipp 
Merkl 
1965 pUC19 PIP 
g- rDNA 
BamHI SacI 
frag 
contains Pol I 
promoter template 
with the BamHI SacI 
fragment of the rDNA, 
for further cloning 
SacI/BamHI rDNA fragment 
from pNOY373 was inserted 
into SacI/BamHI cut vector 
#1247 
in vitro 
txn 
Philipp 
Merkl 
1966 pUC19 tail 
g- rDNA 
contains tailed 
template with 
complete rDNA for in 
vitro transcription 
pUC19 tail g- rDNA 
BamHI/SacI frag was cut with 
SacI, blunted and the blunted 
PCR amplicon from pNOY373 
with primers #3055/3056 was 
inserted 
in vitro 
txn 
Philipp 
Merkl 
1967 pUC19 PIP 
g- rDNA 
contains Pol I 
promoter template 
with complete rDNA 
for in vitro 
transcription 
pUC19 PIP g- rDNA 
BamHI/SacI frag was cut with 
SacI, blunted and the blunted 
PCR amplicon from pNOY373 
with primers #3055/3056 was 
inserted 
in vitro 
txn 
Philipp 
Merkl 
1968 pUC19 tail 
g- TspRI 
TER 
contains 3' part of a 
Studitsky in vitro txn 
template with the 
rDNA terminator 
including the T1 T-rich 
element 
blunt end ligation of a linker 
created via annealing of two 
oligos containing a TspRI 
restriction site into SacI cut 
pUC19 tail g- TER 
in vitro 
txn 
Philipp 
Merkl 
1969 pUC19 tail 
g- TspRI 
5xTTF1 
contains 3' part of a 
Studitsky in vitro txn 
template with 5 TTF1 
blunt end ligation of a linker 
created via annealing of two 
oligos containing a TspRI 
in vitro 
txn 
Philipp 
Merkl 
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binding sites restriction site into EcoRI cut 
#1255 
1970 pUC19 tail 
g- TspRI 
w/o BS 
contains 3' part of a 
Studitsky in vitro txn 
template without 
binding sites 
blunt end ligation of a linker 
created via annealing of two 
oligos containing a TspRI 
restriction site into EcoRV cut 
#1573 
in vitro 
txn 
Philipp 
Merkl 
1971 pUC19 PIP 
g- TspRI 
601 
contains 3' part of a 
Studitsky in vitro txn 
template with one 601 
sequence 
blunt end ligation of a linker 
created via annealing of two 
oligos containing a TspRI 
restriction site into EcoRI cut 
#1247 
in vitro 
txn 
Philipp 
Merkl 
1972 pUC19 tail 
g- TspRI 
3xLexA 
contains 3' part of a 
Studitsky in vitro txn 
template with 3 LexA 
binding sites 
blunt end ligation of a linker 
created via annealing of two 
oligos containing a TspRI 
restriction site into EcoRI cut 
#1254 
in vitro 
txn 
Philipp 
Merkl 
1973 pGEX 4T1 
PAF1 
Expression of Paf1 as a 
GST fusion protein 
ORF from yeast genomic DNA 
amplified with primers 
introducing a 5' BamHI and 3' 
NotI site into BamHI NotI cut 
pGEX 4T1 
protein 
expressio
n 
Philipp 
Merkl 
1974 pGEX 4T1 
HMO1 
Expression of Hmo1 as 
a GST fusion protein 
ORF from yeast genomic DNA 
amplified with primers 
introducing a 5' BamHI and 3' 
NotI site into BamHI NotI cut 
pGEX 4T1 
protein 
expressio
n 
Philipp 
Merkl 
1975 pGEX 4T1 
FOB1 
Expression of Fob1 as 
a GST fusion protein 
ORF from yeast genomic DNA 
amplified with primers 
introducing a 5' BamHI and 3' 
NotI site into BamHI NotI cut 
pGEX 4T1 
protein 
expressio
n 
Philipp 
Merkl 
1976 pGEX 4T1 
Ydr026c 
Expression of Ydr026c 
as a GST fusion protein 
ORF from yeast genomic DNA 
amplified with primers 
introducing a 5' BamHI and 3' 
protein 
expressio
n 
Philipp 
Merkl 
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NotI site into BamHI NotI cut 
pGEX 4T1 
2144 pUC 19 tail 
g- ENH 
elongated 
a sequence 5' of the 
ENH was inserted to 
give a longer 
transcription product 
/better detection 
amplicon of primers #2479 
and #2480 from pT11 
phosphorylated and cloned 
into EcoRI cut #1257 
in vitro 
txn 
Philipp 
Merkl 
2145 pUC 19 tail 
g- TER 
elongated 
a sequence 5' of the 
ENH was inserted to 
give a longer 
transcription product 
/better detection 
amplicon of primers #2479 
and #2480 from pT11 
phosphorylated and cloned 
into SacI cut #1960 
in vitro 
txn 
Philipp 
Merkl 
2146 pUC 19 tail 
g- Rnt TER 
elongated 
a sequence 5' of the 
ENH was inserted to 
give a longer 
transcription product 
/better detection 
amplicon of primers #2479 
and #2480 from pT11 
phosphorylated and cloned 
into SacI cut #1962 
in vitro 
txn 
Philipp 
Merkl 
2147 pUC 19 PIP 
g- ENH 
elongated 
a sequence 5' of the 
ENH was inserted to 
give a longer 
transcription product 
/better detection 
amplicon of primers #2479 
and #2480 from pT11 
phosphorylated and cloned 
into EcoRI cut #1251 
in vitro 
txn 
Philipp 
Merkl 
2148 pUC 19 PIP 
g- TER 
elongated 
a sequence 5' of the 
ENH was inserted to 
give a longer 
transcription product 
/better detection 
amplicon of primers #2479 
and #2480 from pT11 
phosphorylated and cloned 
into SacI cut #1961 
in vitro 
txn 
Philipp 
Merkl 
2149 pUC 19 PIP 
g- Rnt TER 
elongated 
a sequence 5' of the 
ENH was inserted to 
give a longer 
transcription product 
/better detection 
amplicon of primers #2479 
and #2480 from pT11 
phosphorylated and cloned 
into SacI cut #1963 
in vitro 
txn 
Philipp 
Merkl 
2150 pET21a 
Ydr026c 
C terminal His tagging 
of Ydr026c  
BamHI / AvaI fragment of 
amplicon of primers #2604 
and #3096 from a PCR product 
expressio
n 
Philipp 
Merkl 
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with primers 2604# and #2605 
from yeast genomic DNA 
(NOY505) cloned into pET21a 
2244 pUC19 tail 
G- 3xLexA 
elong 
contains tailed 
template 3xLexA for in 
vitro transcription, 
insertion of 124bp 5‘ 
of the first LexA BS 
amplicon from pT11 with 
#2479 and #2480 in EcoRI cut  
and blunted #1254 
in vitro 
transcripti
on 
template 
Philipp 
Merkl 
2245 pUC 19 tail 
g- TER Reb1 
inv 
elongated 
contains tailed 
template with rDNA 
terminator including 
T1 T-rich element for 
in vitro transcription, 
Reb1 BS is inverted 
AflII/BamHI digested amplicon 
of primers #3792 and #2105 in 
likewise digested #2145 
in vitro 
txn 
Philipp 
Merkl 
2246 pUC 19 tail 
g- TER 
noReb1 BS 
elongated 
contains tailed 
template with rDNA 
terminator including 
T1 T-rich element for 
in vitro transcription, 
Reb1 BS is deleted 
AflII/BamHI digested amplicon 
of primers #3793 and #2105 in 
likewise digested #2145 
in vitro 
txn 
Philipp 
Merkl 
2247 pUC 19 tail 
g- TER PsiI 
elongated 
contains tailed 
template with rDNA 
terminator including 
T1 T-rich element for 
in vitro transcription, 
introduction of a PsiI 
site in the Abf1 BS via 
a point mutation 
amplicon of primers #3796 
and #3797 was re-ligated, 
template #2145 
in vitro 
txn 
Philipp 
Merkl 
2248 pUC 19 tail 
g- ENH PsiI 
elongated 
contains tailed 
template with rDNA 
terminator including 
T1 T-rich element for 
in vitro transcription, 
introduction of a PsiI 
site in the Abf1 BS via 
amplicon of primers #3796 
and #3797 was re-ligated, 
template #2144 
in vitro 
txn 
Philipp 
Merkl 
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a point mutation 
2249 pUC19 tail 
g- 601 
elong 
contains tailed 
template 601 for in 
vitro transcription, 
insertion of 124bp 5‘ 
of the 601 sequence 
EcoRI and KpnI digested PCR 
product obtained with primers 
#3798 and #3799 (template 
pT11) was ligated into vector 
#1253 cut with EcoRI and KpnI   
in vitro 
transcripti
on 
template 
Philipp 
Merkl 
Table 3-11: Plasmids. 
 
D) DNA and RNA size markers 
 
1kb ladder: NEB 
fragment size [bp]: 10002, 8001, 6001, 5001, 4001, 3001, 2000, 1500, 1000, 517, 500 
 
100bp ladder: NEB 
fragment size [bp]: 1517, 1200, 1000, 900, 800, 700, 600, 517, 500, 400, 300, 200, 100 
 
GeneRuler™ 1kb Plus DNA ladder: Fermentas 
fragment size [bp]: 75, 200, 300, 400, 500, 700, 1000, 1500, 2000, 3000, 4000, 5000, 7000, 10000, 
20000 
 
Century™ Plus RNA marker templates: Ambion 
Transcribed in vitro with T7 RNA polymerase (3.2.11 E), transcript sizes [nt]: 100, 200, 300, 400, 500, 
750, 1000 
All marker solutions were prepared according to the standard operating protocols of the 
manufacturers. 
 
 
3.1.5 Enzymes and polypeptides 
 
All enzymes were used with the provided buffers. 
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enzyme supplier 
Calf Intestinal Phosphatase New England Biolabs 
GoTaq DNA Polymerase Promega 
Herculase II Fusion DNA Polymerase Stratagene 
iProof High-Fidelity DNA Polymerase Bio Rad 
M-MLV Reverse Transcriptase Invitrogen 
Proteinase K Sigma Aldrich 
Restriction endonucleases New England Biolabs 
RNase A Invitrogen 
RNase H Roche 
T4 DNA Ligase New England Biolabs 
T4 DNA Polymerase New England Biolabs 
T4 Polynucleotide Kinase New England Biolabs 
T7 RNA Polymerase New England Biolabs 
Tobacco Etch Virus Protease (TEV) in-lab-prepared 
Trypsin Sequencing Grade Roche 
PreScission Protease GE Healthcare 
Thrombin Sigma Aldrich 
RNasin® Plus RNase inhibitor Promega 
Proteinase K (from Tritiarchium album) Sigma 
Table 3-12: Enzymes and polypeptides. 
 
 
3.1.6 Antibodies 
 
# antibody species dilution origin 
10 anti A49 rabbit 1:50000  
12 anti A43 rabbit 1:10000  
13 anti A135 rabbit 1:30000 (Buhler et al. 1980) 
32 anti A190 rabbit 1:5000  
33 anti Reb1 rabbit 1:5000  
50 anti Pol III rabbit 1:5000  
59/1 anti TFG1  rabbit 1:5000 Stefan Bjorklund 
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59/2 anti TFG3 rabbit 1:5000 Stefan Bjorklund 
75 anti HA (3F10) rat 1:5000 Roche 
77 
anti Pol II complete 
(8WG16) 
mouse 1:2000 HISS 
78 
anti Rabbit IgG (H+L) 
[peroxidase conjugated] 
goat 1:5000 Dianova 
79 
anti mouse IgG (H+L) 
[peroxidase conjugated] 
goat 1:5000 Dianova 
81 
anti rat IgG (H+L) 
[peroxidase conjugate] 
goat 1:5000 Dianova 
83 anti FLAG M2 mouse 1:5000 Sigma Aldrich 
98 anti GST rabbit 1:5000 Santa Cruz 
102 anti CBP goat 1:5000  
104 
anti goat IgG (H+L) 
[peroxidase conjugated] 
donkey 1:5000 Dianova 
105 anti Protein A (PAP) goat 1:5000 Sigma Aldrich 
110 anti A12.2 rabbit 1:5000 Christophe Carles 
Table 3-13: Antibodies. 
 
 
3.1.7 Organisms 
 
A) Escherichia coli strains 
 
strain genotype 
Escherichia coli (E. coli) XL1 blue 
endA1 gyrA96(nalR) thi-1 recA1 relA1 lac glnV44 F’[ ::Tn10 
proAB+ lacIq Δ(lacZ)M15] hsdR17(rK- mK+) 
E. coli BL21 (DE3) 
F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI lacUV5-T7 gene 
1 ind1 sam7 nin5]) 
E. coli K12 TB1 F- ara Δ(lac-proAB) [Φ80dlac Δ(lacZ)M15] rpsL(StrR) thi hsdR 
E.coli DH10Bac eYFP 
pMON7124 (bom+, tra-, mob-), bMON14272 – eYFP, F– mcrA 
(mrr-hsdRMS-mcrBC) 80lacZΔ M15 lacX74 recA1 endA1 
araD139 (ara, leu)7697 galU galK – rpsL nupG  
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E. coli DH5α 
F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 
(rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 
Table 3-14: E. coli strains. 
 
B) Saccharomyces cerevisiae strains 
 
# name genotype origin 
- 
NOY222 RPA135-ProtA 
A190 SallA 
MATα trp1-1 his4-401 leu2-3,112 ura3-52 
can r rpa190::URA3 RPA135-ProtA::kanMX6 
pRS314 rpa190 SallA 
Jorge Perez-
Fernandez 
- 
NOY222 RPA135-ProtA 
A190 SallD 
MATα trp1-1 his4-401 leu2-3,112 ura3-52 
can r rpa190::URA3 RPA135-ProtA::kanMX6 
pRS314 rpa190 SallD 
Jorge Perez-
Fernandez 
- 
NOY222 RPA135-ProtA 
A190 S936A 
MATα trp1-1 his4-401 leu2-3,112 ura3-52 
can r rpa190::URA3 RPA135-ProtA::kanMX6 
pRS314 rpa190 S936A 
Jorge Perez-
Fernandez 
- 
NOY222 RPA135-ProtA 
A190 S936D 
MATα trp1-1 his4-401 leu2-3,112 ura3-52 
can r rpa190::URA3 RPA135-ProtA::kanMX6 
pRS314 rpa190 S936D 
Jorge Perez-
Fernandez 
- 
NOY222 RPA135-ProtA 
A190 S941A 
MATα trp1-1 his4-401 leu2-3,112 ura3-52 
can r rpa190::URA3 RPA135-ProtA::kanMX6 
pRS314 rpa190 S941A 
Jorge Perez-
Fernandez 
- 
NOY222 RPA135-ProtA 
A190 S941D 
MATα trp1-1 his4-401 leu2-3,112 ura3-52 
can r rpa190::URA3 RPA135-ProtA::kanMX6 
pRS314 rpa190 S941D 
Jorge Perez-
Fernandez 
206 BY4741 MATa, his3-1 leu2-0 met15-0 ura3-0 
Euroscarf 
(Brachmann 
et al. 1998) 
207 BY4742 MATα, his3-1 leu2-0 met15-0 ura3-0 
Euroscarf 
(Brachmann 
et al. 1998) 
531 NOY222 RPA135-ProtA 
MATα trp1-1 his4-401 leu2-3,112 ura3-52 
can r rpa190::URA3 RPA135-ProtA::kanMX6 
Jochen Gerber 
601 Y06861 (BY4741 ∆A12) MATa, his3-1 leu2-0 met15-0 ura3-0 Alarich Reiter 
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YJR063w::kanMX4 
779 NOY222 A190 S685A 
MATα trp1-1 his4-401 leu2-3,112 ura3-52 
can r rpa190::URA3 pRS314-rpa190-p5 
Jochen Gerber 
780 NOY222 A190 S685D 
MATα trp1-1 his4-401 leu2-3,112 ura3-52 
can r rpa190::URA3 pRS314-rpa190-p6 
Jochen Gerber 
2018 NOY505 Fob1-TAP (ySH38) 
MATa ade2-1 ura3-1 trp1-1 leu2-3,112 his3-
11 can1-100 Fob1-TAP-kanMX6 PHO5 RDN 
Stephan 
Hamperl 
2423 BY4741 A135-TEV-ProtA 
MATa, his3-1 leu2-0 met15-0 ura3-0 
rpa135::RPA135-TEV-ProtA-kanMX6 
Jochen Gerber 
2424 BY4741 Rpb2-TEV-ProtA 
MATa, his3-1 leu2-0 met15-0 ura3-0 
rpb2::RPB2-TEV-ProtA-kanMX6 
Jochen Gerber 
2425 BY4741 C128-TEV-ProtA 
MATa, his3-1 leu2-0 met15-0 ura3-0 
c128::C128-TEV-ProtA-kanMX6 
Jochen Gerber 
2559 BY4741 Spt16-TAP 
MATa leu2-0 met15-0 ura3-0 YGL207w-TAP 
HIS3MX6 
Open 
Biosystems 
2560 BY4741 pob3-TAP 
MATa leu2-0 met15-0 ura3-0 YML069w-TAP 
HIS3MX6 
Open 
Biosystems 
2670 yJPF162-1a 
MATα, his3-1 leu2-0 lys2 ura3-0 RPA135-
TEV-ProtA::kanMX6 HIS3MX::GAL::HA-
RPA49 
Jorge Pérez-
Fernández 
2994 DSY5 Int3 
MATα leu2 trp1 ura3-52 his3::PGAL1-GAL4 
pep4 prb1-1122 YGR186W (leu2) YGR005C-
TAP (trp1) YPL129W (ura3) 
(Chen et al. 
2010) 
3051 
BY4741 A135 His7 ProtA 
His7 
MATa, his3-1 leu2-0 met15-0 ura3-0 
rpa135::RPA135-His7-ProtA-His7 (his3) 
this study 
3052 
BY4741 Rpb2 His7 ProtA 
His7 
MATa, his3-1 leu2-0 met15-0 ura3-0 
rpb2::RPB2-His7-ProtA-His7 (his3) 
this study 
3053 
BY4741 C128 His7 ProtA 
His7 
MATa, his3-1 leu2-0 met15-0 ura3-0 
c128::C128-His7-ProtA-His7 (his3) 
this study 
Table 3-15: Yeast strains. 
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C) SF21 insect cells 
 
The SF21 cell line is developed from primary explants of pupal tissue from the insect Spodoptera 
frugiperda (Vaughn et al., 1977). Cells were purchased from Invitrogen™. 
 
3.1.8 Baculoviruses 
 
# expressed protein MultiBac parent vector origin 
46 FLAG-TEV-Reb1 pFL-FLAG-TEV this study 
47 FLAG-TEV-Paf1 pFL-FLAG-TEV this study 
48 FLAG-TEV-Hmo1 pFL-FLAG-TEV this study 
49 FLAG-TEV-Fob1 pFL-FLAG-TEV this study 
50 FLAG-TEV-Ydr026c pFL-FLAG-TEV this study 
51 FLAG-TEV-mTTF-I pFL-FLAG-TEV this study 
Table 3-16: Baculoviruses. 
 
 
3.1.9 Kits 
 
name manufacturer 
peqGOLD Plasmid Miniprep kit Peqlab 
peqGOLD Gel Extraction kit Peqlab 
peqGOLD MicroSpin CyclePure kit Peqlab 
QIAprep Spin Miniprep kit QIAGEN 
QIAquick gel extraction kit QIAGEN 
QIAquick PCR purification kit QIAGEN 
QIAEX II Gel Extraction kit QIAGEN 
PureLink® HiPure Plasmid Filter Maxiprep Kit Invitrogen™ 
PureLink® HiPure Plasmid Filter Midiprep Kit Invitrogen™ 
iTRAQ™ labeling kit Life Technologies™ 
Table 3-17: Kits. 
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3.1.10 Equipment 
 
name manufacturer 
4800 Proteomics analyzer MALDI TOF/TOF Applied Biosystems 
-80°C Fridge Ultra Low Sanyo 
Avanti J-26 XP centrifuge Beckman Coulter 
AxioCam MR CCD camera Carl Zeiss 
Axiovert 200M microscope Carl Zeiss 
BAS cassette 2040 Fuji 
BAS III imaging plate Fuji 
Bc-Mag Separator-24 Bioclone Inc. 
Bc-Mag Separator-50 Bioclone Inc. 
Biofuge Fresco refrigerated tabletop centrifuge Heraeus 
Biofuge Pico tabletop centrifuge Heraeus 
C412 centrifuge Jouan 
C422 r centrifuge Jouan 
Centrifuge 1-14 Sigma 
Centrifuge 5-14 Sigma 
Centrikon T-324 centrifuge Kontron Instruments 
Contamat FHT 111M Thermo Scientific 
ECPS 3000/150 Power supply Pharmacia Biotech 
Electrophoresis system model 45-2010-i Peqlab 
Eraser Raytest 
FlexCycler Thermocycler Twinblock 48x48 Analytic Jena 
Fluorescent Image Analyzer FLA 3000 Fuji 
Gel max UV transilluminator Intas 
Hemocytometer Neubauer II Neubauer 
HB-1000 Hybridization Oven UVP 
IKA-Vibrax VXR IKA 
Incubators Memmert 
Insect cell incubator Binder 
IX 50 microscope Olympus 
LAS 3000 chemiluminescence imager Fuji 
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Microcentrifuge 5415 r Eppendorf 
Microcentrifuge MC6 Sarstedt 
MicroPulser electroporation apparatus Bio-Rad 
Microwave Privileg 
NanoDrop ND-1000 spectrophotometer Peqlab 
PerfectBlot Hybridisation Oven Peqlab 
PIPETMAN® Classic P2, P10, P200, P1000 Gilson Inc. 
Power Pac 3000 Power supplies Bio-Rad 
ProBot MALDI Target Spotter Dionex / Thermo Scientific 
Pumpdrive 5001 Heidolph 
PURELAB Ultra ELGA 
QIAcube QIAGEN 
Shake incubators Multitron/Minitron Infors 
SMART system Pharmacia Biotech 
Sonifier 250 Branson 
Speed Vac Concentrator Savan 
Sterile bench LaminAir HLB2472GS Heraeus 
Sub-Cell GT Agarose Gel Electrophoresis System Bio-Rad 
Superose 12 PC 3.2/30 GE Healthcare 
Thermomixer® Dry block heating shaker Eppendorf 
Trans Blot SD semi-dry transfer cell Bio-Rad 
Ultimate 3000 nanoHPLC Dionex 
Unimax 2010 shaker Heidolph 
UV/Vis Spectrophotometer Ultraspec 3100pro Amersham Biosciences 
Vacufuge Plus Concentrator Eppendorf 
Vortex-Genie 2 Scientific Industries 
Table 3-18: Equipment. 
 
 
3.1.11 Consumables 
 
name supplier 
Anti-FLAG M2 Affinity Resin Sigma Aldrich 
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BcMag™ Epoxy-Activated Magnetic Beads Bioclone Inc. 
Bis-Tris Novex® NuPAGE® 4-12% gel Invitrogen 
Blotting Papers MN 827 B  
BM Chemiluminescence Blotting Substrate (POD) Roche 
Calmodulin Affinity Resin Stratagene 
Century™ RNA Plus marker templates Ambion® 
Color Plus Prestained Protein Marker Broad 
Range (7-175kDa) 
New England Biolabs 
Filter paper 3MM Whatman 
FLAG peptide Sigma Aldrich 
FuGene HD Transfection reagent Promega 
Gene Pulser cuvettes Bio Rad 
Glass beads (ø 0.75-1mm) Roth 
glycogen solution (5mg/ml) Ambion® 
Immobilon-P transfer membrane Millipore 
Multiwell plates (6 wells, 24 wells) Sarstedt 
Ni-NTA superflow Affinity Resin QIAGEN 
NuPAGE® MES buffer Invitrogen 
NuPAGE® MOPS buffer Invitrogen 
Protein Assay Dye Reagent Concentrate Bio Rad 
Rabbit IgG Sigma Aldrich 
SimplyBlue™ SafeStain Invitrogen 
SYBR Safe DNA Gel stain Invitrogen 
Table 3-19: Consumables. 
 
 
3.1.12 Software 
 
name manufacturer 
4000 Series Explorer Applied Biosystems 
Acrobat 7.0 Professional Adobe Systems 
Axio Vision Rel. 4.7 Carl Zeiss 
Data Explorer v. 4.5C Applied Biosystems 
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GPS Explorer v. 3.5 Applied Biosystems 
Illustrator CS3 Adobe Systems 
Image Reader FLA3000 v. 1.8 Fuji 
Image Reader LAS3000 v2.2 Fuji 
Mascot Matrix Science 
Microsoft Office 2007 Microsoft 
MultiGauge v. 3.0 Fuji 
ND1000 v. 3.5.2 Peqlab 
Photoshop Elements 6.0 Adobe Systems 
Sigma Plot Systat 
Vector NTI Advance™ 11 Invitrogen™ 
Table 3-20: Software. 
 
 
3.2 Methods  
 
3.2.1 Enzymatic DNA manipulation 
 
A) Polymerase chain reaction (PCR) 
 
A standard PCR reaction had a volume of 20-50µl. It contained the DNA to be amplified (1-10ng), 
250µM desoxynucleotides, 20pmol of each the forward and the reverse primer, the buffer supplied 
with the polymerase in a final 1x concentration and the appropriate polymerase. If applicable, a 
mastermix was prepared from the components. PCR reactions were carried out in 0.2ml thin-wall 
PCR tubes. For cloning purposes, the Herculase system (Stratagene) was used, for colony PCR the 
GoTaq system (Promega) was applied. Herculase polymerase has proof-reading activity, Taq 
polymerase has not. PCR was performed in a semi-hotstart manner to reduce primer-polymerase 
interactions, mispriming due to secondary structure formation and formation of primer dimers. Thus, 
the tubes were placed in the PCR machine when the block had reached 95°C or 98°C and initial 
denaturation of the DNA was carried out for 3min. DNA amplification was done for 35 cycles. A 
standard PCR cycle starts with an initial denaturation step (95°C for 20s), followed by annealing of 
the primers to their complementary DNA sequence (5°C below the calculated primer TM for 30s) and 
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the amplification step (72°C, 30s per kb for Herculase, 1min per kb for Taq polymerase). For primers 
with non-complementary 5’ overhangs >10nt, the first three cycles were performed at an annealing 
temperature of the complementary part of the primer. A final elongation step (72°C for 3min) is 
added after 35 cycles. Upon completion of the PCR, the samples were slowly cooled down and stored 
at 4°C. 
 
B) Sequence specific restriction digest 
 
Restriction endonucleases hydrolyze DNA phosphodiester bonds at specific recognition sites. All 
restriction digests were performed in 20µl-100µl reactions at the temperatures and buffer conditions 
advised by NEB. The used restriction enzyme volume correlated with the amount of DNA but never 
exceeded 10% of the reaction volume due to glycerol in the enzyme storage buffer. 
 
C) Introduction of single strand breaks 
 
In the context of in vitro transcription with tailed templates (3.2.12), the introduction of single strand 
breaks in DNA is needed. For this purpose, the enzyme Nb.BsmI (NEB) was used. It has the same 
recognition sequence as BsmI (5’-NG’CATTC-3’) but hydrolyzes only the DNA strand with the given 
sequence. The cutting site is indicated with an apostrophe. The reaction contains the template, NEB 
buffer 3 and the enzyme and is carried out at 65°C for 1.5h. Afterwards, Nb.BsmI is heat-inactivated 
at 80°C for 20min. 
 
D) Blunting of single strand DNA overhangs 
 
T4 DNA polymerase (NEB) was used to fill in 5’ overhangs and to digest 3’ overhangs after restriction 
digest. Thus, both DNA strands within a duplex have the same length afterwards (blunt ends). The 
reaction contains 100µM dNTPs, 1U T4 DNA polymerase per µg DNA and the template. It is directly 
carried out in the restriction digest buffer. Incubation conditions are 15min sharp at 12°C. 
Afterwards, the reaction is stopped by DNA purification with the PCR cleanup kit (3.1.9). 
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E) Dephosphorylation at the 5’ end 
 
After restriction digest, a terminal orthophosphate group remains at the 5’ end of each DNA strand. 
To prevent re-ligation of matching ends of a DNA vector, treatment with calf intestinal phosphatase 
(CIP, NEB) is necessary. This is done by incubation of the restriction digest with 1µl of the enzyme at 
37°C. 
 
F) DNA Ligation 
 
DNA fragments with matching or blunt ends can be ligated with T4 DNA ligase (NEB). A standard 
reaction was 10µl and contained 100ng of plasmid DNA and a 3- to 5-molar excess of insert DNA. It 
was carried out in the supplemented buffer containing ATP with 0.5µl DNA ligase. Reaction time 
varied from 1h at room temperature to overnight incubation at 16 °C. 1-2 µl were used for 
transformation of E. coli. 
 
G) DNA sequencing 
 
For DNA sequencing, samples were sent to GENEART (Life Technologies). The obtained sequences 
were compared to annotated database sequences with vector NTI (Invitrogen). 
 
3.2.2 DNA purification and analysis 
 
A) Plasmid DNA purification 
 
Plasmid DNA was isolated from E. coli XL1 Blue overnight cultures with kits. The amount of purified 
plasmid DNA corresponds with culture size. “Minipreps” (2-5ml culture volume, yield of 
approximately 20µg of DNA) were done with a Peqlab “peqGold plasmid miniprep” kit), “Maxipreps” 
(150ml culture, 200µg of DNA) were prepared with an Invitrogen “PureLink® HiPure Plasmid 
Maxiprep” kit. In general, the manufacturer’s protocol was always followed. In a first step, the 
pelleted cells are lysed in a buffer containing NaOH, SDS and RNase A. After 5min incubation at RT, 
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the mixture is neutralized with potassium acetate (KOAc), which results in precipitation of the 
proteins and the genomic DNA. The precipitate is removed from the solution by centrifugation. The 
plasmid DNA-containing supernatant is transferred onto an anion-exchange column (Maxiprep) or a 
silica-based column (Miniprep), to which the DNA binds at low salt conditions. Residual RNAs and 
proteins are washed away. Plasmid DNA is eluted under high salt conditions. Excess salt is removed 
by isopropanol or ethanol precipitation and the precipitated DNA dissolved in water, EB or TE buffer. 
Plasmid DNA is stored at -20°C. 
 
B) Purification of genomic DNA from yeast 
 
Cells from an overnight culture (100ml YPD, OD600 0.6), were harvested by centrifugation (45ml, 
4000rpm, 15min, 4°C). The cells were resuspended in 2.5ml buffer AE (3.1.3) and split into 5 samples. 
To each sample, 50µl 10% SDS and 500µl Phenol equilibrated in AE were added, the solution 
vortexed and incubated at 65°C for 7min in a thermoblock. The suspension was chilled on ice for 
2min and centrifuged for 2min at 16000g and 4°C in a tabletop centrifuge. The RNA in the 
supernatant was sequentially extracted with 500µl Phenol/AE and 500µl chloroform and then 
subjected to EtOH precipitation. After each step, the solution was centrifuged for 2min at 16000g 
and 4°C. After precipitation, the pellet was dissolved in RNase free water and the RNA concentration 
was determined (3.2.2 G).  
 
C) PCR purification 
 
PCR products and DNA from restriction digests were purified with the “QIAquick PCR purification” kit 
(Qiagen) or the “peqGOLD cycle pure” kit (Peqlab). The manual of the manufacturer was always 
followed. The DNA above a certain exclusion size is bound to a silica-based column and proteins, 
salts, nucleotides and primers are washed away. The exclusion limit depends on the manufacturer 
and the reaction conditions. DNA is eluted in water or EB buffer. 
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D) DNA extraction from agarose gels 
 
Purification of one DNA fragment from a mixture of different DNA species was done via agarose gel 
electrophoresis. The “QIAquick gel extraction” kit (Qiagen) was used and the manufacturer’s protocol 
was followed. First, the band of interest is excised from the gel and weighed in a reaction tube. The 
gel slice is dissolved in the appropriate volume of a buffer containing chaotropic salts at 50°C. 
Afterwards, the DNA is bound to a silica-based column and residual agarose and salts are washed 
away. The DNA is eluted in water or EB buffer. 
 
E) Precipitation of DNA and RNA 
 
Nucleic acids are precipitated by ethanol or isopropanol in presence of monovalent cations. This 
method is applied to concentrate or desalt DNA solutions. 10% of the sample volume from a 3M 
sodium acetate (NaOAc) solution are added to the tube followed by 2.5 sample volumes of ethanol 
(EtOH) or 1 volume of isopropanol. Precipitation time was 1h at -20°C. The DNA is pelleted by 
spinning in a tabletop microcentrifuge at 16000g for 20min at 4°C. Residual salts are washed away 
with 70% ethanol and the centrifugation step is carried out again. The pellet is air-dried and dissolved 
in water or EB. 
 
F) Agarose gel electrophoresis 
 
Agarose gel electrophoresis was used to separate DNA fragments of different lengths. Agarose forms 
a three-dimensional matrix with defined spacing, in which separation in an electric field depends on 
size and charge. DNA is negatively charged with the charge correlating with its size. Thus, separation 
during electrophoresis depends on molecule size. By default, 0.8% (m/v), 1% and 1.5% agarose gels 
containing 1xTBE and Sybr® Safe (Invitrogen) were used. The running buffer was 1xTBE and gels were 
run at 2-7 V/cm. After electrophoresis, the DNA was visualized on an UV imaging system (Intas). To 
determine the size of the DNA fragments, 1µg of the DNA standards “1kb ladder” or “100bp ladder”, 
(NEB) were loaded. 
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G) UV spectrometric DNA concentration analysis 
 
DNA concentrations were determined with a Nano Drop device (Peqlab). After equilibration with the 
respective buffer, 1.7µl of the sample were applied. The DNA concentration is measured at 260nm 
wavelength. Contamination with proteins was simultaneously detected at 280nm. Pure DNA has an 
OD260/OD280 ratio of 1.8 -2.0. The DNA concentration is calculated according to the following 
formula: 
𝑐 �
µ𝑔
𝑚𝑙
� = 50 µ𝑔
𝑚𝑙
× 𝑣𝑜𝑙𝑢𝑚𝑒−1 × 𝑂𝐷260 
 
 
3.2.3 Techniques with Escherichia coli 
 
A) Preparation of electrocompetent E. coli 
 
For preparation of electrocompetent E. coli XL1 Blue, an overnight culture in SOB medium (3.1.2) was 
diluted 1:1000 in pre-warmed (37°C) SOB. This culture was then grown with vigorous shaking to an 
OD600 of 0.4 to 0.6 for 3h. Afterwards, the culture was chilled on ice for 15min and centrifuged at 
1000g for 10min at 4°C. The pellet was washed with 400ml of sterile ice-cold water. Centrifugation 
and resuspension (200ml) were repeated. After a next centrifugation step, the washed cells were 
resuspended in 10ml sterile 10% (v/v) glycerol and pelleted at 5000g for 10min at 4°C. Finally, the 
cells were resuspended in 1.5ml of the 10% glycerol solution, 50-100µl aliquots were prepared and 
stored at -80°C. 
 
B) Preparation of chemical competent E. coli 
 
200 ml SOB medium were inoculated from a stationary E. coli culture to an OD600 of 0.2 and grown at 
37°C to an OD600 of 0.5. Cells were harvested by centrifugation (50ml, 4500 rpm, 10 min, 4°C), 
resuspended in 15 ml cold Tfb-I buffer (3.1.3), incubated on ice for 20 min and spun down again. The 
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pellets were dissolved and combined in a total volume of 4 ml cold Tfb-II buffer (3.1.3) and incubated 
on ice for 20 min. Chemical competent E. coli were stored in 100µl aliquots at -80°C 
 
C) Liquid culture of E. coli 
 
Liquid cultures of E. coli were started in three different ways. Either, a single colony was picked from 
a freshly streaked selective plate or a glycerol culture was used or a fresh overnight culture was 
taken. Inoculation was done using a sterile loop or pipette tip. If necessary, antibiotics were added to 
the medium. Culture sizes ranged from 2ml for Minipreps to 2l for recombinant protein expression. 
 
D) Transformation of electrocompetent E. coli 
 
The required competent cell aliquots were thawed on ice. Upon liquefaction, about 1ng of plasmid 
DNA or 1-2µl of a ligation reaction were added to the cells and mixed carefully. As a control, one 
aliquot of competent cells was used without adding DNA. The solution was transferred into a pre-
cooled electroporation cuvette with a 2mm gap. Electroporation was performed in a micropulser 
(BioRad) at setting EC2 (1.8kV output, 9V/cm, 8ms duration). Immediately afterwards, 1ml of 
prewarmed (37°C) LB medium was added, the cell suspension transferred to a microreaction tube 
followed by an incubation step at 37°C for 30min. 100µl of this suspension were directly plated on 
LBx, the rest was spun down at 5000g for 1min in a microcentrifuge and all but 100µl of the 
supernatant were removed and the pellet resuspended. The resulting suspension was then also 
plated on LBx and the plates were incubated at 37°C over night.  
 
E) Transformation of chemical competent E. coli 
 
The required competent cell aliquots were thawed on ice. Upon liquefaction, about 10ng of plasmid 
DNA or 1-2µl of a ligation reaction were added to the cells and mixed carefully. As a control, one 
aliquot of competent cells was used without adding DNA. The solution was incubated on ice for 
5min, subjected to a heat shock (42°C, 40s) and incubated on ice for another 3min. Immediately 
afterwards, 1ml of prewarmed (37°C) LB medium was added, the cell suspension transferred to a 
microreaction tube followed by an incubation step at 37°C for 30min. 100µl of this suspension were 
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directly plated on LBx, the rest was spun down at 5000g for 1min in a microcentrifuge and all but 
100µl of the supernatant were removed and the pellet resuspended. The resulting suspension was 
then also plated on LBx and the plates were incubated at 37°C over night.  
 
 
3.2.4 Techniques with Saccharomyces cerevisiae 
 
A) Preparation of competent yeast cells 
 
Treatment of yeast cells with monovalent cations (e.g. Li+, Cs+, K+) induces competence for the uptake 
of linear and circular DNA molecules. Competent yeast cells were prepared from 50ml of an 
exponentially growing liquid culture. The cells were pelleted (500g, 5min, RT) and first washed with 
25ml sterile H2O, followed by a washing step with 5ml SORB (3.1.3). After a next centrifugation step, 
the cells were resuspended in 500µl LitSORB (3.1.3), transferred to a reaction tube and spun down 
again. 360µl SORB and 40µl of boiled (95°C, 5min) salmon sperm DNA were added to the pellet and 
the suspension carefully mixed. Competent yeast cells were stored at -80°C in 50µl aliquots. 
 
B) Transformation of S. cerevisiae 
 
The required competent cell aliquots were thawed on ice. Upon liquefaction, 2-8µg (corresponding 
to less than 10µl) of DNA were added and the cells were mixed carefully. As a control, one aliquot of 
competent cells was used without adding DNA. In the next step, 6 volumes of LitPEG (3.1.3) were 
added and the suspension thoroughly mixed, followed by 30min incubation at RT. Sterile 
dimethylsulfoxide (DMSO) was added to an extent of 1/9 of the total sample volume and the mixture 
was heat-shocked at 42°C for 15min. Afterwards, the cells were spun down (2000g, RT, 2min), the 
supernatant discarded and the pellet resuspended in rich medium. The cells were then transferred 
into a culturing tube and regenerated at 30°C for 3h. Then, the cells were centrifuged and 90% of the 
supernatant was discarded. The cells were resuspended in the remaining liquid, plated on selective 
media and the plates were incubated at 30°C. 
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C) Liquid culture of S. cerevisiae 
 
Liquid cultures of S. cerevisiae were started in three different ways. Either, a single colony was picked 
from a freshly streaked selective plate or a glycerol culture was used or a fresh overnight culture was 
taken. Inoculation was done using a sterile loop or pipette tip. If necessary, antibiotics were added to 
the respective medium. Culture sizes ranged from 2ml for preparation of genomic DNA to 2l for 
affinity purification of proteins. 
 
D) Permanent glycerol culture of S. cerevisiae 
 
For glycerol cultures, 2ml of a culture which had just reached stationary phase were mixed with 1ml 
of sterile 50% glycerol. The suspension was divided in two aliquots, frozen on dry ice and stored at -
80°C. 
 
E) Spot test analysis of yeast strains 
 
Overnight cultures of the yeast strains to be tested were diluted to OD600 = 0.1 with sterile H2O. 7-10 
μl of this cell suspension and of serial 1:10, 1:100, and 1:1000 dilutions with sterile H2O were spotted 
on the appropriate test plates. Phenotypes were monitored after incubation for 2-4 days at 24°C, 
30°C, and 37°C, respectively. 
 
F) Generation of yeast strains with affinity tagged proteins 
 
In this work, yeast strains with the tandem affinity purification (TAP) tag were created. The TAP tag is 
a succession of protein A (Prot A), a tobacco etch virus (TEV) cleavage site and the calmodulin binding 
protein (CBP). In the fusion protein, CBP is connected to the C-terminus of the protein of interest. In 
general, these strategies have been outlined in (Knop et al. 1999; Puig et al. 2001). Briefly, tagging 
cassettes were generated by PCR and transformed into yeast cells. Stable integration into the 
genome is achieved by homologous recombination. Positive clones are selected via resistance to 
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antibiotics or auxotrophy markers integrated in the tagging cassettes. The used oligonucleotides and 
plasmids are listed in Table 3-10Fehler! Verweisquelle konnte nicht gefunden werden. and Table 3-11, 
resulting yeast strains are given in Table 3-15 
 
 
3.2.5 Heterologous protein expression in SF21 insect cells using 
recombinant baculoviruses 
 
A) Overview 
 
Expression of recombinant proteins with the baculovirus-mediated SF21 insect cell system was 
performed according to (Berger et al. 2004; Fitzgerald et al. 2006). Expression of eukaryotic proteins 
in E. coli can lead to non-functionality due to the lack of posttranslational modifications or problems 
with solubility. Independent purification of affinity tagged proteins directly from their host cells bears 
the risk of cross-contamination with other factors of interest and yields less material than 
recombinant techniques. These issues are even more significant, if protein complexes are to be 
analyzed. The baculovirus-mediated recombinant expression system combines the advantages of 
recombinant techniques with correct (or similar) posttranslational modifications and solubility. In this 
work, the system was used to express single proteins from S. cerevisiae. 
 
B) Cultivation of SF21 cells 
 
Techniques directly involving SF21 cells were executed in a sterile bench in a separate tissue culture 
room SF21 insect cells were cultivated in SFII 900 SFM medium (Life Technologies) at 27°C on a 
platform shaker at 100rpm (Heidolph Unimax 2010). Culture density and purity were monitored daily 
under a microscope with a hemocytometer (Neubauer II). Cells were kept in logarithmic growth by 
adjusting the density to 0.5x106 cells/ml every day. If cell viability dropped below approximately 95% 
or the culture had reached passage number 30, the cells were trashed. Erlenmeyer flasks for cell 
culture were cleaned with 1% acetic acid and water and adherent cells removed mechanically. 
Afterwards, the flasks were twice autoclaved. 
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C) Long term storage of SF21 cells 
 
Long-term storage cultures were prepared at a low passage number (< 10). A total of 60x106 cells 
were harvested per aliquot (500g, 10min, RT), resuspended in 1ml medium supplemented with 30°C 
fetal calf serum (FCS) and 10% sterile DMSO. This suspension was frozen in -20°C cold isopropanol 
and stored at -80°C. A maintenance culture was started by permanent addition of just thawed cells of 
one cryo-culture to 60ml medium supplemented with 10% FCS. This culture was grown for 48h 
before the first determination of the cell density. 
 
D) Cloning, generation and isolation of bacmids 
 
Yeast genes of interest were inserted into the multiple cloning site 2 of the acceptor vector pFL-
FLAG-TEV (#1212) by standard cloning techniques. Thus, the gene will be expressed in SF21 cells 
under control of the strong viral polyhedrin promoter as an N-terminal FLAG tag fusion protein.  
The resulting plasmid was then integrated in vivo into a modified viral genome (bacmid) via Tn7 
transposition sites present in the pFL vector. For this, the respective plasmid was transformed into 
the E. coli strain DH10MultiBac-eYFP, which carries the bacmid and a helper plasmid pMON7124 
encoding the DNA recombinase Tn7 transposase (see Bac-to-Bac® Baculovirus Expression System 
manual; Invitrogen). Transformation was in general carried out as described in 3.2.3 E, but cells were 
allowed to regenerate overnight. Transformed DH10MultiBac-eYFP cells were subjected to 
blue/white colony screening and thus plated on LB supplemented with ampicillin (100µg/ml), 
gentamycin (10µg/ml), tetracycline (10µg/ml), IPTG (0.5mM) and X-GAL (5-bromo-4-chloro-3-indolyl-
β-D-galactopyranoside, 50mg/ml) and incubated overnight at 37°C. Three positive (white) colonies 
and one negative (blue) colony were streaked out again on the respective plates to confirm 
integration of the plasmid in the bacmid.  
For isolation of recombinant bacmid from E. coli DH10MultiBac-eYFP cells, 3ml of an overnight 
culture of a positive clone in LBAmp Tetra Genta were spun down (5min, 4000rpm, RT) and cells were 
resuspended in 0.3ml solution I (Table 3-2). Cells were lysed by addition of 0.3ml solution II (Table 3-2) 
and incubated for 5min at RT. Proteins were precipitated by addition of 0.3ml 3M KOAc pH 5.5, the 
solution incubated on ice for 10min and centrifuged for 10min at 16000g and RT in a tabletop 
centrifuge. The bacmid DNA in the supernatant was precipitated with isopropanol as described (3.2.2 
E) and the air-dried pellet resuspended in 50µl sterile H2O. 
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E) Transfection of SF21 cells 
 
Transfection of SF21 cells was done in 6-well plates. For each transfection, 1x106 cells were seeded in 
two wells each. As mock and medium control, one additional well with cells and one well with 
medium only was prepared. The plate was incubated for 15min at RT to let the cells adhere to the 
bottom, the supernatant was removed and 3ml fresh medium were added. To 20µl bacmid solution 
(50-100ng DNA), 300µl medium and 10µl transcfection reagent (FuGene, Promega) were added in a 
microreaction tube. The solution was carefully mixed and incubated for 30min at RT. Of this mixture, 
160µl were added to each well. Mock controls did not contain bacmid DNA. Cells were incubated at 
27°C and transcfection success monitored by fluorescence microscopy. Usually, after 48h - 60h, the 
virus-containing supernatant (V0) was harvested and stored at 4°C. 
 
F) Amplification of recombinant baculoviruses 
 
Recombinant baculoviruses were amplified by infecting 50ml SF21 cultures (passage 5-15, 0.5x106 
cells/ml) with 50µl V0 followed by incubation at 27°C under shaking. Cell density was monitored daily 
at the same time and cells were diluted to 0.5x106 cells/ml. Infection success was also monitored 
daily under a fluorescence microscope. Growth arrest was defined as the inability to reach a density 
of 1x106 cells/ml in 24h and occurred usually 72h post infection. Then, the culture was incubated for 
another 24h and cells were harvested at 130g for 15min at RT. The supernatant (V1) contains the 
amplified virus and is stored at 4°C. The cells were used for protein expression and purification tests. 
 
G) Large scale expression of recombinant proteins in SF21 cells 
 
For large scale infections, cells from passages between 5 and 10 were used. A large scale culture 
usually was 200ml in a 1l Erlenmeyer flask with a cell density of 1x106 cells/ml. Infection was 
performed with 5ml V1 and cultures were incubated at 27°C for 48h. The infection was monitored 
under a fluorescence microscope. Cells were harvested in 50x106 cells aliquots (130g, 15min, RT), 
frozen in liquid nitrogen and stored at -20°C. 
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3.2.6 Protein biochemical methods 
 
A) Denaturing protein extraction from yeast cells 
 
Denaturing protein extraction was performed as a first step in the verification of protein tags in 
before manipulated yeast cells. 1ml of an overnight culture was harvested in a microcentrifuge 
(5min, 5000rpm, RT). Cells were resuspended in 1ml ice-cold water and 150µl of pre-treatment 
solution (1.85M NaOH, 1M β-mercaptoethanol) were added. The solution was incubated on ice for 
15min. Proteins were precipitated by adding 150µl 55% trichloroacetic acid (TCA) and incubating on 
ice for 10min. The precipitate was spun down at 13000rpm for 10min at 4°C in a table-top centrifuge. 
The pellet was resuspended in 5µl HU buffer and the solution neutralized with NH4OH gas, if the 
buffer turns yellow. A neutral pH is indicated by a blue buffer colour. Denaturation was performed at 
65°C for 10min and approximately half of the sample was analyzed in Western blot. 
 
B) Methanol/chloroform precipitation 
 
For mass-spectrometric analyses, proteins were precipitated with methanol and chloroform 
according to (Wessel & Flügge 1984). The sample was first adjusted to 150µl with H2O. Afterwards, 4 
volumes (600µl) methanol (MeOH), one volume (150µl) of chloroform and three volumes (450µl) of 
H2O were added. After every step, the sample was thoroughly mixed. Phase separation was achieved 
by centrifugation in a table-top centrifuge for 5min at RT and 13000rpm. The upper phase is 
discarded without distortion of the protein containing interphase. Another 3 volumes (450µl) MeOH 
were added, the solution was vortexed and spun down again (13000rpm, 5min, RT). The supernatant 
was removed and the pellet was air-dried at RT. 
 
C) TCA precipitation 
 
Proteins can be precipitated with TCA to reduce sample volumes. 0.2 sample volumes of 100% TCA 
were added and the reaction tube was kept on ice for 30min. Afterwards, the precipitate was 
pelleted at 13000rpm for 30min at 4°C in a table-top centrifuge. The supernatant was discarded and 
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the pellet dissolved in an appropriate volume of SDS sample buffer. If the colour of the buffer was 
yellow, the solution was neutralized with NH4OH gas until it turned blue. The proteins were 
denatured at 95°C for 5min and then subjected to SDS-PAGE. 
 
D) Ammonium sulfate precipitation 
 
Ammonium sulfate precipitation is a classical approach for fractionation of cell extracts and is thus 
used in early stages of protein purification (Sambrook et al. 1989). With increasing concentration of 
(NH4)2SO4, the ionic strength of the solution rises. This first leads to enhanced protein solubility 
(salting in). After reaching a solubility optimum, proteins start to precipitate (salting out). Thus, 
fractionation is based on differences in solubility at certain (NH4)2SO4 concentrations with the 
protein of interest being precipitated. In this work, it was included in the purification of Reb1. To one 
sample volume, 3 volumes of a 4°C cold, saturated (NH4)2SO4 solution were added slowly (75% 
fractionation). The saturated solution was prepared by dissolving more than 70.6g (NH4)2SO4 per 
100ml water at RT. The solution was constantly stirred and upon use allowed to form a precipitate. 
The clear supernatant is the saturated solution. The cell extract supplemented with (NH4)2SO4 was 
kept on ice for 30min and the precipitate harvested at 16000g and 4°C for 1h. The pellet containing 
the protein of interest is then further processed. 
 
E) Protein concentration measurement 
 
Protein concentrations were measured in two different ways. First, the Bio-Rad protein assay was 
employed, which is based on the Bradford assay (Bradford 1976) to measure total protein 
concentration of a fraction. Briefly, 1µl of the fraction of interest was mixed with 800µl H2O and 
200µl of the protein assay stock solution. The mixture was incubated for 5min at RT and the optical 
density (OD) monitored with a UV/vis spectrophotometer at 595nm. The approximate protein 
concentration in mg/ml can be calculated by multiplying the absorbance with factor 23 resulting 
from a calibration curve with BSA. In cases, where protein preparations were not completely pure, 
the concentration of the protein of interest had to be further calculated. After Coomassie staining of 
the SDS gel, a profile analysis was performed with the respective gel lane (function “profile” in Multi 
Gauge). Background and peaks were assigned automatically and the percentage of the peak of 
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interest calculated based on the peak areas. Finally, the concentration obtained by Bradford 
measurement was corrected by this percentage.  
Second, protein concentrations were determined with BSA calibration curves on SDS gels. Defined 
amounts of BSA ranging from 100 to 1000ng were loaded on a SDS gel together with a defined 
volume of the protein fraction of interest. After Coomassie staining, protein bands were quantified 
with the function “quant” in the program Multi Gauge (Fuji) and a calibration curve was calculated to 
evaluate the unknown concentration. 
If protein concentrations had to be calculated for EMSAs (3.2.6 K) or in vitro transcription (3.2.12), 
both methods were applied and the average of both obtained concentrations was determined. 
 
F) SDS-polyacrylamide gel electrophoresis (PAGE) 
 
Proteins are separated according to their molecular weight by vertical discontinuous gel 
electrophoresis (Laemmli 1970). In this work, 10% polyacrylamide separating gels and 4% stacking 
gels were used: 
substance separating gel stacking gel 
30% AA/ 0.8% bisAA solution 4.16ml 0.65ml 
Lower Tris buffer 2.5ml - 
Upper Tris buffer - 1.25ml 
10% APS 40µl 30µl 
TEMED 10µl 6µl 
water 4.16ml 3.1ml 
Table 3-21: SDS polyacrylamide gel recipe. 
Electrophoresis was performed at constant voltage (120-180V) in SDS-PAGE running buffer until the 
bromophenol blue band reached the end of the gel. To estimate the molecular weight of the 
proteins, 8µl of a pre-stained marker solution (NEB) were applied on the gel.  
For mass spectrometry, precast 4%-12% gradient Bis-Tris Novex® NuPAGE® gels (Life Technologies) 
were used. The running buffer was either NuPAGE® MES ((2-N-morpholino)ethanesulfonic acid) or 
MOPS (3-N-morpholino)propanesulfonic acid), complemented with the NuPAGE® antioxidant 
reagent. Electrophoresis was carried out according to the manufacturer’s protocol (200V constant, 
35 [MES] or 50min [MOPS] running time). 
CHAPTER III – MATERIAL & METHODS  101 
__________________________________________________________________________________ 
 
G) Coomassie staining 
 
After SDS-PAGE, proteins were visualized with Coomassie or silver staining. For standard analytical 
purposes, the gel was stained for 30min in the Coomassie staining solution (Table 3-3Table 3-8) 
containing the Coomassie brilliant blue R250 dye. Destaining was done in the appropriate solution 
(Table 3-3) until the gel background was clear (Meyer & Lamberts 1965). 
For mass spectrometry or more sensitive analyses, the visualization was done with the SimplyBlue 
SafeStain® (Life Technologies). This staining solution is based on colloidal Coomassie brilliant blue 
G250 (Diezel et al. 1972). Briefly, the gel was washed 3 times with ultrapure water to remove SDS 
and salts. Staining was done for 1h at RT. The gel was destained in ultrapure water until the 
background was clear. 
 
H) Silver staining 
 
Gels containing low amounts of protein were stained with the more sensitive silver staining method 
based on studies by (Switzer et al. 1979). The detection limit is between 1 and 10ng protein per 
band. First, the gel was incubated with the fixation solution for >1h and then washed in 50% EtOH for 
20min. Next, the gel was washed with pretreatment solution for 1min followed by three rinsing steps 
with ultrapure water for 20s each. The gel was then soaked with staining solution for 20min and 
again rinsed with water twice. Finally, the protein bands were made visible by applying the 
developing solution. The staining process was ended upon treatment with 1% acetic acid (HOAc). The 
composition of the solutions is listed in (Table 3-3) 
 
I) Western blotting and protein detection with immuno-chemiluminescence 
 
Transfer of proteins from an SDS gel to a membrane was first described by (Renart et al. 1979; 
Towbin et al. 1979). After electrophoresis, the proteins are associated with SDS and thus negatively 
charged. Therefore, they can be transferred to a PVDF (polyvinylidene fluoride) membrane in an 
electric field. Three layers of whatman paper were soaked in blotting buffer, and put on the anode of 
the blotting apparatus avoiding air bubbles. The membrane (Immobilon PSQ 0.2µm, Millipore) was 
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activated in MeOH and then washed in blotting buffer. Next, the SDS gel was transferred onto the 
membrane and both put on top of the whatman papers. Finally, the gel was covered with three 
layers of wet whatman paper. Remaining air bubbles were carefully removed and blotting was 
performed at constant 24V for 75min. Afterwards, the stack was disassembled and the lanes were 
marked on the membrane with a pen. 
The transfer success was verified by putting the membrane in Ponceau S staining solution (Table 3-2) 
for 2min. The diazo dye Ponceau S reversibly binds the amino groups of the proteins. Thus, after 
detection, it can be washed away with water. 
For protein detection via immune-chemiluminescence, the membrane was first put in a 5% milk 
powder solution in PBST for 1h under shaking to saturate the unspecific protein binding capacity of 
the membrane. Then, the membrane was wrapped and put into a 50ml falcon tube containing the 
primary antibody in its appropriate dilution in 1ml PBST with 1% milk powder. The tube was attached 
to a rotating wheel and incubated for 45min at RT. Next, the membrane was washed three times 
with PBST for 5min. Again, the membrane was wrapped and put into a 50ml tube containing the 
secondary antibody in its appropriate dilution in 1ml PBST with 1% milk powder and rotated for 
30min at RT. This was followed by three washing steps in 5ml PBST for 5min each. The secondary 
antibodies are coupled to horseradish peroxidase (HRP) which catalyses the oxidation of 
diacylhydrazides via an activated intermediate that decays to the ground state by emission of light in 
the visible range. The blots were developed with the chemiluminescence substrate and a starter (BM 
chemiluminescence blotting susbtrate (POD), Roche), transferred to a translucent plastic bag and the 
positions of the prestained marker protein bands were indicated with a fluorescent pen. The readout 
was done with a LAS 3000 fluorescence reader (Fuji) with the setting “increment”. 
 
J) Protein gel filtration chromatography 
 
Gel filtration of recombinant proteins was performed to determine oligomerization state and 
homogeneity. They were analyzed on the Smart system (Pharmacia Biotech) with a Superose 6 PC 
3.2/30 gel filtration column (GE Healtcare) equilibrated with the respective protein storage buffer. 
Buffers for gel filtration did not contain detergents present in the storage buffers. Samples were 
loaded with a Hamilton syringe on a 50µl loop. Separation was performed according to the program 
ROSUP61 at 4°C and a flow rate of20µl/min. Thirty 50µl fractions were collected starting with the 
void volume for subsequent SDS PAGE analysis. For molecular weight and thus oligomerization 
estimations, calibration curves were calculated based on retention times of a set of standard 
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proteins (thyreoglobulin, bovine serum albumin (BSA), immune globulin G, catalase, glutathione-S-
transferase, ferredoxin and cytochrome c). 
 
K) Electrophoretic mobility shift assay 
 
Electrophoretic mobility shift assays were used to analyze the DNA binding ability of recombinant 
protein factors and to determine optimal binding conditions, respectively. Proteins of interest were 
purified (3.2.9) and their concentration calculated (3.2.6 E). DNA templates were obtained via 
annealing of oligonucleotides (Table 3-10) for templates up to 50bp or PCR, with one of the 
oligonucleotides/primers carrying a 5’ Cy5 fluorescent label. PCR products were purified and 
concentrated via EtOH precipitation. The final DNA concentration in the assay was 10nM. Template, 
buffer and protein(s) of interest were mixed in a reaction tube in a total volume of 10µl and 
incubated for 15min at RT. Binding conditions (buffer, template concentration, ionic strength) were 
chosen identically to in vitro transcription. After incubation, 2µl of 6x EMSA loading buffer (Table 3-2) 
were added and the mixture was separated on a native 6% polyacrylamide 0.4x TBE gel. Gels were 
pre-run in 0.4xTBE for 1h and electrophoresis was performed at 100V constant with a Novex® XCell™ 
sure lock Mini cell gel apparatus (Invitrogen). Gels were analyzed with a FLA3000 imaging device 
(Fuji). 
Native 6% PA 0.4x TBE gel 1x 6x 
Rotiphorese Gel 30 AA/Bis-AA 
solution 37.5:1 (Roth) 
2ml 10ml 
5x TBE 0.8ml 4ml 
water 7.2ml 36ml 
10% APS 80µl 400µl 
TEMED 8µl 12µl 
total 10ml 50ml 
Table 3-22: Native polyacrylamide gel recipe. 
 
L) Cleavage of GST fusion proteins 
 
GST fusion proteins expressed from pGEX6-P1 contain a cleavage site recognized by PreScission 
protease (GE Healthcare) and fusion proteins expressed from pGEX4-T1 contain a cleavage site for 
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thrombin, respectively. The cleavage sites are located between the N-terminus of the protein of 
interest and the GST tag. Cleavage with PreScission protease was performed according to the 
manufacturer’s protocol with 1U/100µg fusion protein at 4°C over night. Thrombin was used 
according to the manufacturer’s protocol at 1U/100µg fusion protein at 12°C over night. Cleavage 
success was monitored via SDS PAGE. 
 
M) Formation of the Pol II-TFIIF complex 
 
The Pol II-TFIIF complex was reconstituted from one-step purified yeast Pol II (KCl conditions, strain 
#2424, see 3.2.10 A) and TFIIF purified with 500mM KCl from strain #2994 (3.2.10 C). 20µl of Pol II 
and TFIIF were mixed, adjusted to a volume of 200µl with buffer C1 (Table 3-4) and incubated on ice 
for 15min (input). The mixture was added to 50µl of Calmodulin resin (Stratagene) equilibrated in C1 
and incubated rotating for 2h at 4°C. The FT was collected and the beads washed twice with 1ml C2. 
The beads were resuspended in 40µl C2. 10µl of input and flowthrough, 20µl of the washing steps 
and 20µl of beads were boiled in SDS sample buffer and analyzed via SDS PAGE. 
 
 
3.2.7 Mass spectrometry 
 
A) Identification of proteins with MALDI TOF/TOF 
 
Protein bands of interest were cut out of Coomassie stained gels and processed as in principle 
described in (Shevchenko et al. 1996; Shevchenko et al. 2006). Briefly, the bands were cut into small 
pieces and washed first with 600µl 50mM NH4HCO3 for 30min at RT in a thermomixer. The 
supernatant was discarded and the gel pieces incubated again under the same conditions with 60µl 
of 50mM NH4HCO3 supplemented with 25% (v/v) acetonitrile (AcN) and a final washing step was 
performed with 600µl of 50mM NH4HCO3 + 50% (v/v) AcN. The supernatant was discarded and the 
gel pieces lyophilized for 1h. The dried gel pieces were re-hydrated in an equal volume (approx. 10µl) 
of a 10mM NH4HCO3 solution containing sequencing grade trypsin (Roche) to a final concentration of 
0.1µg/µl (approx. 1µg trypsin per sample). Re-hydration was done for 45min at 37°C followed by 
addition of another volume of the trypsin containing solution. The tryptic digest was carried out over 
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night at 37°C and the supernatant transferred to a new reaction tube. The tryptic peptides were 
eluted by diffusion in a series of washing steps with twice 15µl of 100mM NH4HCO3 and 15µl of 
100mM NH4HCO3 + 35% (v/v) AcN. Incubation time was 1h for each step at 37°C under shaking. The 
supernatants were all pooled and then lyophilized. Afterwards, 25µl 1% (v/v) acetic acid (HOAc) were 
added to remove carbonates followed by another lyophilization step. The peptides were solubilized 
in 5µl freshly prepared matrix solution (2 mg/ml α-cyano-4-hydroxycinnamic acid (CHCA), 50% (v/v) 
acetonitrile, 0.1% (v/v) TFA) and spotted on a cleaned MALDI plate manually.  
Peptide mass fingerprints (PMF) and MS/MS analyses were performed on a 4800 Proteomics 
Analyzer MALDI-TOF/TOF mass spectrometer (ABI) operated in positive ion reflector mode and 
evaluated by searching the NCBInr protein sequence database with Mascot implemented in GPS 
Explorer v.3.5 (ABI). 
 
B) Semi-quantitative comparative iTRAQ LC MALDI TOF/TOF analysis 
 
Isobaric tags for relative and absolute quantification (iTRAQ™ (Ross et al. 2004)) were used for 
comparative analysis of the protein content of RNA polymerase and transcription factor preparations 
from yeast. As a maximum, comparisons of four different preparations were performed with usually 
10-20µl of the elution fraction per sample (see 3.2.9). Labeling was done with the iTRAQ™ labeling kit 
(Life Technologies). 
To reduce the unspecific protein content, His6-tagged tobacco etch virus protease (TEV) was 
depleted from the samples. 40µl Ni-nitrilotriacetic acid (NTA) agarose slurry (QIAGEN) per sample 
were washed with 400µl and then equilibrated on a rotating wheel for 1h at 4°C with 500µl of the 
respective elution buffer (3.1.3). The protein fraction volume was adjusted to 150µl with elution 
buffer and the solution applied to the column. TEV binding was done at 4°C on a rotating wheel for 
30min. The flowthrough was collected and methanol/chloroform precipitated (3.2.6 B). 
The precipitate was solubilized in in 20µl iRTAQ™ dissolution buffer and reduced with 2µl iTRAQ™ 
reducing agent (5mM Tris-(2-carboxyethyl)phosphine). Incubation time was 1h at 60°C in a 
thermomixer. Cystein sulfhydryl groups were modified with 1µl iTRAQ™ cystein blocking reagent 
(10mM methyl-methanethiosulfonate (MMTS)) at room temperature for 10min. 25µg sequencing 
grade trypsin (Roche) were resuspended in 25µl water and 6µl of this suspension were added to each 
sample. The tryptic digest was carried out over night at 37°C. 
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The tryptic peptides were labeled with different combinations of iTRAQ™ reagents according to the 
manufacturer’s protocol. Briefly, one unique labeling reagent was assigned to one protein 
preparation of interest, re-dissolved in 70µl 70% (v/v) EtOH and incubated with the tryptic peptide 
solution for ≥ 1.5h. Afterwards, up to four differently labeled samples were unified and lyophilized. 
The lyophilized sample was dissolved in 30µl 0.1% (v/v) trifluoroacetic acid (TFA) and spun down at 
13000rpm for 10min in a tabletop centrifuge. The supernatant was loaded on a nano-flow HPLC 
system (Dionex) harbouring a C18-Pep-Mep column (LC-Packings). The peptides were separated by a 
gradient of 5% to 95% of buffer B (80% acetonitrile/0.05% TFA) and fractions were mixed with 5 
volumes of CHCA (alpha-cyano-4-hydroxy cinnamic acid; Sigma) matrix (2mg/ml in 70% 
acetonitrile/0.1%TFA) and spotted on-line via the Probot system (Dionex) on a MALDI plate. 
MS/MS analyses were performed on an Applied Biosystems 4800 Proteomics Analyzer. MALDI-
TOF/TOF mass spectrometer operated in positive ion reflector mode and evaluated by searching the 
NCBInr protein sequence database with the Mascot search engine (Matrix Science) implemented in 
the GPS Explorer software (Applied Biosystems). Laser intensity was adjusted due to laser condition 
and sample concentration. The ten most intense peptide peaks per spot detected in the MS mode 
were further fragmented yielding the respective MS/MS spectra. 
Only proteins identified by peptides with a Confidence Interval > 95% were included in the analysis. 
The peak area for iTRAQ™ reporter ions were interpreted and corrected by the GPS-Explorer 
software (Applied Biosystems) and Excel (Microsoft). An average iTRAQ ratio of all peptides of a given 
protein was calculated and outliers were deleted by manual evaluation. 
 
 
3.2.8 In vitro chromatin assembly 
 
In vitro assembly of chromatin via salt gradient dialysis is a well established technique in the field 
(Kleiman & Huang 1972; Woodcock 1977; Wilhelm et al. 1978; Gadski & Chae 1976). Purified core 
histones H2A, H2B, H3 and H4 from chicken erythrocytes (as first described by (NEELIN & BUTLER 
1959)) were a kind gift from the Längst lab. Chromatin was reconstituted on templates for in vitro 
transcription containing one or multiple 601 nucleosome positioning sequences (Table 3-11) (Lowary & 
Widom 1998). This results in defined positions of the nucleosomes and thus homogeneity of the 
chromatin templates.  
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For in vitro transcription, only fully assembled template DNA was used. To determine optimal 
assembly conditions, histones were titrated to the DNA: 
ratio  
histones : DNA 
0.4 : 1 0.6 : 1 0.8 : 1 1 : 1 
high salt buffer 44µl 42.75µl 41.5µl 40.25µl 
BSA (10mg/ml) 1µl 
DNA template 
(2µg/µl) 
2.5µl 
chicken histones 
(0.8mg/ml) 
2.5µl 3.75µl 5µl 6.25µl 
total volume 50µl 
Table 3-23: Assembly titration series scheme. 
Dialysis chambers were prepared from siliconized microreaction tubes (Eppendorf) by clipping off the 
conical part and perforation of the cap with a red-hot metal rod (ø 0.5cm). The dialysis membrane 
(molecular weight cutoff 6.8kDa) was pre-wet in high salt buffer (Table 3-8) and fixed between tube 
and cap. The dialysis chambers were put in a floater in a bucket containing 300ml high salt buffer, air 
bubbles were removed and the mixture of histones and DNA was applied to the chambers. Dialysis 
from 2M NaCl to 0.23M NaCl was performed over night at RT with constant stirring and at a low salt 
buffer flow rate of 200ml/h (3l total). Upon completion, the assembly solution was transferred to a 
siliconized tube, its volume was measured and chromatin was stored at 4°C. To determine the 
assembly success, 5µl of the reaction were supplemented with 1µl loading buffer (Table 3-8) and 
analyzed on a 6% polyacrylamide, 0.4xTBE gel as described (3.2.6 K). Gels were stained in 0.4xTBE 
containing ethidium bromide for 15min, washed in 0.4xTBE for 15min and read out on a FLA3000 
imager (Fuji). 
 
 
3.2.9 Recombinant protein affinity purification 
 
A) Purification via the FLAG tag [Nsi1, Fob1, Paf1] 
 
Nsi1, Fob1 and Paf1 were expressed as N-terminal FLAG tag fusion proteins in SF21 insect cells 
(3.2.5). A recognition site for TEV protease is located between the FLAG tag and the protein of 
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interest. 50x106 infected SF21 cells were resuspended in 40ml TAP 300 (Table 3-5) and a crude cell 
extract was prepared by sonication for 5min with a pattern of 30s pulse and 30s pause using the 
macrotip (output 5, Branson sonifier). Cell debris were removed by centrifugation (4000g, 15min, 
4°C) and the supernatant added to 50µl (100µl slurry) anti-FLAG M2 beads (Sigma Aldrich) 
equilibrated three times with 5ml TAP300. The suspension was incubated on a rotating wheel at 4°C 
for 2h. After centrifugation (130g, 5min, 4°C) the supernatant was removed and the beads washed 
three times with 10ml TAP 100 (w/o PIs) each. For elution, the beads were resuspended in 100µl TAP 
100 (w/o PIs), transferred to a microreaction tube and incubated with 8µl of in-lab-prepared TEV 
protease for 2h at 16°C in a thermomix. The suspension was centrifuged at 16000g for 5min at 4°C 
and the supernatant loaded on a MobiCol column (MoBiTec). For removal of remaining beads, the 
column was spun again (16000g, 5min, 4°C). Each sample taken during the purification process was 
analyzed via SDS PAGE to monitor the purification success and the protein concentration in the 
elution fraction was determined. 
 
B) Purification via the hexahistidine (His6) tag [Reb1, Hmo1, A49/A34.5 dimer] 
 
Reb1, Hmo1 and the RNA polymerase I (Pol I) subunits A49 and A34.5 were expressed in E. coli BL21 
(DE3). Reb1 and Hmo1 were cloned into the expression vector pET21a and thus expressed as fusion 
proteins with a C-terminal His6 tag. The vector expressing A49-His6 and A34.5 subunits (pET28b) was 
a generous gift from the Cramer lab and cloning was described in (Geiger et al. 2010). All purification 
steps were carried out on ice in a 4°C room. In first place, an overnight culture (20ml LB 
supplemented with the respective antibiotic) was inoculated from a single colony picked from a 
freshly streaked selective plate. The culture was grown at 37°C over night. On the next day, the main 
culture (800ml LB with the respective antibiotic) was inoculated to an OD600 of 0.1 and grown at 37°C 
until an OD600 of 0.6 to 0.8 was reached. Then, protein expression was induced by adding 
isopropyl-β-thiogalactopyranoside (IPTG) to a final concentration of 1mM. After 3h at 37°C, the cells 
were harvested at 4000g for 20min at 4°C. From here, different strategies were followed. 
 
i. Reb1 and Hmo1 
 
The Reb1and Hmo1 purification strategy was adapted from (Morrow et al. 1990; Morrow et al. 
1993). The amount of cells representing 250ml of the main culture was directly used for purification. 
CHAPTER III – MATERIAL & METHODS  109 
__________________________________________________________________________________ 
First, cells were resuspended in 20ml resuspension buffer 1 (Table 3-6) and lysed via sonication for a 
total of 5min with a pattern of 30s pulse and 30s pause using the macrotip (output 5, Branson 
sonifier). The cell debris were removed via centrifugation (16000g, 30min, 4°C) and the soluble 
fraction subjected to 75% ammonium sulfate precipitation (3.2.6 D). The precipitate was solubilized 
in resuspension buffer 2 and loaded on a Ni-NTA agarose column with a bed volume of 0.5ml (1ml 
slurry) equilibrated with resuspension buffer 2. The column was drained by gravity flow and washed 
in two steps with each 30ml washing buffer 1 and 2. Reb1-His6 and Hmo1-His6 were eluted in 5 steps 
with 0.5ml elution buffer each. Each sample taken during the purification process was analyzed via 
SDS PAGE to monitor the purification success and the protein concentration in each elution fraction 
was determined. 
 
ii. A49/A34.5 dimer 
 
The harvested cells were washed in buffer A (Table 3-7), divided into aliquots reflecting 200ml of the 
main culture and spun down again. The cells were frozen in liquid nitrogen and stored at -80°C. 
A standard purification was from one cell aliquot and the purification strategy was adapted from 
(Geiger et al. 2010). Cells were resuspended in 40ml buffer B (Table 3-7). A crude cell extract was 
prepared by sonication for a total of 5min with a pattern of 30s pulse and 30s pause using the 
macrotip (output 5, Branson sonifier). The cell debris were pelleted at 16000g and 4°C for 40min. The 
supernatant was loaded on a Ni-NTA agarose column with a bed volume of 0.6ml (1.2ml slurry) 
equilibrated with buffer B. The column was drained by gravity flow and washed first with 25ml buffer 
C and subsequently with 15ml buffer D (Table 3-7). The A49-His6/34.5 dimer was eluted from the 
column in four steps with 0.6ml buffer E (Table 3-7) each. Each sample taken during the purification 
process was analyzed via SDS PAGE to monitor the purification success and the protein concentration 
in each elution fraction was determined. 
 
C) Purification via the glutathione-S-transferase (GST) tag [LexA, LacI] 
 
LexA and LacI were expressed in E. coli BL21 (DE3). LexA was cloned into pGEX6-P1 and LacI was 
cloned into pGEX4-T1 thus resulting in expression of N-terminal GST fusion proteins. All purification 
steps were carried out on ice in a 4°C room. In first place, an overnight culture (20ml LB 
supplemented with the respective antibiotic) was inoculated from a single colony picked from a 
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freshly streaked selective plate. The culture was grown at 37°C over night. On the next day, the main 
culture (500ml LB with the respective antibiotic) was inoculated to an OD600 of 0.1 and grown at 37°C 
until an OD600 of 0.6 to 0.8 was reached. Then, protein expression was induced by adding 
isopropyl-β-thiogalactopyranoside (IPTG) to a final concentration of 1mM. After 3h at 37°C, the cells 
were harvested at 4000g for 20min at 4°C, washed with phosphate buffered saline (PBS) and pelleted 
again. Cell pellets were frozen in liquid nitrogen and stored at -80°C.  
Upon purification, the cells were resuspended in 25ml PBS supplemented with 3mM β-
mercaptoethanol and PIs. A crude cell extract was prepared by sonication (Branson Sonifier) for a 
total of 5min with a pattern of 30s pulse and 30s pause using the macrotip. The cell debris were 
pelleted at 9000g and 4°C for 20min. The supernatant was loaded on a glutathione agarose column 
with a bed volume of 1ml (2ml slurry) which was equilibrated with 20ml PBS + 3mM  β-
mercaptoethanol before. Binding of GST-LexA/GST LacI was done for 30min on a rotating wheel.  
The column was drained by gravity flow and washed three times with 10ml PBS + 3mM β-
mercaptoethanol. GST fusion proteins were eluted in six steps with 1.5ml PBS + 10mM glutathione 
(reduced) each. Each sample taken during the purification process was analyzed via SDS PAGE to 
monitor the purification success and the protein concentration in each elution fraction was 
determined. If applicable, the GST tag was cleaved off with thrombin (GST-LacI) or PreScission 
protease (GST-LexA) (Table 3-12). 
 
 
3.2.10 Purification of yeast RNA polymerases and transcription factors 
 
A) Wild-type RNA polymerases 
 
Wild-type RNA polymerases I, II and III (Pol I, II and III) were purified from yeast strains # 2423 (Pol I), 
# 2424 (Pol II) and # 2425 Pol III (Table 3-15) via the protein A affinity tag. In each strain, the second 
largest subunit of one polymerase is expressed as a C-terminal fusion protein with protein A tag. 
Between the subunit’s C-terminus and the protein A part, a recognition site for TEV protease is 
located. A 20ml YPD culture was grown to stationary phase at 30°C. From this culture, 2l of YPD were 
inoculated to an OD600 such that it would result in an OD600 of 1.5 after overnight cultivation at 30°C. 
At OD600 1.5, the cells were harvested (4000g, 6min, RT) and washed in ice cold water. Cells were 
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split in aliquots representing 400ml culture volume and again spun down (4000g, 6min, 4°C). Cell 
aliquots were frozen in liquid nitrogen and stored at -20°C. 
Polymerase purification was performed with 1-4 cell aliquots under two different conditions in a 4°C 
room. The buffers used during lysis and washing either contained 200mM KOAc or 200mM KCl (Table 
3-4), elution was always done in KOAc conditions (P2 KOAc). Cells were thawed, washed in 5ml P1 + 
protease inhibitors (PIs) and spun down again (4000g, 6min, 4°C). The pellet was weighed and 
resuspended in 1.5ml of the respective P1 + PIs per gram. 0.7ml of this solution were added to 2ml 
reaction tubes containing 1.4g glass beads (diameter 0.75-1mm, Roth). Cells were lysed on an IKA 
Vibrax VXR basic shaker with 2200 rpm at 4°C for 15 min, followed by 5 min on ice. This procedure 
was repeated four times. The cell extract was cleared from glass beads by perforation of the cup at 
bottom and cap and a centrifugation step (150g, 1min, 4°C). Cell debris were removed by 
centrifugation at 16000g and 4°C for 30min. The protein content of the supernatant and thus lysis 
success were determined with the Bradford assay. The lysate was supplemented with NP40 to a 
concentration of 0.5% and PIs were added. Equal protein amounts (usually 1ml cell extract, 30-40mg) 
were incubated with 200 μl of IgG (rabbit serum, I5006-100MG, Sigma) coupled magnetic beads 
slurry (1 mm BcMag, FC-102, Bioclone) for 1h on a rotating wheel. The slurry had previously been 
equilibrated three times with 500µl of the respective P2. The beads were washed three times with 
700µl of the respective P2 +PIs and then washed three times with 700µl P2 (KOAc). For elution, the 
beads were resuspended in 25µl P2 (KOAc) supplemented with 3µl of in-lab-prepared TEV protease. 
Cleavage was performed for 2h at 16°C in a thermomix at 1000rpm. The supernatant was collected, 
the beads were washed with 25µl P2 (KOAc) and both fractions combined. This elution fraction 
containing either Pol I, II or III was split in 10µl aliquots, frozen in liquid nitrogen and stored at -80°C. 
Each sample taken during the purification process was analyzed via SDS PAGE to monitor the 
purification success and the protein concentration in the elution fraction was determined. 
 
B) Mutants of RNA polymerase I 
 
Mutants of Pol I were purified in the same way than wild-type polymerases with the exception of Pol 
I ∆A49. It was purified from yeast strain #2670 , a BY4742 derivative with a chromosomal knockout of 
A49, rescued by A49 being expressed from a plasmid under the control of the GAL promoter. To 
ensure optimal growth, a 20ml YPG culture was inoculated to an OD600 of 0.1 and grown overnight at 
30°C. Depletion of A49 was carried out for ~ 48h in two steps. First, 50ml YPD were inoculated to an 
OD600 of 0.05 and grown for 24h at 30°C. The main culture (2l YPD) was then started at an OD600 of 
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0.005 and grown at 30°C under shaking to an OD600 of 1.5 (≥ 24h). From here, the described protocol 
was followed (3.2.10 A). Absence of subunit A49 was controlled with Western analysis and iTRAQ LC 
MALDI-MS/MS and the growth phenotype was monitored.  
 
C) Transcription factor IIF (TFIIF) 
 
TFIIF was purified from yeast strain #2994 (DSY5 Int3), a kind gift from the Cramer lab. Cloning and 
yeast genetic manipulation are explained in (Chen et al. 2010). In this strain, the TFIIF subunits Tfg1, 
2 and 3 are expressed under the ADH promoter, with Tfg2 being expressed as a fusion protein with a 
C-terminal tandem affinity purification (TAP) tag. A 20ml YPD culture was grown to stationary phase 
at 30°C. From this culture, 2l of YPD were inoculated to an OD600 such that it would result in an OD600 
of 1.5 after overnight cultivation at 30°C. At OD600 1.5, the cells were harvested (4000g, 6min, RT) 
and washed in ice cold water. Cells were split in aliquots representing 800ml culture volume and 
again spun down (4000g, 6min, 4°C). Cell aliquots were frozen in liquid nitrogen and stored at -20°C.  
TFIIF was purified in general like wild-type RNA polymerases as described (3.2.10 A). Diverging from 
this protocol, TFIIF purifications were performed in three different salt conditions (200mM, 300mM 
or 500mM KCl). TFIIF was eluted in P2 (KOAc). 
 
 
3.2.11 Cloning strategy for the in vitro transcription template library  
 
The constructed library was developed using the set of template-containing plasmids created in 
(Merkl 2009) and was further extended in the same systematical approach. 
A first subset of templates contains cis-elements of the 35S rDNA terminator (Fig. 4-1). It is based on 
vectors #1960 (pUC19 tail G- TER), #1961 (pUC19 PIP G- TER), #1251 (pUC19 PIP G-ENH) and #1257 
(pUC19 tail G- ENH). Here, “TER” refers to the terminator region spanning trom the T-rich 1 element 
to the 3’ end of the RFB, whereas “ENH” templates lack the first T-rich site (4.1.2). Reeder and co-
workers showed that Reb1 is involved in the termination of Pol I transcription in vitro and in vivo 
(Morrow et al. 1993; Reeder et al. 1999) and stated, that a fraction of Pol I is terminated at T1. In our 
in vitro transcription system this results in short RNAs (<100nt) whose detection is at the technical 
limit of the gel system. Therefore, 125bp of the 18S rDNA amplified with primers #2479 and #2480 
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were inserted into EcoRI cut and blunted vectors #1251 and #1257 and SacI cut and blunted vectors 
#1961 and #1960. This resulted in plasmids #2148 (pUC19 PIP G- TER elong), #2145 (pUC19 tail G- 
TER elong), #2147 (pUC19 PIP G- ENH elong) and #2144 (pUC19 tail G- ENH elong) carrying additional 
125bp upstream of the rDNA terminator cis-elements. To include the possibility of studies involving 
Rnt1, template vectors were constructed containing a larger version of TER starting at -20bp with 
respect to the end of the 25S rDNA hence including the Rnt1 cleavage site (#1963 [pUC19 PIP G- Rnt 
TER] and #1962 [pUC19 tail G- Rnt1 TER]). Elongated template vectors were obtained as described 
before (#2149 [pUC19 PIP G- Rnt1 TER elong] and #2146 [pUC19 tail G- Rnt1 TER elong]). To study 
the cis-element dependency of elongation roadblocks or termination events, templates were 
constructed lacking or carrying an inverted version of the Reb1 BS (#2246 [pUC19 tail G- TER noReb 
elong] and #2245[pUC19 tail G- TER Reb1inv elong]). Deletion (inversion) of the Reb1 BS was 
achieved by insertion of the AflII/ BamHI digested PCR amplicons obtained with primers #3793 
(#3792) and #2105 on plasmid #1960 into equally cut vector #2145, respectively. This also involved 
the creation of a blunt-end PsiI cutting site in the Abf1 binding site by introduction of a point 
mutation. Thus, from these vectors templates with or without the RFB can be prepared. The PsiI site 
was also introduced in plasmid #2247 (pUC19 tail G- TER elong PsiI) by amplification and re-ligation 
of the complete plasmid #2145 with primers #3796 and #3797. 
A series of templates for in vitro transcription containing one or multiple 601 nucleosome positioning 
sequences (Lowary & Widom 1998) was created (Fig. 4-2). The subset is comprised of the vectors 
#1247 (pUC19 PIP G- 601), #1253 (pUC19 tail G- 601), #1252 (pUC19 PIP G- 12x601), #1258 (pUC19 
tail G- 12x601) and #2249 (pUC19 tail G- 601 elong). The first four constructs are described in detail 
in (Merkl 2009). #2249 was created by insertion of an EcoRI/KpnI digested amplicon with primers 
#3798 and #3799 (18S rDNA, 125bp) into the equally cut vector #1253. The insertion was made 
upstream of the 601 sequence, to increase length and thus detectability of prematurely 
terminated/abortive transcripts. 
Vectors #1573 (pUC19 tail G- w/o BS) and #1959 (pUC19 PIP G- w/o BS) were constructed by re-
ligation of the EcoRI/HindIII fragment of vectors #1254 and #1248, respectively. The resulting 
templates do not contain binding sites for one of the investigated DNA-binding proteins (Fig. 4-1). 
Templates with a cluster of three LexA binding sites were described in (Merkl 2009). An elongated 
version of the tailed template vector was created by insertion of 125bp upstream of the LexA binding 
sites as described before, resulting in vector #2244 (pUC19 tail G- 3xLexA elong). In (Merkl 2009) 
template vectors with a part of the mouse rDNA terminator region containing 5 binding sites for the 
termination factor TTF-I were created (#1249, #1250, #1255 and #1256). Digestion of plasmid #1255 
with EcoRV/DraI, EcoRV/SapI and EcoRV/SalI followed by agarose gel purification resulted in 
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derivative templates containing two, one or a half binding site, respectively. Based on studies by 
Tschochner and co-workers (Tschochne & Milkereit 1997), template vectors were designed 
containing one (#1561 [pUC19 tail G- 1xLacR] and #1562 [pUC19 PIP G- 1xLacR]) or two (#1563 
[pUC19 tail G- 2xLacR] and 1564 [pUC19 PIP G- 2xLacR]) binding sites for the Lac repressor LacI or the 
complete Lac operator DNA sequence (#1572 [pUC19 tail G- LacO]). Hence, the annealed oligos 
#2619/#2620, #2621/#2622 or #2623/#2624 were cloned into the EcoRI/BamHI digested vectors 
#1247 or #1253, respectively. Furthermore, a hybrid template with the ENH region followed by two 
LacI binding sites was created (#1571 [pUC19 tail G- ENH 2xLacR]). Plasmid #1574 (pUC19 tail G-tRNA 
Ala) contains the yeast alanyl tRNA gene to provide a template which is transcribed by Pol III in vivo.  
Vectors containing a complete yeast rDNA repeat or a BamHI/SacI fragment thereof were 
constructed. Plasmids #1965 (pUC19 PIP rDNA BamHI/SacI) and #1964 (pUC19 tail G- rDNA 
BamHI/SacI) were constructed by insertion of the SacI/BamHI rDNA fragment from vector #190 into 
the equally digested vectors #1247 and #1253, respectively. The missing part of the 18S rDNA gene 
was introduced via ligation of the SacI digested amplicon obtained by PCR with primers #3055 and 
18S_end_rev on vector #190 with the equally digested plasmids #1965 and 1964, respectively. This 
resulted in plasmids #1967 (pUC19 PIP G- rDNA) and #1966 (pUC19 tail G- rDNA). 
To adapt the in vitro transcription system to the assay established by the Kashlev group (Komissarova 
et al. 2003; Kireeva et al. 2000), a recognition site for TspRI was introduced upstream of the third 
template module (4.1.1) in plasmids #1247, #1255, #1960, #1573 and #1254. The annealed oligos 
#3119 and #3120 were introduced at the respective 5’ restriction site of the third module via blunt-
end ligation which resulted in plasmids #1968, #1969, #1970, #1971 and #1972. 
 
 
3.2.12 In vitro transcription 
 
In general, the protocol for in vitro transcription is based on the method published by Tschochner 
and co-workers (Tschochner 1996). The assay was further developed, partially newly established 
(Merkl 2009) and used in this work. As in most in vitro transcription systems, the underlying principle 
is homogeneous incorporation (body labeling) of radioactively labeled nucleotides. In this case, [α-
32P]-CTP was used. All ingredients were purchased RNAse free or checked for RNase contamination 
by incubation with genomic RNA from S. cerevisiae. The RNA was then separated on a 
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polyacrylamide gel and visualized under UV light. RNase free water was obtained from the standard 
water purification apparatus. 
 
A) Template preparation 
 
The system is suitable for transcription from promoter containing templates (Tschochner 1996) as 
well as for tailed templates (Keener et al. 1998). Template plasmid libraries were generated as 
described in (Merkl 2009) and an overview of available constructs is given in (Table 3-11). Plasmids 
containing in vitro transcription templates with the Pol I promoter were linearized with PvuII (1.5h, 
37°C). The restriction enzyme was then heat inactivated at 80°C for 20min, the DNA was EtOH 
precipitated (3.2.2 E) and redissolved in RNase free water.  
Tailed templates were first cut out of the respective vector with EcoRV and PvuII or EcoRV and PsiI 
(1.5h, 37°C), followed by incubation for 20min at 65°C to inactivate EcoRV. The DNA was EtOH 
precipitated, washed with 70% EtOH (3.2.2 E) and resuspended in RNase free water. Next, the DNA 
was treated with the sequence specific nicking endonuclease Nb.BsmI (NEB) at 65°C for 1.5h to 
introduce a single strand break in the coding strand. PvuII and Nb.BsmI were heat inactivated by 
incubation at 80°C for 20min. After 10min, a competitor oligo (#2207) with the same sequence as the 
24nt tail overhang was added in excess to anneal with the 5' single strand DNA released upon the 
nicking reaction. The DNA was subjected to EtOH precipitation, resuspended in RNase free water and 
its concentration determined. 
Transcription on a tailed template starts right at the point, where the DNA becomes double stranded 
again. Pol I promoter template transcription starts in the core element (CE I), 8 bp from its 3’ end.  
 
B) Reaction setup and RNA extraction 
 
Buffers and solutions are summarized in (Table 3-9). A standard basic reaction contained: 
substance final concentration/quantity 
template DNA ~200fmol (30-100ng) 
[α-32P]-CTP (400Ci/mmol, 10µCi/µl, Hartmann 
Analytic) 
1.25µM (1µl) 
cold CTP (100µM) 24µM (4,8µl) 
mix of cold ATP, UTP and GTP (10mM each) 0.5mM each (1µl) 
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2.5M KOAc 50mM/150mM (0,4µl/1.2µl) 
10x new transcription buffer (NTB) 1x (2µl) 
RNasin 10-20U (0.5µl) 
RNA polymerase (3.2.10) 1µl 
RNase free H2O to 20µl 
Table 3-24: Standard basic in vitro transcription reaction. 
All substances were thawed and kept on ice until the start of the reaction and filter tips were always 
used. If multiple reactions were carried out, a mastermix was prepared from the constituents except 
recombinant proteins, chromatin and RNA polymerases. If applicable, protein factors binding to cis 
elements on the transcription template were added and the reaction was mixed and incubated for 
15min at RT. The reaction was always started by addition of the polymerase, immediately mixed 
thoroughly and incubated for 30min at 30°C. Incubation was done in a hybridization oven, to 
overcome condensation of water on the microreaction tube lid and thus altering salt concentrations.  
Transcription was stopped by addition of 200µl Proteinase K mix and subsequent incubation at 37°C 
for 15min. Afterwards, 22µl of 3M NaOAc, 2µl glycogen solution (5mg/ml, Ambion) and 750µl EtOH 
were added and the RNA precipitated at -20°C over night. The precipitate was spun down by 
centrifugation at 16000g for 20min at 4°C, the supernatant was discarded and the pellet was washed 
with 50µl 70% EtOH. After a second centrifugation step at 16000g for 20min at 4°C, the pellet was 
dried at 90°C for 15s. For gel electrophoresis, the sample was redissolved in 9µl of loading buffer. 
RNA secondary structures were denatured by heating the solution to 70°C for 10min followed by 
immediate incubation on ice. 
Transcription with T7 RNA polymerase (NEB) was conducted as described in the manufacturer’s 
protocol, incubation time was 1h at 37°C and the RNA workup was done as described before. 
 
C) Denaturing gel electrophoresis and transcript visualization 
 
The transcripts were separated via denaturing PAGE. Electrophoresis was carried out on a vertical, 
0.4mm thick polyacrylamide gel of approximately 25x10cm. The glass plates, spacers and the comb 
were treated with 0.1% SDS to remove RNases, washed with RNase free water and 70% ethanol. One 
plate was silanized with the GelSave solution (Applichem) and the gel was cast. The usual 
concentration of acrylamide was 5% with 0.3% bisacrylamide. The buffer was 0.5x TBE and the 
denaturing agent urea at a concentration of 7M. The recipe is given here:  
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Ingredient 10% gel 5% gel 
30% AA /0.8% BisAA stock 
solution (Roth) 
6.6ml 3.3ml 
5xTBE 2ml 2ml 
H2O 4.7ml 8ml 
urea 6.4g 6.4g 
TEMED 20µl 20µl 
20% APS 100µl 100µl 
Table 3-25: Denaturing polyacrylamide gels for RNA electrophoresis. 
 
After polymerization, the gel was kept for no longer than one day at 4°C and then used. The gel was 
inserted into the apparatus, the tanks were filled with 0.5xTBE buffer and the comb was removed. 
Not polymerized acrylamide in the pockets and air bubbles were removed by flushing with a syringe. 
To avoid inhomogeneous running behavior of the gel due to temperature gradients, a 
pre-electrophoresis was done at constant 25W and a limit of 1150V for 1h. Afterwards, the pockets 
were flushed again, to remove urea, diffusing from the gel. Electrophoresis was carried out at 
constant 25W with a limit of 1150V for approximately 30min. The gel was transferred to whatman 
filter paper and dried at 80°C for 45min. 
The radioactive transcripts were visualized by exposure to a previously erased imaging plate (Fuji) 
and the read-out was done on a FLA 3000 phosphoimager (Fuji). 
 
D) Transcript quantification 
 
In vitro transcription images were quantified with Multi Gauge (Fuji). Compared to the template of 
interest, equal molar amounts of a reference template (tail g- w/o BS) were co-transcribed in every 
reaction. Thus every lane of the resulting gel showed a signal obtained from this transcript which 
served as an internal control. All lanes were quantified with the function “profile” and the 
background was subtracted automatically as a polygonal line. Peaks were assigned by the software 
according to the default settings and the assignment was manually reviewed. Signal intensities were 
calculated as 𝑡𝑜𝑡𝑎𝑙 𝑝𝑖𝑥𝑒𝑙𝑠−𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑
𝑝𝑒𝑎𝑘 𝑎𝑟𝑒𝑎  and normalized to the signal intensity of the reference 
transcript.  
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For absolute determination of transcript mass, a dilution series of a solution with known 
concentration of [α-32P]-CTP was created. Equal volumes of the diluted solutions were spotted in 
duplicate on whatman paper and exposed together with the gel of interest. After visualization, the 
spots were quantified with the function “quant” in Multi Gauge and a calibration curve generated. 
The signal intensities of the bands of interest were also determined with “quant” and absolute 
transcript mass was calculated by correlation with the calibration curve. 
 
E) Preparation of an in vitro transcribed RNA marker 
 
To determine the length of in vitro transcribed RNAs, a radioactively labeled RNA marker was 
included in every gel run. RNA marker templates were purchased (Century™ Plus RNA marker, 
Ambion) and transcribed with T7 RNA polymerase according to the manufacturer’s protocol. Briefly, 
0.5µg of the template mix were incubated with 3µl of [α-32P]-CTP (400Ci/mmol, 10µCi/µl), 0.5mM of 
each NTP, 0.5µl RNasin and 50U of T7 RNA polymerase in T7 RNA polymerase buffer. The reaction 
volume was 20µl and incubation was done at 37°C for 1h. The RNA workup was performed as 
described (3.2.11 B). Transcription of the marker templates results in a mixture of RNAs with lengths 
of 100, 200, 300, 400, 500, 750 and 1000nt. 
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4.1 Creation of a template library for in vitro transcription 
 
4.1.1 Outline 
 
Development of a template library was the first step in establishment of a solid in vitro transcription 
system. To address the questions outlined in 2.5, the respective templates had to contain i) yeast Pol 
I terminator cis elements, ii) recognition sites for the DNA binding factors which were analyzed 
regarding their ability to serve as elongation obstacles or iii) positioning sequences for nucleosomes. 
The constructed library is based on the set of template-containing plasmids created in (Merkl 2009) 
and was further developed in the same systematical approach. 
Each template consists of three main DNA modules. The first module carries elements for 
transcription initiation. This is either the RNA polymerase I (Pol I) promoter (PIP) from Saccharomyces 
cerevisiae (S. cerevisiae, yeast) (Kempers-Veenstra et al. 1985) or a single stranded 3’ extension (tail) 
to the template strand (Dedrick & Chamberlin 1985). PIP templates can be transcribed by the PA600 
extract (Tschochner 1996) or a mixture of core factor (CF) and the Pol I-Rrn3 complex (unpublished 
data), thus allowing promoter-specific initiation in analogy to the in vivo situation. Initiation on tailed 
templates does not depend on additional factors, which allows comparative investigation of 
elongation and termination of various RNA polymerases. The second module serves to stall 
elongating RNA polymerases. This is achieved by a G-less cassette of 22nt length, which contains no 
cytosine in the template strand. Thus, if GTP is missing in the reaction, the polymerase will stop when 
encountering three cytosine residues. Transcription can be resumed upon addition of GTP. The third 
DNA module is variable and contains different cis-elements. These elements allow comparison of 
DNA binding factor-dependent elongation and termination of RNA polymerases in absence or 
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presence of the respective factor. A schematic overview of the templates is given in Fig. 4-1 and Fig. 4-2 
and all parent vectors are listed in Table 3-11. Cloning strategies are explained in (3.2.11). Several 
templates exist in short and long versions (“elong”). If not indicated otherwise, the elongated 
versions were used in the assays. 
 
 
4.1.2 Template cis-element combinations 
 
A) Templates containing elements of the yeast rDNA terminator 
 
A subset of templates contains different cis-elements of the yeast rDNA terminator and 
combinations thereof. The respective tailed templates are listed in Fig. 4-1. In this context, “TER” 
refers to a sequence in the rDNA terminator region between +70 and +414bp downstream of the end 
of the 25S rRNA gene, covering the first T-rich stretch (T-rich 1), the Reb1 binding site (Reb1 BS), an 
Abf1 binding site, the second T-rich stretch (T-rich 2) and the replication fork barrier (RFB, 2.3.3 A). In 
contrast, the “Reb1 BS RFB” template contains a truncated version of the TER DNA sequence starting 
at +96bp and thus missing T-rich 1. To include the possibility of studies involving Rnt1, template 
vectors were constructed containing a larger version of TER, starting at -20bp with respect to the end 
of the 25S rDNA, hence including the Rnt1 cleavage site. To study the cis-element dependency of 
elongation roadblocks or termination events, templates were constructed lacking or carrying an 
inverted version of the Reb1 BS or missing the RFB (Fig. 4-1).  
 
B) Templates containing the 601 nucleosome positioning sequence 
 
RNA polymerases encounter nucleosomes during transcription in vivo. To investigate how different 
RNA polymerases deal with an elongation obstacle like the nucleosome, templates for in vitro 
transcription containing one (1x 601) or multiple (12x 601) 601 nucleosome positioning sequences 
(Lowary & Widom 1998) were created (Fig. 4-2). 
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Fig. 4-1: Schematic representation of tailed templates containing different cis elements of the yeast rDNA terminator 
region. The initiation sequence and the G-less cassette are indicated. The red arrow marks the transcription start site. 
Selected cis elements of the rDNA terminator are represented by colored boxes. Exact positions of the respective elements 
in the rDNA are given in the text. Arrows indicate whether the cis element was inserted in the same orientation compared 
to an enlongating RNA polymerase in vivo or inverted. The Rnt1 cleavage site is visualized by a flash. 
 
C) Internal reference template 
 
The Internal reference template (reference w/o BS) does not contain binding sites for one of the 
investigated DNA-binding proteins (Fig. 4-1). Furthermore, it was demonstrated, that the factors of 
interest do not interact specifically with the template DNA nor interfere in in vitro transcription 
122  CHAPTER IV – RESULTS 
__________________________________________________________________________________ 
(4.5.2, 4.3.1, 4.3.2, 4.3.3, 4.3.4). Thus, transcript signal intensities from these templates were used as 
a bona fide internal control for normalization during quantification and the templates were included 
in every in vitro transcription reaction. 
 
Fig. 4-2: Selected tailed templates containing different cis elements. The red arrow marks the transcription start site. Cis 
elements are represented by colored boxes and ellipses. Identity of the respective elements in the rDNA is discussed in the 
text. Arrows indicate, whether the cis element is in the same orientation compared to an enlongating RNA polymerase in 
vivo or inverted. 
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D) Templates with binding sites for non-yeast proteins 
 
Templates with binding sites for non-yeast proteins were constructed to elucidate RNA polymerase 
diversity at transcriptional roadblocks (Fig. 4-2). In (Merkl 2009), templates containing a cluster of 
three LexA binding sites (3x LexA) or a part of the mouse rDNA terminator region harboring 5 binding 
sites for the termination factor TTF-I (5x TTF-I) were described. Based on observations that 
termination by TTF-I is dependent on the orientation of its binding sites (Jansa et al. 2001; Grummt, 
Rosenbauer, et al. 1986; Schnapp et al. 1996), a template with the inverted mouse rDNA terminator 
sequence was constructed (Fig. 4-2). According to studies by Tschochner and co-workers (Tschochne & 
Milkereit 1997), template vectors were designed containing one (1xLacR) or two (2xLacR) binding 
sites for the Lac repressor LacI or the complete Lac operator DNA sequence (LacO) (Fig. 4-2). 
 
E) Other templates 
 
Template “tRNAAla” contains the yeast alanyl tRNA gene to provide a template which is transcribed by 
Pol III in vivo (Fig. 4-2). Vectors containing a complete yeast rDNA repeat (rDNA) or a BamHI/SacI 
fragment thereof (rDNA BamHI/SacI) were constructed, to compare transcription of the naked 35S 
rDNA with ex vivo purified 35S rDNA (Hamperl 2012) in vitro (Fig. 4-2). 
 
 
4.2 Purification and characterization of RNA Pol I, II and III from S. 
cerevisiae 
 
4.2.1 Outline 
 
Objectives of this study included the comparison of Pol I, II and III in their capability to deal with 
elongation obstacles and the comparison of wild-type Pol I with Pol I mutants in transcription 
termination. To assay different RNA polymerases in comparable conditions, it was necessary to purify 
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Pol I, II and III equally. In this regard, a standardized purification protocol was established combined 
with thorough characterization of the protein content of the polymerase fraction. 
 
 
4.2.2 Wild-type and mutant RNA polymerases can be purified in one step 
 
Yeast RNA polymerases were purified in one step as described in (3.2.10). Cells were harvested in 
logarithmic phase to ensure maximum polymerase activity and expression levels. The purification 
strategy is based on immunoprecipitation of a C-terminal Protein A (Prot A) tag on one of the second 
largest subunits A135, Rpb2 or C128 with IgG-coupled magnetic beads. This purification method was 
chosen because recently Oeffinger and co-workers demonstrated that IgG-coupled magnetic beads 
reduce background contaminants and improve the yield in affinity purification of yeast RNP 
complexes (Oeffinger et al. 2007). In general, a slightly modified protocol of Oeffinger was followed 
using IgG-coupled magnetic beads. Upon elution, the ProtA tag was cleaved off with TEV protease to 
rule out diminished activity due to steric hindrance (Fig. 4-3 A). 
First purifications were carried out with buffers containing 200mM KOAc (Table 3-4) which yielded 
elution fractions (E), in which the respective RNA polymerase was sufficiently enriched and pure for 
in vitro transcription. On Coomassie-stained SDS gels, the two largest subunits A190/A135, 
Rpb1/Rpb2 or C160/C128 could be detected in the lane containing the eluate (10µl, 10%) together 
with TEV protease (Fig. 4-3 A). Presence or absence and identity of the ProtA tag and single subunits 
were confirmed by Western analysis. Mono Q anion exchange chromatography (Jochen Gerber) (Fig. 
4-3 B), LC-MALDI MS/MS analysis (Fig. 4-4) and silver staining (data not shown) revealed the presence 
of the remaining subunits. Polymerase activity was finally demonstrated by in vitro transcription. 
To this end, wild-type Pol I, II, III and several Pol I mutants were purified. The Pol I mutant library 
includes Pol I deletion mutants lacking either subunit A12.2 or the A49/34.5 dimer. Deletion of A49 
or A49/A34.5 results in reduced Pol I activity and thus a reduced growth phenoptype (Huet et al. 
1975; Liljelund et al. 1992). The dimer is believed to be a built-in elongation factor with similar 
function like TFIIF in Pol II (Kuhn et al. 2007). Thus, Pol I ∆ A49 is an interesting candidate for in vitro 
elongation/termination analysis. Subunit A12.2 is required for cleavage of the nascent RNA (Kuhn et 
al. 2007) like its homolog C11 in Pol III (Chédin et al. 1998) and was identified as a Pol I termination 
factor (Prescott et al. 2004). Furthermore, deletion of A12.2 is synthetically lethal, if serine residue 
685 in subunit A190 is mutated to aspartate (Gerber et al. 2008, Fig. 4-3 D). Therefore, Pol I ∆ A12.2, 
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Pol I A190 S685A and Pol I S685D were candidates to be included in the subsequent analyses. 
Furthermore, a series of Pol I phosphomutants was purified based on results of a mutagenesis screen 
of the A190 serine residues (J. Pérez-Fernández, unpublished data) and the work described in 
(Gerber et al. 2008). Hence, one or all serine residues which were identified as phosphosites in the 
largest subunit A190 were exchanged to alanine or aspartate which includes mutations A190 SallA, 
A190 SallD, A190 S936A, A190 S936D, A190 S941A and A190 S941D. 
 
Fig. 4-3: Yeast RNA polymerases can be purified in one step. (A) Coomassie stained 10% SDS gels of wild-type Pol I, II and 
III purifications in KOAc conditions. Fractions from left to right: whole cell extract (WCE, 0.6%), flowthrough of the IP (FT, 
0.6%), washing steps (W1, 0.7%; W2, 0.7%) elution fraction (E, 10%) and beads after elution (B, 50%). The two largest 
subunits of Pol I, II or III and TEV protease are indicated. Western blots representing the same fractions as above were 
developed with antibodies directed against Protein A (PAP) or the specific polymerase subunits A135, Rpb2 and C53. (B) 
One-step purified polymerases (KOAc conditions) and the polymerase peak fractions after MonoQ ion exchange 
chromatography were separated on a 10% SDS gel. (C) Coomassie stained 10% SDS gels of one-step purified RNA 
polymerases and Pol I mutants (KCl conditions, 10% of IP). (D) Western blots of Pol I, II and III purifications (KCl conditions) 
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were developed with antibodies against specific subunits A135, Rpb2 and C53. Fraction abbreviations and loading are 
explained in (A). Western blots developed with the anti C53 antibody exhibit signals around 50kDa due to cross-reactivity 
with the IgG heavy chain. (E) Cartoon from (Gerber et al. 2008) visualizing the synthetic lethality of mutation A190 S685D in 
combination with deletion of subunit A12.2. Western blots of Pol I ∆A12 and Pol I ∆A49 in comparison with the wild-type 
were done after separation on a 10% SDS gel. Blots were developed with antibodies recognizing subunits A135, A43, A12.2 
and the 3xHA tag. 
The absence of subunit A12.2 from the respective Pol I mutant purification was confirmed by 
Western blotting and development with an antibody recognizing A12.2 (Fig. 4-3 E). Pol I ∆A49 was 
purified from BY4742 ∆A49 pGAL A49-3xHA in which the chromosomal copy of the A49 gene is 
knocked out and A49 is expressed from a plasmid under the control of the GAL promoter. Hence, the 
purification was carried out after A49 had been depleted for 48h after shifting to glucose. Since loss 
of A49 is believed to destabilize the polymerase, the presence of subunits A135, A43 and A12.2 was 
verified by Western blot. In the respective strain, A49 was 3xHA tagged. The tag could not be 
detected in Western analysis of a Pol I ∆A49 preparation thus pointing towards homogeneity of Pol I 
∆A49 (Fig. 4-3 E). Note that the absence of subunit A34.5 was not formally proven in this study but 
other studies demonstated that A49 and A34.5 form a distinct subcomplex which is associated with 
the Pol I core (Geiger et al. 2010). In a Pol I ∆A34.5 also A49 was missing (Gadal et al. 1997) and a Pol  
I ∆A49 was lacking subunit A34.5 (Beckouet et al. 2008). Therefore it can be hypothesized that our 
Pol I ∆A49 also lacks subunit A34.5. 
 
 
4.2.3 Purified RNA polymerases are not cross-contaminated 
 
To show that the purified polymerase fractions were not cross-contaminated with transcription 
factors and other RNA polymerases, Western analyses and mass spectrometric analyses with the 
isobaric tags for relative and absolute quantification (iTRAQ) were carried out (3.2.7)(Ross et al. 
2004). Polymerase samples were first depleted of the His-tagged TEV protease by incubation with Ni-
NTA agarose to avoid overloading of HPLC and mass spectrometer and thus diminished detection 
sensitivity. After digestion with trypsin, the resulting peptides were separately labeled with two, 
three or four different isotopic iTRAQ reagents depending on the number of fractions to be 
compared. Chemically, a covalent bond is formed between the peptide reactive group of the iTRAQ 
reagent and the peptide N-terminal α-amino groups as well as ε-amino groups of lysines. The 
differentially labeled fractions were combined and the peptides separated by reversed-phase high 
performance liquid chromatography (HPLC) followed by MALDI MS/MS analysis (3.2.7). A database 
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search based on the fragmentation data identified the peptides and so the respective proteins. 
Fragmentation of the isobaric tag creates unique reporter ions in the low m/z region of the 
respective MS/MS spectra. Reporter ion signal intensities allow calculation of the relative abundance 
of a peptide (single iTRAQ ratio) and thus of the protein of interest (average iTRAQ ratio). 
Comparative analysis of Pol I, Pol II and Pol III purifications revealed, that specific polymerase 
subunits were enriched in the respective purification up to factor 100 with regard to the other 
purified polymerase fractions (Fig. 4-4). Subunits common to all three polymerases could be detected 
at roughly equal levels. If Pol I and Pol III were compared, the two common subunits AC40 and AC19 
were present at similar levels. Note that common subunits sometimes do not result in an expected 
iTRAQ ratio of 1 as the protein concentration slightly varies between purifications of Pol I, II or III. The 
obtained results allow to state that purified RNA polymerases are not significantly cross-
contaminated. 
However, iTRAQ analysis showed, that the Pol II purification (KOAc conditions) contained subunits 
Tfg1, Tfg2 and Taf14 of transcription factor IIF (TFIIF) as well as transcription factors Spt5 and Spt6 
(data not shown). Hence, a more stringent purification procedure had to be established to rule out 
that effects seen in an in vitro transcription assay are due to the co-purified factors. Polymerase 
purification was then switched to new buffers containing 200mM KCl instead of KOAc (Table 3-4). 
Albeit the second washing step and elution were still done in KOAc buffer conditions to ensure 
comparability of the differently purified polymerases in the transcription assay. In general, yield, 
enrichment and purity of the polymerase fractions were comparable to the previous conditions (Fig. 
4-3 C). With antibodies recognizing subunits A135, Rpb2 or C53, specific signals were only obtained in 
Western analysis of the respective polymerase preparation (Fig. 4-3 D) indicating absence of 
polymerase cross-contamination. Subsequent MALDI analysis demonstrated that if the purification 
was done with 200mM KCl, TFIIF Spt4 and 5 could not be detected in the Pol II fraction (Fig. 4-4).  
In all purifications, a similar content of ribosomal proteins (data not shown) and housekeeping 
proteins could be detected via mass spectrometry. Proteins belonging to these groups mostly had an 
average iTRAQ ratio of close to 1 and were often identified with only one peptide. Therefore, their 
abundance was generally low and comparable in the analyzed purifications.  
In summary, the established protocol for RNA polymerase purification is complying with the three 
prerequisites for in vitro transcription formulated above. If not stated otherwise, all in vitro 
transcription experiments were executed with KCl-purified polymerases. 
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Fig. 4-4: Comparative iTRAQ analysis of RNA polymerase preparations purified with KCl demonstrates selective 
enrichment. Pol I, II and III preparations were subjected to comparative iTRAQ analysis versus each other. Average iTRAQ 
ratios of identified proteins were plotted against a list enumerating all identified proteins. The number of allocated 
peptides per protein is given in brackets. Robosomal proteins were excluded from the diagrams. Note the log 10 scale of 
the x-axis. 
 
 
 
 
 
 
CHAPTER IV – RESULTS  129 
__________________________________________________________________________________ 
 
4.3 Purification and characterization of trans-acting protein factors 
 
4.3.1 Reb1-His6 
 
A) Reb1-His6 can be purified in high yield and purity in a two-step procedure  
 
The yeast rDNA repeat contains two binding sites for Reb1, one of them in close proximity to the Pol I 
promoter region and a second one in the 5’ part of the enhancer/terminator region (Morrow et al. 
1989; Chasman et al. 1990). Additionally, binding sites for Reb1 occur frequently in promoter regions 
of Pol II genes (Liaw & Brandl 1994). Reb1 was described by the Reeder group as a potent Pol I 
termination factor in vitro and in vivo (Reeder et al. 1999; Morrow et al. 1993; Lang & Reeder 1995). 
However, recent data indicate that efficient transcription termination requires further factors (Reiter 
et al. 2012). For comparison, Reb1 has to be included in any analysis of Pol I transcription 
termination. 
A first purification protocol for recombinant Reb1 from E. coli was established by Morrow and co-
workers (Morrow et al. 1990; Morrow et al. 1993) and further developed in (Merkl 2009, Fig. 4- A). 
Nonetheless, baculovirus-mediated expression in SF21 insect cells would have been advantageous. In 
general, this expression system leads to better solubility of the proteins and post-translational 
modifications of this cell line are similar to the ones observed in yeast. However, the attempts to 
express Reb1 in SF21 cells failed (data not shown). Therefore, the original protocol was refined to 
yield highly purified Reb1-His6 in large quantities (3.2.9). Purification was done as described by 
Morrow and co-workers and the results are shown in (Fig. 4-5). The apparent molecular weight of 
Reb1-His6 was calculated from a calibration curve resulting in 103kDa with an error of 1%, which is 
above the theoretical value (92.7kDa) (Fig. 4-5 C). Quantification of the Reb1-His6 protein 
concentration (3.2.6 E) resulted in 1.27mg/ml (13.7µM) for fraction E2 and 0.81mg/ml (8.7µM) for 
E3, respectively.  
However, the elution fraction lanes contained further Coomassie stained bands. Western analysis 
with the INDIA His probe indicated that some of the additional bands could be N-terminal 
truncations of Reb1-His6. Nonetheless, a visible background of contaminating proteins presumably 
from E. coli remained. To assess, if those proteins influence further downstream applications like in 
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vitro transcription, an equal mock purification was carried out from an E. coli culture transformed 
with the empty vector. Notably, the band pattern observed in SDS PAGE analysis of the mock elution 
fractions, showed similarity to the background in Reb1-His6 elution fractions. 
 
Fig. 4-5: Reb1-His6 is purified in a two-step procedure. (A) The cleared cell extract was fractionated by addition of 
ammonium sulfate to 75%. The precipitate was redissolved and subjected to Ni-NTA affinity chromatography. (B) Fractions 
collected during the Reb1 purification were separated on a 10% SDS gel. From left to right: whole cell extract (WCE, 0.1%), 
insoluble fraction (P, 0.1%), supernatant of the ammonium sulfate precipitation (S, 0.027%), pellet of the ammonium 
sulfate precipitation (P, 0.2%), flowthrough of the Ni-NTA column (FT, 0.2%), washing steps (W1 & W2, 0.07%), elution 
frations (E1-E5, 4%), beads after elution (B, 50%). The band representing Reb1-His6 is marked with a red asterisk (*). For 
Western analysis, identical amounts were analyzed. The blot was developed with a probe detecting the His6 epitope. 
Fractions collected during a respective mock purification from E. coli were separated on a 10% SDS gel and visualized with 
Coomassie blue. (C) A calibration curve for the determination of the apparent MW of Reb1-His6 was calculated from the 
migration distances of the marker proteins in the topmost gel of (B). The curve was approximated with a logarithmic 
function and the apparent MW calculated. The red dot indicates the ln of the MW of Reb1-His6. 
 
B) In gel filtration chromatography, Reb1-His6 behaves like a pentamer 
 
Gel filtration of Reb1-His6 was performed to assess the question of sample homogeneity. 50µl of 
elution fraction E2 (Fig. 4-5) were separated on a Superose6 column as described (3.2.6 J) with Reb1 
elution buffer as the eluent. The collected fractions were subjected to SDS PAGE and the proteins 
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were detected with Coomassie staining (Fig. 4-6). The chromatogram showed a minor peak at the 
beginning, representing the void volume (fractions 3-4) and two major peaks (fractions 13-15 [P1] 
and 22-25[P2]). Between the two major peaks, absorption did not reach background levels nor form 
a single peak either (fractions 17-21 [P3]). Correlation with the SDS gel revealed that P3 contained 
contaminating proteins of different sizes and P2 mainly consisted of the major low molecular weight 
contaminant (< 17kDa). In contrast, most of the full length Reb1-His6 was detected in P1. This 
indicated that fraction E2 and thus presumably the other elution fractions contained an almost 
homogeneous population of Reb1-His6. To address the question of the multimerization state, a 
calibration curve was calculated from elution volumes of marker proteins with known molecular 
weights. Taken the apparent molecular weight of 103 kDa as a basis, Reb1-His6 seems to form a 
pentamer (510kDa). However, further studies on the multimerization of the trans-acting factors were 
not within the scope of this work. 
  
Fig. 4-6: Gel filtration analysis reveals a homogeneous population of Reb1-His6. (A) Gel filtration was performed with 50µl 
of fraction E2 (Fig. 4-5) on a Superose6 column with a SMART system. UV280 absorption was detected and arbitrary units 
were plotted against the fraction number. (B) 4% of fractions 3 to 25 collected during the run were analyzed on a 10% SDS 
gel. The band respresentng Reb1-His6 is marked with a red asterisk (*). 
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C) Reb1-His6 specifically recognizes its binding site in the rDNA terminator 
 
Reb1-His6 was further characterized by testing its ability to bind its designated recognition site in the 
rDNA terminator and the specificity thereof. Additionally, it was crucial to determine an optimal 
Reb1-His6 concentration where the binding site was fully occupied. In (Wang & Warner 1998), Reb1 
binding to three recognition sites named A, B and C 5’ upstream of its own gene was analyzed. KD 
values of 25nM (A), 70nM (C) and 250-700nM were estimated from gel shift experiments. Thus, 
electrophoretic mobility shift assays (EMSA) were conducted as described (3.2.6 K). EMSA templates, 
specific and unspecific competitors were designed mimicking the in vitro transcription situation as 
closely as possible. Furthermore, buffer, ionic strength and template concentration were chosen 
equally to in vitro transcription conditions. This allowed drawing direct conclusions of binding site 
occupancy in a respectively performed transcription assay. 
Experiments were conducted with three different specific DNA targets. The first target (T-rich Reb1 
BS) was created by annealing oligos #3109 and #3110 resulting in a 60bp DNA fragment with a Cy5 
label. It contained the sequence reaching from +75bp to +135bp downstream of the end of the 25S 
rDNA gene including T1 and the Reb1 binding site. The second target (Reb1 BS) contained the 
sequence between +95bp and +135bp including the Reb1 BS and a random 5’ part. It was obtained 
by annealing oligos #3113 and #3114 resulting in a 56bp Cy5-labeled DNA fragment. The third target 
(TER) was created via PCR using primers #3051 and #3486 producing a 344bp Cy5 labeled amplicon 
representing the complete terminator region including the RFB (+70bp to +414bp). Equal constructs 
were created with unlabeled oligos (#3476, #3477 and #3050) to test the specificity of the DNA 
binding activity. For unspecific competition experiments, a Cy3-labeled 55bp DNA was chosen, which 
is a part of the third module of the reference in vitro transcription template (4.1.2 C). Therefore, 
oligos #3111 and #3112 (55nt) were annealed. 
In titration assays with a constant DNA concentration of 10nM and the Reb1-His6 concentration 
ranging from 17.5nM to 1.4µM, DNA binding activity could be verified on all three templates (Fig. 4-7 
A, B, E). Gel electrophoresis revealed a band resembling shifted DNA which appeared first at roughly 
50nM Reb-His6 and increased in intensity when Reb1-His6 was added up to 175nM. Above this 
concentration, slower migrating bands could be detected probably due to an emerging 
superstructure. At the highest concentration of Reb1-His6, the DNA did not enter the gel, pointing to 
the formation of random protein-DNA aggregates. The binding behavior did not significantly depend 
on the template used, leading to the conclusion that the only cis-element within the rDNA terminator 
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influencing Reb1 binding was its designated binding site. Specific and unspecific competition assays 
were performed at fixed Reb1-His6 concentrations of 175nM (Reb1 BS) or 350nM (T-rich Reb1-BS) 
and 10nM template DNA (Fig. 4-7 C, D). Specific and unspecific competitor DNA were titrated in 
stepwise from 10nM to 0.5µM. The specific competitor induced a significant decrease in signal 
intensity of the shifted DNA band starting at low concentrations. Contrary, the signal intensity 
decreased very slightly even at high concentrations of the unspecific competitor.  
In summary, Reb1-His6 binds specifically to the binding site in the rDNA terminator. The binding is 
not influenced by other cis elements present in a DNA stretch ranging from position +70bp to +414bp 
from the end of the 25S rDNA gene. In in vitro transcription, Reb1 is used at 700nM final 
concentration if not otherwise stated, which marks full occupancy of the template DNA (Fig. 4-7 E). 
 
Fig. 4-7: EMSAs demonstrate specific binding of Reb1-His6 to the yeast rDNA terminator Reb1 binding site. Reb1 was 
titrated on Cy5-labeled templates containing the T-rich element and the Reb1 BS (A) or only the Reb1 BS (B) or the 
complete rDNA terminator region (E). From left to right: No protein control, titration of Reb1 in steps (17.5nM, 26.25nM, 
35nM, 61,25nM, 87.5nM, 175nM, 350nM, 700nM, 1.4µM). Template DNA concentration was 10nM. (C) and (D): Specificity 
of Reb1 binding was challenged in competition assays with templates containing the T-rich element and the Reb1 BS or only 
the Reb1 BS. From left to right: No protein control, positive control (marked with red or green asterisk), titration series of 
the unspecific competitor in 4 steps 10nM, 50nM, 100nM, 500nM, titration series of the unspecific competitor in 4 steps 
10nM, 50nM, 100nM, 500nM. The blue asterisk (E) marks full occupancy of the template and thus the condition used in in 
vitro transcription. Samples were allowed to equilibrate for 15min at RT and then separated on a 6% native PA gel. DNA 
bands were visualized in a FLA3000 fluorescence reader. Titration of the unspecific competitor was monitored via Cy3 
fluorescence. 
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4.3.2 Nsi1 / Ydr026c 
 
A) Establishment of a strategy to purify Nsi1 from SF21 insect cells  
 
Nsi1 or Ydr026c was just recently described as a bona fide termination factor for Pol I in vivo in yeast 
(Reiter et al. 2012). Moreover, Ha and colleagues suggested that Nsi1 plays a role in silencing of rDNA 
repeats (Ha et al. 2012, p.1). Thus, Nsi1 is an obvious candidate for thorough analysis in an in vitro 
transcription system for elongation/termination. In a newly developed strategy, recombinant Nsi1 
was expressed in SF21 insect cells using the MultiBac system (3.2.5) as an N-terminal FLAG tag fusion 
protein (Fig. 4-8 A). FLAG-Nsi1 was purified via immunoprecipitation (IP) with an anti-FLAG M2 agarose 
matrix as described (3.2.9 A). For elution, two different methods were tested: Addition of the FLAG 
peptide or cleavage with TEV protease via a recognition site between the tag and Nsi1. Elution 
efficiency turned out to be comparable however, TEV cleavage results in an untagged version of Nsi1 
which is preferable. Hence, all further purifications were carried out with TEV protease. The 
purification success was monitored by SDS PAGE and Western analysis. 
SDS PAGE and Coomassie staining revealed that the elution fraction (E) contained only the two 
characteristic bands for TEV protease as well as an additional band with the expected size of Nsi1 
(66.5kDa) (Fig. 4-8 B). No antibody is available for Nsi1. Nonetheless, Western analysis of the whole 
cell extract (WCE) and the elution (E) fractions with an antibody detecting Reb1 resulted in a signal at 
the position where Nsi1 is expected (apparent MW 62.4kDa) ) (Fig. 4-8 C). Since Nsi1 was purified 
recombinantly from insect cells and the molecular weight of yeast Reb1 is 92kDa, presence of a 
66.5kDa truncated version of Reb1 was very unlikely. Albeit it is speculative, the structural similarity 
of Reb1 and Nsi1 may explain a cross-reactivity of the polyclonal antibody. The purifications yielded 
highly purified Nsi1 in low amounts. Different purifications were very comparable with Nsi1 
concentrations (3.2.6 E) ranging from 1.4µM to 1.7µM. 
Strategies to express Nsi1 in larger quantities in E. coli with a C-terminal His6 tag and an N-terminal 
GST tag were successful on the purification level, however failed as no road-blocking activity could be 
detected in in vitro transcription (data not shown). Purification of Nsi1 from yeast with a C-terminal 
TAP tag according to the polymerase purification protocol was unsuccessful (data not shown). 
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Fig. 4-8: Nsi1 is purified in one step from SF21 insect cells. (A) The clear cell extract from 50x106 cells was subjected to anti 
FLAG immune precipitation. Nsi1 was eluted with the FLAG peptide or via TEV cleavage of the FLAG tag. (B) Fractions 
collected during the purification of Nsi1 (TEV cleavage) were separated on a 10% SDS gel and visualized by Coomassie 
staining. From left to right: whole cell extract (WCE, 0.04%), pellet (P, 0.04%), flowthrough of the IP (FT, 0.04%), washing 
steps (W1 – W4, 0.2%), elution fraction (E, 5%), beads after elution (50%). For Western analysis, identical amounts were 
separated on a 10% SDS gel. The blot was developed with antibodies directed against Reb1 and the FLAG epitope. (C) A 
calibration curve for the determination of the apparent MW of Nsi1 was calculated from the migration distances of the 
marker proteins in the Coomassie gel. The curve was approximated with a linear function and the apparent MW calculated. 
The red dot indicates the ln of the MW of Nsi1. 
 
B) Nsi1 exhibits DNA binding activity in gel shift experiments 
 
A binding motif for Nsi1 which is nearly identical with the recognition site of Reb1 was identified in a 
mass spectrometry based yeast proteome screen (Fleischer et al. 2006). Therefore, templates T-rich 
Reb1 BS and TER (4.3.1 C) were used to characterize the DNA binding ability of Nsi1. EMSAs were 
conducted as described in (3.2.6 K) and designed to mimic the in vitro transcription situation as 
closely as possible (4.3.1 C). The main focus laid on determination of template occupancy by Nsi1. 
Thus, experiments were carried out with the template DNA concentration held constant at 10nM and 
Nsi1 being titrated from 3.2nM to 320nM. In contrast to EMSAs with Reb1 and Fob1, only a faintly 
stained blurred band representing the shifted DNA could be detected (Fig. 4-9). Additionally, upon 
higher concentrations of Nsi1, signals were observed in the gel pockets pointing to random aggregate 
formation. This suggests that either EMSA conditions were not optimal to detect this interaction, 
Nsi1 concentration was to low or Nsi1 binding is mediated by other factors. However, the amount of 
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free DNA clearly decreased upon increased levels of Nsi1. The binding pattern slightly changed, if the 
TER template was used. Here, the free DNA signal vanished when 320nM Nsi1 were used. In 
summary, it was shown that Nsi1 exhibits DNA binding activity. Specificity thereof could not be 
addressed, due to the low signal intensity of the shifted DNA. Therefore, the question of functionality 
had to be addressed in in vitro transcription assays (Fig. 4-24) in which unless otherwise stated the 
standard Nsi1 concentration was 88nM. 
 
Fig. 4-9: Nsi1 binds to templates containing cis elements of the yeast rDNA terminator. Nsi1 was titrated on Cy5-labeled 
templates containing the T-rich element and the Reb1 BS (A) or the complete rDNA terminator region (B). From left to right: 
No protein control, titration of Nsi1 in steps (3.2nM, 4.8nM, 6.4nM, 11.3nM, 16.1nM, 40.3nM, 80.5nM, 161nM, 320nM). 
Template DNA concentration was 10nM. Samples were allowed to equilibrate for 15min at RT and then separated on a 6% 
native PA gel. DNA bands were visualized in a FLA3000 fluorescence reader. The red asterisk marks the Nsi1 concnetration 
which was used in in vitro transcription, the green asterisk marks the blurred band representing shifted DNA. 
 
 
4.3.3 Fob1 
 
A) Establishment of a strategy to purify Fob1 from SF21 insect cells  
 
Fob1 was described as a factor involved in blocking of the DNA replication fork from entering the 35S 
rDNA, and was linked to homologous recombination events of the yeast rDNA (Kobayashi & Horiuchi 
1996). Additionally, Fob1 was implicated to function in Pol I transcription termination (El Hage et al. 
2008). A known target to which Fob1 binds in vivo is the replication fork barrier (RFB) in which three 
sites (RFB 1-3) were identified as being responsible for the blocking activity (Ward et al. 2000; 
Kobayashi 2003). One aim of this study was to elucidate the influence of Fob1 on Pol I transcription 
termination and its general road-blocking ability for RNA polymerases.  
Fob1 was expressed as an N-terminal FLAG fusion protein in SF21 cells as described in (3.2.5). Like 
Nsi1 (4.3.2), Fob1 was purified via IP with anti-FLAG M2 beads (3.2.9 A). Elution was either 
performed by addition of the FLAG peptide or cleavage with TEV protease. Both methods yielded 
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Fob1 in comparable amounts and purity. TEV-eluted Fob1 was used in all further described 
experiments if not stated otherwise. The purification was monitored via SDS-PAGE and Western 
blotting. On a Coomassie stained SDS gel including all fractions collected during the purification, the 
lane containing a sample of the elution fraction (E) showed three distinct bands (Fig. 4-10 B). Around 
25kDa, two bands probably representing TEV protease were visible while the third band was in the 
range of the theoretical molecular weight of Fob1 (65.3kDa). Other contaminants could not be 
detected on Coomassie level. No antibody was available recognizing Fob1. Therefore, a purification 
where elution was done with the FLAG peptide was used for Western analysis. FLAG-Fob1 was 
detected with antibody #83 directed against the FLAG epitope. The fusion protein was detected in 
every fraction of the purification including the eluate. Note that the Western blot showed two signals 
in the lane of the eluate fraction, which could be due to a C-terminal proteolytic fragment of Fob1. 
This second band was also visible in other Coomassie gels of Fob1 purifications. An apparent MW of 
64.2kDa was calculated. 
In summary, a strategy for purification of recombinant Fob1 from SF21 cells was developed, yielding 
highly pure protein. In repetitive purifications, Fob1 concentrations ranged from 6.5µM to 8.5µM. 
Attempts to purify Fob1 from E. coli as a GST fusion protein or from yeast with a C-terminal TAP tag, 
failed (data not shown). 
 
Fig. 4-10: Fob1 is purified in one step from SF21 insect cells. (A) The clear cell extract from 50x106 cells was subjected to 
anti FLAG immune precipitation. Fob1 was eluted with the FLAG peptide or via TEV cleavage of the FLAG tag. (B) Fractions 
collected during the purification of Nsi1 (TEV cleavage) were separated on a 10% SDS gel and visualized by Coomassie 
staining. From left to right: whole cell extract (WCE, 0.04%), pellet (P, 0.04%), flowthrough of the IP (FT, 0.04%), washing 
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steps (W1 – W4, 0.2%), elution fraction (E, 5%), beads after elution (50%). For Western analysis, identical amounts were 
separated on a 10% SDS gel. The blot was developed with an antibody directed against the FLAG epitope. (C) A calibration 
curve for the determination of the apparent MW of Fob1 was calculated from the migration distances of the marker 
proteins in the Coomassie gel. The curve was approximated with a linear function and the apparent MW calculated. The red 
dot indicates the ln of the MW of Nsi1. 
 
B) Gel filtration suggests multimerization of Fob1  
 
Gel filtration of Fob1 was performed as described (3.2.6 J) to shed light on sample homogeneity. 50µl 
of purified Fob1 eluted with the FLAG peptide were separated on a Superose6 column with TAP100 
buffer (Table 3-5) as the eluent. Fractions were collected and analyzed via SDS-PAGE and Coomassie 
staining. The chromatogram showed three distinct peaks, of which the first (fractions 2-4) 
represented the void volume (Fig. 4-11).  
    
Fig. 4-11: Gel filtration analysis of Fob1. (A) Gel filtration was performed with 50µl of fraction E (Fig. 4-10) on a Superose6 
column with a SMART system. UV280 absorption was detected and arbitrary units were plotted against the fraction number. 
(B) 4% of fractions 13 to 29 collected during the run were analyzed on a 10% SDS gel.  
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Peak two reached from fraction 15-17 and the third and largest peak was detected around fractions 
25-27. Fractions up to 7 could not be analyzed due to malfunction of the sample collector. SDS gel 
analysis of fractions 13-30 demonstrated that peak two consisted of Fob1, whereas peak three most 
certainly contained the FLAG octapeptide, which could not be resolved in a standard gel system.  
This indicated that the population of Fob1 obtained by the described purification method was almost 
homogeneous, albeit not excluding the possibility that the first peak could be due to Fob1 
aggregates. The question of possible Fob1 multimerization was addressed by calculation of a 
calibration curve made up of elution volumes of proteins with known molecular weights. Fob1 eluted 
at an apparent molecular weight of 252kDa, which is roughly 4 times the apparent molecular weight 
of 64.2kDa indicating a tetrameric state. 
 
C) Fob1 specifically binds its RFB recognition sites in EMSA experiments 
 
Kobayashi demonstrated that RFB 1 and 3 are specifically bound by GST-Fob1 (Kobayashi 2003) 
whereas RFB 2 exhibits no or very low Fob1 binding activity. Based on this study, EMSAs were 
conducted as outlined in (3.2.6 K). To draw conclusions about template occupancy in in vitro 
transcription assays, gel shift conditions were chosen respectively (4.3.1 C). To verify the results of 
Kobayashi and to elucidate the influence of further rDNA terminator cis elements, a series of Cy5-
labeled templates was created. Template RFB 1 (44bp) contained the equally named sequence 
identified by Kobayashi (+363bp - +383bp from the end of the 25S gene) flanked by random DNA. It 
was obtained by annealing of oligos #3482 and #3483. Annealing of oligos #3478 and #3480 resulted 
in template RFB 3 (45bp), which consisted of the RFB 3 region (+265bp – +286bp) flanked by random 
sequences. In his work of 2003, Kobayashi claimed that the RFB is wrapped around Fob1, implying 
concurrent binding to both RFB 1 and 3. Therefore, a template with both binding sites was created 
via PCR with oligos #3051 and #3484 (RFB 1 -3, 160bp) spanning from position +244bp to +404bp. For 
specific competition assays, an equal set of unlabeled templates was manufactured with oligos 
#3497 [RFB 3], #3482[RFB1] and 3485[RFB 1-3]). The unspecific competitor was identical to the one 
used before (4.3.1 C).  
In a first approach, Fob1 was titrated from 16nM to 1.2µM on all templates at constant 10nM 
template concentration (Fig. 4-12 A, B). With templates RFB 1 and 3, a band representing shifted DNA 
was visible upon addition of the lowest amount of Fob1. This band increased in intensity whereas the 
signal of the free DNA vanished. The highest concentrations of Fob1 led to supershifting likely due to 
random Fob1 binding activity. However, EMSAs with RFB 1 and RFB 3 showed subtle differences (Fig. 
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4-12 E). With RFB 3, the free DNA signal was not detectable when Fob1 was present at 160nM, 
whereas with RFB 1 this point was reached between 55nM and 80nM Fob1. Taken into account that 
Fob1 came from the same purification and the templates were annealed from oligos side by side, 
uncertainties regarding protein or DNA concentration could be ruled out. Hence, the result 
suggested, that Fob1 has a bigger affinity for RFB 1 than for RFB 3. This is in agreement with the 
Kobayashi data from 2003 although it was not commented in the manuscript.  
When both RFB 1 and RFB 3 were present in the template, shifted DNA first formed a double band 
which could represent two states of single occupancy of either the RFB 1 or RFB 3 site (Fig. 4-12 E). 
Upon higher Fob1 concentrations a second, slower migrating sharp band appeared, correlating with 
vanishing of the free DNA (5nM-80nM). This species might occur when the template was bound by 
two Fob1 proteins. Further increase in Fob1 probably resulted in formation of random aggregates 
which could not enter the gel. Interestingly, full occupancy of the RFB 1-3 template was reached at a 
similar Fob1 concentration than observed with the RFB 1 template, implicating that binding of the 
RFB1 site is the decisive event. Finally, gel shifts were conducted with the TER template (4.3.1 C), 
giving similar results as observed with the RFB 1-3 template (Fig. 4-12 G). 
For specific and unspecific competition studies on RFB 1 and 3 templates, DNA concentration was 
fixed at 10nM and Fob1 concentration was held constant at 55nM (RFB 1) and 160nM (RFB 3) 
representing the states of complete shifting. Specific and unspecific competitor DNA was added in 
four steps between 10nM and 0.5µM. Unspecific competition with both RFB 1 and 3 lead to a minor 
decrease in the shifted DNA signal (Fig. 4-12 C, D). Upon addition of a specific competitor, signal 
intensity of the shifted DNA decreased substantially. Notably, RFB 1 and RFB 3 show different 
behavior in this regard as well. Whereas with RFB 1 free DNA signals could only be detected if high 
amounts of competitor DNA were present, free RFB 3 template was visible at low amounts thereof 
already. Competition assays performed with the RFB 1-3 template were done at 10nM template and 
80nM Fob1 concentrations (Fig. 4-12 F). Unspecific competitor was added like before and exerted little 
effect on the shifted DNA signal. Specific competition was done in two steps with 10nM and 50nM 
resulting in significant decrease of the shifted band signal.  
In summary, data from (Kobayashi 2003) could be verified. Fob1 specifically bound DNA fragments 
containing the RFB 1 or RFB 3 site. Further EMSAs revealed that other cis elements present in the 
rDNA terminator did not influence Fob1 binding. Interestingly, binding to the RFB 1 site seemed to 
occur with a lower affinity than binding to RFB 3. 
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Fig. 4-12: EMSAs demonstrate specific binding of Fob1 to the replication fork barrier. Fob1 was titrated on Cy5-labeled 
templates containing the RFB1 (A), RFB3 (B), the complete RFB (E) or the complete rDNA terminator region (G). From left to 
right: No protein control, titration of Fob1 in steps (16nM, 24nM, 32nM, 56nM, 80nM, 158nM, 317nM, 635nM, 1.2µM). 
Template DNA concentration was 10nM. The red (RFB1), green (RFB3) and cyan (RFB1&3) asterisks represent the Fob1 
concentrations used in later competition experiments. (C), (D) and (F): Specificity of Fob1 binding was challenged in 
competition assays with templates containing RFB1, RFB3 or the complete RFB. From left to right: No protein control, 
positive control (marked with red, green or cyan asterisk), titration series of the unspecific competitor in 4 steps (10nM, 
50nM, 100nM, 500nM), titration series of the unspecific competitor in 4 steps (10nM, 50nM, 100nM, 500nM). Titration of 
the unspecific competitor was monitored via Cy3 fluorescence. In (F), the specific competitor was titrated in two steps at 
concentrations of 10nM and 50nM. The orange asterisk in (G) marks the Fob1 concentration used in transcription 
experiments. Samples were allowed to equilibrate for 15min at RT and then separated on a 6% native PA gel. DNA bands 
were visualized in a FLA3000 fluorescence reader. 
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4.3.4 LexA 
 
A) LexA is purified from E. coli as a GST fusion protein 
 
LexA is a well studied strong DNA binding protein in bacteria. Together with RecA, it is one of the 
major effectors within the SOS system thus being involved in maintenance of genome stability and 
DNA damage repair (Butala et al. 2009). LexA consists of an N-terminal domain responsible for its 
DNA binding activity and a C-terminal domain involved in LexA dimerization. Specific DNA binding 
activity occurs in the context of recognition sites called SOS boxes (CTGTN8ACAG ) in dimeric state. As 
a strong DNA binding protein in a bacterial system, LexA was used as an external reference to 
elucidate differences in road blocking of eukaryotic polymerases.  
 
Fig. 4-13: GST-LexA is purified from E. coli in two steps. (A) The clear cell extract was subjected to GSH-sepharose affinity 
chromatography. GST-LexA was eluted by addition of GSH. PreScission protease cleaves the fusion protein to yield GST and 
LexA (3.2.6 L). (B) Coomassie stained SDS gel of all fractions collected during the purification. From left to right: cell extract 
(WCE, 0.04%), insoluble fraction (P, 0.04%), flowthrough of the GSH sepharose column (FT, 0.04%), washing steps (W1-3, 
0.1%), elution steps (E1-6, 0.67%), beads after elution (B, 0.5%). The band representing GST-LexA is indicated. (C) A 
calibration curve for the determination of the apparent MW of GST-LexA was calculated from the migration distances of the 
marker proteins in the Coomassie gel (B). The curve was approximated with a linear function and the apparent MW 
calculated. The red dot indicates the ln of the MW of Nsi1. (D) The GST and LexA mixture was separated on a 10% SDS gel. 
From left to right: GST-LexA before cleavage, GST and LexA after cleavage, PreScission protease control, GST control. 
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LexA was purified as from E. coli as described (3.2.9 C) according to a protocol developed by Joachim 
Griesenbeck (Fig. 4-13 A). Expression was done from pGEX-6P-1 resulting in an N-terminal GST fusion 
protein. After cell lysis and centrifugation, the whole cell extract (WCE) was subjected to affinity 
purification via glutathione (GSH) agarose. Following binding (FT) and washing (W1-W3), GST-LexA 
was eluted in 6 steps (E1 - E6) with a buffer containing 10mM GSH. Fractions of every purification 
step were collected and analyzed via SDS PAGE and Coomassie staining (Fig. 4-13 B). All elution 
fraction lanes contained a strong signal in the range of 46kDa, which presumably represented GST-
LexA (48.4kDa). Calculation of its apparent molecular weight with a calibration curve resulted in 
45.6kDa with an error of 2% (Fig. 4-13 C). However, in elution fractions 2, 3 and 4, additional bands 
with lower molecular weights were detected. Mass spectrometry (3.2.7 A) after gel filtration 
revealed that these bands represent fragments of the fusion protein (see also 4.3.4 B).  
 
B) LexA behaves like a monomer in gel filtration 
 
The question of homogeneity of the GST-LexA preparation was addressed in gel filtration 
experiments (3.2.6 J). 50µl of fraction E2 were separated on a Superose 6 column with PBS as the 
eluent (Fig. 4-14 A). The chromatogram consisted of a broad peak spanning from fractions 10 to 23 
with two summits. SDS gel analysis of the collected fractions followed by Coomassie staining 
demonstrated that this peak consisted of GST-LexA. This random distribution suggests that purified 
GST LexA represents a mixture of different multimerization states, presumably due to the 
dimerization capacity of both LexA and GST. Notably, several bands at lower molecular weights were 
detected in every fraction containing GST-LexA, in a similar pattern as observed before (4.3.4 A). To 
clarify, whether these were proteolytic fragments of GST-LexA, selected bands were excised and 
subjected to mass spectrometry as described (3.2.7 A). The result proved the hypothesis, as only 
peptides of GST or LexA were found with a significant score. However, the question remained, why 
proteins of different molecular weights co-eluted in one peak. Possible explanations included 
complex formation of full-length GST-LexA with its fragments or instability of the fusion protein 
during the experimental procedure.  
For further characterization, the fusion protein was cleaved (3.2.6 L) with PreScission protease at a 
recognition site between GST tag and LexA. Separation on a SDS gel demonstrated the successful 
cleavage of GST-LexA (Fig. 4-13 D). Two bands in the range of the molecular weights of LexA (22.4kDa) 
and GST (26kDa) appeared upon protease treatment. With a MW close to 46kDa, PreScission 
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protease was detected, whereas GST-LexA was absent. Most interestingly, no LexA and GST 
fragments were visible after digestion of the fusion protein.  
                           
Fig. 4-14: Gel filtration analysis reveals a fairly homogeneous population of LexA. (A) Gel filtration was performed with 
50µl of GST LexA (fraction E2, Fig. 4-13) on a Superose6 column with a SMART system. UV280 absorption was detected and 
arbitrary units were plotted against the fraction number. 4% of fractions 8 to 25 collected during the run were analyzed on 
a 10% SDS gel. (B) Gel filtration of LexA and GST was performed with 50µl of the cleaved fusion protein on a Superose6 
column with a SMART system. UV280 absorption was detected and arbitrary units were plotted against the fraction number. 
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4% of fractions 8 to 4 and 17 to 31 collected during the run were analyzed on a 10% SDS gel. “in” represents the gel 
filtration input. 
The mixture of LexA and GST was again characterized by separation on a Superose 6 column followed 
by SDS PAGE analysis of the collected fractions (Fig. 4-14 B). The chromatogram contained one major 
(fractions 20-22) and one minor (fractions 25-27) peak. With Coomassie staining, it was 
demonstrated that the major peak contained LexA and GST which were not resolved, while no signals 
were obtained for the minor peak. An apparent molecular weight of 24kDa was calculated via a 
calibration curve leading to the assumption that LexA and GST were in monomeric state. The GST and 
LexA mixture was referred to as LexA only in further studies. 
 
C) LexA binds to SOS box-containing templates in vitro 
 
EMSA experiments with GST-LexA were successful in conditions different from in vitro transcription 
(data not shown & bachelor thesis Sonja Blumenstock) making the results not conclusive for 
downstream applications. However, GST-LexA and LexA were also successfully used in EMSAs 
conducted in the conditions mentioned before (4.3.1 C). Two DNA targets with either one (1x LexA 
BS) or three (3x LexA BS) LexA binding sites (SOS boxes) were designed: Template 1x LexA BS was 
obtained by annealing of oligos #3115 and #3116 resulting in a Cy5-labeled 50bp DNA. For template 
3x LexA BS, a PCR was done with primers #3801 and #3117 on vector #1254 yielding a FAM-labeled 
265bp DNA representing nearly the complete transcription template which was used later on. In 
titration experiments with 1x LexA BS, template concentration was held constant at 10nM and GST-
LexA or LexA concentrations were ranging from 165nM to 8,26µM or 112nM to 5.63µM, respectively. 
Both titrations with GST-LexA and LexA did not lead to full template occupancy (Fig. 4-15 A, B). 
However, upon rising protein concentrations, two (LexA) or three (GST-LexA) bands with lower 
electrophoretic mobility became visible. These shifted DNA species could represent templates bound 
to one, two or three proteins, given the facts that LexA binds SOS boxes as a dimer and GST is also 
able to dimerize (Liew et al. 2008). In an equally performed shift assay with the 3x LexA BS template, 
results differed substantially. In a low LexA concentration range from 220nM to 450nM, a pattern of 
three distinct bands was observed besides the free DNA, presumably representing templates 
occupied by one, two or three LexA proteins or LexA dimers (Fig. 4-15 C). Upon rising LexA 
concentrations, the triple-occupied template became the predominant species (1.1µM – 1.7µM). The 
highest LexA concentrations resulted in fuzzy bands suggesting random aggregate formation.  
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In summary, GST-LexA could be purified in vast amounts and high purity. GST LexA showed a random 
distribution in gel filtration probably due to multimerization domains in both LexA and GST. The 
fusion protein was successfully cleaved with PreScission protease to yield an equimolar mix of LexA 
and GST. Gel filtration of this mixture suggested that LexA and GST were eluting as monomers. A 
LexA concentration of 56.3µM was calculated (3.2.6 E). In gel shift experiments, DNA-binding activity 
of both GST-LexA and LexA to SOS boxes was confirmed as expected from literature. Specificity of 
LexA binding was already addressed in other studies (Butala et al. 2007; A. P. P. Zhang et al. 2010). 
 
Fig. 4-15: LexA binds to templates containing SOS boxes. LexA or GST-LexA were titrated on Cy5-labeled templates 
containing one (A), (B) or three (C) SOS boxes. From left to right: No protein control, titration of GST-LexA (165nM, 248nM, 
330nM, 413nM, 660nM, 826nM, 1.6µM, 4.1µM, 8.26µM) or LexA (112nM, 168nM, 225nM, 281nM, 450nM, 562nM, 1.1µM, 
2.8µM, 5.63µM) in steps. Template DNA concentration was 10nM. Samples were allowed to equilibrate for 15min at RT and 
then separated on a 6% native PA gel. DNA bands were visualized in a FLA3000 fluorescence reader. The red asterisk marks 
the LexA concnetration which was used in in vitro transcription.  
 
 
4.3.5 LacI 
 
A) LacI is purified from E. coli as a GST fusion protein 
 
The Lac repressor protein (LacI) is a key regulator of gene expression in bacteria which was first 
described by (JACOB & MONOD 1961) in context of the lac operon. Its in vivo target are three binding 
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sites in the lac operator region. LacI binds DNA as a tetramer, recognizing a 
GAATTGTGAGCGCTCACAATT consensus sequence or slight variations thereof. LacI exhibited road-
blocking activity for elongating yeast RNA Pol I in vitro (Tschochne & Milkereit 1997), thus making it 
an interesting reference in this study. 
LacI was purified as descried (3.2.9 C) from E. coli as an N-terminal GST fusion protein. The same 
strategy was followed as was used for GST-LexA (4.3.4), except that expression was from pGEX-4T-1 
(Fig. 4-16 A). Thus, GST-LacI contained a recognition site for thrombin between LacI and GST. SDS gel 
analysis of the collected fractions showed that a large percentage of GST-LacI was unsoluble (P) (Fig. 
4-16 B). Elution fractions 1 to 6 were mainly composed of a protein in the range of 58kDa, which 
matched with the theoretical MW of GST-LacI (64kDa). MW calculation via a calibration curve 
resulted in 57.1kDa with an error of 2% (Fig. 4-16 C). Only minor amounts of contaminants were 
detected in either of the elution fractions. GST-LacI was cleaved with thrombin as described (3.2.6 L) 
resulting in an equimolar mix of GST and LacI (Fig. 4-16 D).  
 
Fig. 4-16: LacI is purified from E. coli in two steps. (A) The clear cell extract was subjected to GSH-sepharose affinity 
chromatography. GST-LacI was eluted by addition of GSH. Thrombin cleaves the fusion protein to yield GST and LacI (3.2.6 
L). (B) Coomassie stained SDS gel of all fractions collected during the purification. From left to right: cell extract (WCE, 
0.04%), insoluble fraction (P, 0.04%), flowthrough of the GSH sepharose column (FT, 0.04%), washing steps (W1-3, 0.1%), 
elution steps (E1-6, 0.67%), beads after elution (B, 0.5%). The band representing GST-LacI is indicated. (C) A calibration 
curve for the determination of the apparent MW of GST-LacI was calculated from the migration distances of the marker 
proteins in the Coomassie gel (B). The curve was approximated with a linear function and the apparent MW calculated. The 
red dot indicates the ln of the ln of the MW of Nsi1. (D) The GST and LacI mixture was separated on a 10% SDS gel. From left 
to right: Thrombin, GST and LacI after cleavage, uncleaved GST-LacI, GST control. 
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B) Gel filtration suggests a multimeric state of GST-LacI 
 
A Superose 6 column was used to assess the homogeneity and multimerization of the GST-LacI 
preparation.  
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Fig. 4-17: Gel filtration analysis reveals an almost homogeneous population of LacI. (A) Gel filtration was performed with 
50µl of GST LacI (fraction E2, Fig. 4-16) on a Superose6 column with a SMART system. UV280 absorption was detected and 
arbitrary units were plotted against the fraction number. 4% of fractions 3 to 19 and 26 to 27 collected during the run were 
analyzed on a 10% SDS gel. (B) Gel filtration of LacI and GST was performed with 50µl of the cleaved fusion protein on a 
Superose6 column with a SMART system. UV280 absorption was detected and arbitrary units were plotted against the 
fraction number. 4% of fractions 1 to 6 and 14 to 23 collected during the run were analyzed on a 10% SDS gel. “in” 
represents the gel filtration input. 
In the chromatogram two peaks were visible including fractions 4 to 7 and 16 to 18. While for the 
first peak no signals were obtained after Coomassie staining, the second peak was comprised of GST-
LacI (Fig. 4-17 A). Calculation of the apparent MW of GST-LacI with a calibration curve resulted in 
163kDa, suggesting a dimeric or trimeric state. However, purified GST-LacI was a fairly homogeneous 
fraction eluting in one peak. After cleavage, three peaks were visible in the gel filtration 
chromatogram (Fig. 4-17 B). On a SDS gel, no signal was obtained for the first peak representing the 
void volume, whereas the second and third peak consisted of LacI and GST, respectively. Compared 
to a calibration curve of standard proteins, LacI eluted at 152kDa, suggesting a tetrameric state 
(monomer MW 38kDa) in good agreement with the literature (Pace et al. 1990). 
 
 
4.3.6 TFIIF 
 
TFIIF stimulates Pol II elongation rates and decreases elongation pausing (Flores et al. 1989; Price et 
al. 1989; Bengal et al. 1991; Izban & Luse 1992; Tan et al. 1994). It was extensively studied and 
further described as an initiation factor, albeit this role is being challenged (Luse 2012). Yeast TFIIF is 
comprised of three subunits Tfg1 (82.2kDa), Tfg2 (46.6kDa) and Tfg3 (Taf14, 27.4kDa). It was shown, 
that Tfg1 and Tfg2 are partially structurally related to the Pol I subunits A49 and A34.5 (Kuhn et al. 
2007; Geiger et al. 2010). The A49/A34.5 dimer is being discussed as a built-in elongation factor for 
Pol I (Kuhn et al. 2007). Thus, we wanted to compare TFIIF and the A49/A34.5 dimer regarding their 
functions in transcription elongation. 
 
A) TFIIF is purified from yeast via immunoprecipitation 
 
TFIIF was purified as described (3.2.10 C) from yeast strain #2994 via IP with IgG coupled magnetic 
beads (Fig. 4-18 B). All three TFIIF subunits were expressed under the control of the ADH promoter, 
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with a C-terminal TAP tag on the second largest subunit Tfg2 (Chen et al. 2010). First purifications 
were carried out with buffers containing 200mM KCl (Table 3-4) yielding a complex mixture of proteins 
after elution via TEV cleavage (E). Analysis of the elution fraction via SDS PAGE showed four 
predominant bands, of which three were in the MW range of the TFIIF subunits (Fig. 4-18 A). The 
identity of the three TFIIF subunits was proven in mass spectrometry and Western analysis with 
antibodies detecting Tfg1, Tfg3 and CBP. Furthermore, two bands representing Rpb1 and Rpb2 (*) 
were detected with Coomassie staining and identified by Western blot and mass spectrometry, 
leading to the assumption that Pol II was co-purified with TFIIF in these conditions. In in vitro 
transcription experiments, the TFIIF preparation exhibited polymerase activity, thus proving the 
hypothesis (Fig. 4-18 D). Interestingly, TFIIF did not co-purify with Pol II in similar conditions (200mM 
KCl), if Rpb2-ProtA was the bait (4.2.3). Mass spectrometry did not return a significant result for the 
co-purifying protein with a MW between Tfg1 and Tfg2-CBP (*). 
 
Fig. 4-18: TFIIF is purified from yeast in one step. (A) Fractions collected during purification of TFIIF in three different salt 
concentrations were separated on a 10% SDS gel and visualized by Coomassie staining. From left to right: cell extract (WCE, 
0.6%), flowthrough of the IP (FT, 0.6%), washing steps (W1, 2, 0.7%), elution fraction (E, 10%), beads after elution (B, 50%). 
Bands representing TFIIF subunits are indicated. Two red asterisks mark Rpb1 and Rpb2. The green asterisk indicates an 
unknown major contaminant. (B) The cleared cell extract is subjected to immune precipitation with IgG coupled magnetic 
beads with Tfg2-TAP as the bait. TFIIF is eluted by addition of TEV protease and cleavage of the TAP tag. (C) Western 
analysis was done with identical amounts of the elution fractions from the different TFIIF purifications and a Pol II 
preparation. The blot was developed with two antibodies against Rpb1 and CBP. (D) Comparative in vitro transcription was 
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conducted with TFIIF prepared with 200mM KCl and Pol II using the tailed reference template (Fig. 4-1). 1µl of Pol II or TFIIF 
were used in a 20µl standard reaction and exposure was 1h. Transcriptional activity of a TFIIF (500) preparation is shown in 
Fig. 4-37. 
 
B) Pol II is co-purified with TFIIF depending on ionic strength of the buffers 
 
Aim of this part of the study was to purify only TFIIF. Therefore, purifications were carried out in 
buffers with different ionic strength, ranging from 200mM KCl to 500mM KCl (Table 3-4). Side-by-side 
analysis of the respective elution fractions revealed significant differences (Fig. 4-18 A, C). With 
Coomassie staining, Rpb1 and Rpb2 could not be detected in 300mM and 500mM KCl conditions, the 
background decreased in general and the significant band with a MW between Tfg1 and Tfg2-CBP 
vanished. In Western analysis, roughly equal amounts of Tfg2-CBP were observed in all TFIIF 
purifications, while Rpb1 was detected at 200mM, faintly at 300mM but not at 500mM KCl. 
Therefore, TFIIF purified with 500mM KCl was used in all further studies, unless indicated otherwise. 
 
C) Interactions between Pol II and TFIIF in vitro 
 
Next, the question was addressed, whether a TFIIF-Pol II complex could be reconstituted from TFIIF 
purified with 500mM KCl and purified Pol II (4.2). After the purification, Tfg2 was still fused to the 
CBP part of the TAP tag, making an affinity capture via Calmodulin beads possible. The complex 
formation was conducted as described (3.2.6 M). TFIIF and Pol II concentrations were calculated 
(3.2.6 E) and mixes with equal amounts or excess TFIIF were prepared. Respective amounts of either 
purified Pol II or TFIIF which were treated equally served as controls. After incubation with the 
affinity matrix, unbound proteins were separated (FT) and 2 washing steps (W1, W2) were 
performed with a buffer containing 100mM KCl. The beads were boiled in SDS sample buffer to 
determine associated proteins. The collected fractions were separated by SDS PAGE followed by 
silver staining or Western blot in parallel (Fig. 4-19). TFIIF alone was present in input and beads 
fractions, thus confirming the expected result. In the polymerase control, Pol II was mainly detected 
in the input (IN) and FT. However minor amounts were associated with the beads, thus determining 
the Pol II background. In both Pol II/TFIIF mixtures, the beads fraction contained Pol II and TFIIF with 
Pol II signal intensity being elevated in comparison with the Pol II background. With rising amounts of 
TFIIF, more Pol II was recruited, as visible in silver staining and Western blot. However, Pol II was 
never completely bound to the beads.  
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In summary, TFIIF could be purified from yeast in a strategy adapted from (Chen et al. 2010). 
Depending on the ionic strength of the buffers, Pol II co-purified with TFIIF. Our results indicate 
interactions of Pol II with TFIIF in vitro. TFIIF concentration (500mM KCl) was calculated as 2.5µM. 
 
Fig. 4-19: In vitro interaction between Pol II and TFIIF. Pol II and TFIIF were incubated on ice for 15min in a buffer 
containing 50mM NaCl. The sample was incubated with Calmodulin beads for 2h at 4°C. The flowthrough was collected and 
the affinity resin washed twice with a buffer containing 100mM NaCl. Fractions were analyzed on a 10% SDS gel and the 
proteins visualized with silver staining. From left to right: Pol II control, TFIIF control, Pol II + TFIIF , Pol II + excess TFIIF; input 
(in, 6.7%), flowthrough of the Calmodulin column (FT, 7.7%), washing steps (W1, 2, 2%), beads after washing (B, 25%). The 
TFIIF amount in 1:1 was the same than in the TFIIF control, in 1:7 7x the TFIIF amount was used. Western blots were 
performed respectively and developed with antibodies against complete Pol II and CBP. 
 
 
4.3.7 A49/A34.5 
 
A) The A49/A34.5 dimer is purified from E. coli via a His6 tag 
 
The recombinant A49/A34.5 dimer was purified as described (3.2.9 B ii) according to a protocol 
adapted from (Geiger et al. 2010). Both Pol I subunits were expressed from pET28b resulting in a C-
terminal A49-His6 fusion protein. After cell lysis, the whole cell extract was subjected to Ni-NTA 
affinity chromatography (Fig. 4-20 A). A49-His6 and A34.5 were eluted from the beads in four steps 
with 200mM imidazole. Fractions of every purification step were collected, separated by SDS PAGE 
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and analyzed either by Coomassie staining or Western blotting. The elution fractions (E1-4) showed a 
slightly changing band pattern with less different proteins in later fractions (Fig. 4-20 B). However, 
three main protein bands were observed, of which two were in the range of the theoretical size of 
A49-His6 and A34.5. Western analysis with antibody #10 confirmed the identity of subunit A49. The 
three bands of interest were excised and subjected to mass spectrometry (3.2.7 A), resulting again in 
identification of A49 and A34.5. No significant result was obtained for the third band in a yeast 
database search, which suggests that it was an E. coli protein. Protein concentration measurement 
(3.2.6 E) of the A49/A34.5 dimer in fraction E4, which was used in further experiments, resulted in 
3.0µM.  
 
Fig. 4-20: The A49/A34.5 dimer is purified from E. coli in one step. (A) The cleared cell extract is incubated with Ni-NTA 
affinity resin and A49/A34.5 is eluted stepwise with a buffer containing imidazole. (B) Fractions collected during the 
purification were analyzed on a 10% SDS gel. From left to right: Cell extract (WCE, 0.05%), insoluble fraction (P, 0.05%), 
flowthrough of the nickel column (FT, 0.05%), washing steps (W1, 2, 0.08%), elution fractions (E1-4, 1.6%), beads after 
elution (B, 2%). The positions of A49 and A34.5 are indicated. The red asterisk points out a major unidentified contaminant. 
Western analysis was done respectively with an antibody detecting subunit A49. 
 
 
4.4 Determination of in vitro transcription system parameters 
 
4.4.1 Optimal Pol I, II and III activity depends on ionic strength 
 
To compare Pol I, II and III in in vitro transcription, it was crucial to determine activity optima of the 
respective polymerases. Since the NTB buffer (Table 3-9) contained only standard components and 
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nearly no salt, optimal conditions thereof had to be determined. Hence, to standard in vitro 
transcription reactions conducted with Pol I, II and III, KOAc was titrated from 50mM to 400mM. The 
template of choice was the reference template (Fig. 4-1). The three polymerases showed distinctly 
different behavior. While Pol II activity was highest without additional KOAc ,Pol I reached the 
activity optimum at 100mM (Fig. 4-21). At higher salt concentrations, both polymerase activities 
declined. Contrary, Pol III activity increased with rising KOAc concentrations. Same results were 
observed with polymerases purified under KOAc conditions (data not shown). Thus, in the beginning, 
transcription experiments were conducted in two salt conditions (50mM and 150mM KOAc) ensuring 
that robust signals were obtained with all polymerases. Furthermore, misguided interpretations of 
salt-dependent effects upon addition of protein factors in transcription experiments could be 
excluded. However, later experiments showed that the results obtained in both KOAc conditions 
were comparable. Thus, in vitro transcription experiments were carried out at 50mM KOAc, if not 
otherwise stated. 
 
Fig. 4-21: RNA polymerase I, II and III have different activity optima with regard to ionic strength. Transcription reactions 
were performed as described with 10nM of the reference template and 1µl of each polymerase preparation. Isolated RNAs 
were separated on a 5% denaturing PA gel. Exposition time of the dried gel was 1h. The signal intensities of the tail full 
length transcripts were calculated and plotted against the KOAc concentration. The maximum signal intensity in every 
graph was set to 1. 
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4.4.2 Tailed template usage in in vitro transcription is 10% 
 
The molar ratio of generated transcript to template is defined as the template usage. It is an 
important characteristic of an in vitro transcription system and was hence calculated for the tailed 
template assay. The used template was a derivative of tail G- Reb1 BS RFB (Fig. 4-1) with a length of 
667bp (412kDa) of which 100ng (242fmol) were included in the reaction. Via a calibration curve, the 
molar amount of the generated transcript can be correlated to the signal intensity of the respective 
band visualized by autoradiography. To establish a calibration curve, a titration series of the α-32P-
CTP solution was spotted on whatman filter paper and exposed side-by-side with the transcription 
gel (Fig. 4-22 A).  
 
Fig. 4-22: Tailed template usage in in vitro transcription is 10%. (A) The α-32P-CTP stock solution was spotted on whatman 
filter paper in serial dilutions and exposed together with the transcription gel. (B) Signal intensities of those spots were 
quantified and plotted against the dilution. (C) Transcription was performed as described with 10nM of the reference 
template and 1µl Pol I. The isolated RNA was separated on a 5% denaturing PA gel. 2µl of the 10-2 dilution of the α-32P-CTP 
stock solution were applied on the gel shortly before the end of the run. Exposition time of the dried gel was 1h. (D) For 
determination of a quenching effect of the polyacrylamide gel, the signals obtained with 2µl of the 10-2 dilution of the α-
32P-CTP stock solution in (A) and (C) were compared. 
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The signal intensities of the spots were measured and plotted against the molar amount of 
radioactively labeled nucleotides taking into account the specific activity and the labeling efficiency 
of the nucleotide stock solution as well as the radioactive decay (Fig. 4-22 B). Next, the average 
number of incorporated α-32P-CTP per transcript was calculated by multiplication of the number of 
cytosine residues in the transcript with the fraction of radioactive CTP in the transcription reaction. 
Taken together, this allowed determination the molar amount of transcript. To estimate signal 
quenching due to the polyacrylamide urea gel, 1µl of the 10-2 dilution of the α-32P-CTP solution was 
applied on the gel shortly before the end of the run (Fig. 4-22 C). The signal intensities on the gel and 
on the filter paper were compared resulting in a quenching effect of roughly 30% (Fig. 4-22 D). Taken 
this into account, the molar amount of the generated RNA was 24fmol, leading to a template usage 
of 10%. In comparison with other in vitro transcription systems, this is a rather high value (personal 
communication, Herbert Tschochner, Philipp Milkereit). 
 
 
4.4.3 Tailed templates are transcribed only once 
 
Studies conducted by (Kadesch & Chamberlin 1982) indicated, that during in vitro transcription with 
tailed templates the two DNA strands are displaced and RNA-DNA hybrids are formed subsequently. 
In turn, this means that every template can be only transcribed once under the assumption that 
single stranded DNA cannot serve as a template. To challenge this hypothesis, the tailed template 
Reb1BS RFB was transcribed in different conditions in the presence of heparin. Heparin is a sulfated 
and thus negatively charged glucosaminoglycan with protein-binding features related to that of DNA. 
Heparin tightly binds to RNA polymerases forming a stable complex which is not initiation-competent 
in promoter dependent and independent transcription assays. If heparin was titrated to a standard in 
vitro transcription reaction conducted with T7 RNA polymerase, the signal intensity of the full length 
transcript decreased with rising concentration (Fig. 4-23) due to declining amount of polymerase. To 
mimic single round transcription, the polymerase was stalled at the G-less cassette, heparin was 
added and transcription resumed by addition of GTP. In this condition, roughly identical signal 
intensities were observed compared to the control without heparin, leading to the conclusion that 
tailed templates are transcribed only once (Fig. 4-23). This experiment was performed only with T7 
RNA polymerase. However, strand displacement during transcription most probably is a template-
inherent feature which suggests single round transcription also for transcription with Pol I, II and III. 
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Fig. 4-23: Tailed templates are transcribed only once. Transcription reactions were performed as described with 10nM of 
the Reb1 BS RFB template and T7 RNA polymerase. Heparin was titrated to the samples before transcription was started (-
G-less arrest) or during G-less arrest (+G-less arrest). After arrest, transcription was resumed by addition of GTP. Heparin 
concentrations ranged from 5ng/µl to 50ng/µl. Isolated RNAs were separated on a 5% denaturing PA gel. Exposition time of 
the dried gel was 1h. The signal intensities of the tail full length transcripts were calculated and 
 
 
4.5 In vitro transcription with complexed templates reveals road-
blocking ability of protein factors 
 
This study addressed the question, whether the purified proteins possessed the ability to function as 
elongation road blocks or transcription termination factors. Thus, the respective templates 
complexed with Nsi1, Reb1, Fob1, LexA or TTF-I were transcribed in vitro, with the main focus on the 
yeast proteins. Since TTF-I, Nsi1 and Reb1 were identified as Pol I termination factors (Reiter et al. 
2012; Lang & Reeder 1995; Evers et al. 1995), they will be referred to as such in the following 
chapters besides the terms elongation barriers/obstacles. 
 
 
4.5.1 Reb1, Nsi1 and Fob1 impose barriers in in vitro transcription 
 
In a first step, Reb1, Nsi1 or Fob1 were titrated to transcription reactions with Pol I and the tailed 
template TER (Fig. 4-1). Template concentration was 10nM and protein concentrations ranged from 
13.8nM to 1380nM (Fob1), 8.7 to 870nM (Reb1) and 8nM to 320nM (Nsi1) corresponding to the 
respective EMSA conditions (Fig. 4-12, Fig. 4-7, Fig. 4-9). The samples were allowed to equilibrate at RT 
for 15min before the reactions were started by addition of the polymerase. In vitro transcription 
reactions were carried out as described in (3.2.12). Besides the bands representing the run-off TER 
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and reference transcripts, one further band was each detected on the gel upon addition of Reb1 and 
Nsi1 in the range of 205nt (Fig. 4-24). Addition of Fob1 resulted in two different extra signals of 
roughly 395nt and 490nt. RNA length calculations were based on calibration curves generated with 
an in vitro transcribed RNA marker which was applied on every gel. Comparison of the transcript 
sizes with the position of the cis elements in the template DNA indicated that the RNA obtained with 
Reb1 and Nsi1 was ending at the T-rich 1 element (209nt-221nt) and the two bands gained with Fob1 
were mapping to the RFB3 (394nt-415nt) and RFB1 (492nt-512nt) sites. RNA lengths and cis element 
positions are referenced to the tailed template transcription start site. Quantification of the 
percentage of the remaining full-length transcript upon addition of a protein factor was done as 
described (3.2.12 D). This evaluation method was in general preferred over calculation of the 
percentage of the abortive or terminated transcript as the full length RNA bands always show robust 
signal intensities. However, in case of the titration series the respective vice versa calculation was 
performed as well to assess plausibility of the results. 
Upon titration of Reb1, the fraction of TER run-off transcript was gradually reduced to 40% compared 
to the negative control (Fig. 4-24 B). This result was expected and in good agreement with earlier 
observations made by Reeder and co-workers (Morrow et al. 1993). The fraction of full-length 
transcript was plotted against the Reb1 concentration resulting in a curve best approximated by a 
logarithmic fit, seemingly reaching a plateau. This suggested that full template occupancy as 
determined in EMSA analysis (700nM Reb1, Fig. 4-7) also reflected the maximum effect in in vitro 
transcription. Note, that the overall signal intensity decreased with rising amounts of Reb1 present in 
the reaction thus leading to the hypothesis that Reb1 negatively influences transcription at high 
concentrations. This effect was not observed, if a mock purification from E. coli (Fig. 4-5) was titrated 
to a transcription reaction instead of Reb1 (data not shown). 
Similarly, rising concentrations of Nsi1 led to a reduction of the TER full length transcript to roughly 
60% (Fig. 4-24 A). The curve obtained by plotting the proportion of TER run-off transcript versus the 
Nsi1 concentration reached a plateau at the higher Nsi1 concentrations. At full template occupancy 
identified in EMSA experiments (88nM Nsi1, Fig. 4-9), the maximum road-blocking effect was not yet 
reached. However, technical limits prohibited addition of larger Nsi1 volumes and attempts to obtain 
more concentrated Nsi1 failed. 
Fob1 was a less potent elongation obstacle for Pol I than Reb1 and Nsi1. Even at high concentrations, 
75% of the full length transcript were obtained than without Fob1 (Fig. 4-24 C). Thus, in the respective 
plot of full length transcript fraction against Fob1 concentration, saturation was reached at lower 
concentrations. With Fob1, full template occupancy (276nM Fob1, Fig. 4-12) correlated with the 
maximum road-blocking effect. 
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In summary, we could verify the pausing effect described for Reb1 qualitatively and quantitatively. 
Furthermore, we could show that Nsi1 and Fob1 are elongation obstacles for Pol I. 
 
Fig. 4-24: Titration of Nsi1, Reb1 and Fob1 reveals road blocking ability in in vitro transcription reactions conducted with 
Pol I and the tailed template TER. (A) Transcription reactions were performed as described with 10nM of each template 
and 1µl Pol I preparation. Nsi1 was titrated from 8nM to 320nM. After addition of the respective factor, the sample was 
allowed to equilibrate for 15min at RT before the reaction was started. Isolated RNAs were separated on a 5% denaturing 
PA gel. Exposition time of the dried gel was 1h. Signals were normalized to the reference transcript and the ratio of the full 
length transcript signal intensities of the lane of interest versus the negative control was calculated. The proportion of the 
abortive transcript compared to the negative control was determined respectively. Red asterisks indicate the factor 
concentration at which full template occupancy was observed in EMSA experiments. (B) Reb1 was titrated from 8.7nM to 
870nM. The experiment was carried out as described in (A). (C) Fob1 was titrated from 13.8nM to 1380nM. The experiment 
was carried out as described in (A) 
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4.5.2 Controls demonstrate that the observed effects can be traced back to 
the protein factors 
 
In all in vitro studies, thorough controls are of great importance to draw solid conclusions. Therefore, 
multiple sets of experiments were conducted to exclude that observed effects were experimental 
artifacts.  
As always two templates were present in the transcription reactions, it had to be clarified, whether 
the observed effects were due to the template of interest, or if the reference template was 
interfering. This was tested for Reb1, Nsi1, Fob1, LexA and TTF-I with KCl- and KOAc-purified RNA 
polymerases and the respective templates TER, 3xLexA or 5xTTF-I in transcription reactions 
containing additional 50mM or 150mM KOAc. Fig. 4-25 exemplary shows the results for Nsi1, Reb1 
and Fob1 with Pol I (KOAc-purified) in reactions containing 50mM KOAc. It could be demonstrated 
that the effects caused by Nsi1, Reb1 or Fob1 depended specifically on the presence of the TER 
template. Transcription of the reference template was not affected by the presence of either of the 
factors. Same results were obtained if Pol II or III were used, if the reactions contained 150mM KOAc 
or if the polymerases were KCl-purified (data not shown). All possible combinations thereof were 
tested. The results were also in coordinance with the results obtained by gel shift experiments with 
competitor DNA (Fig. 4-12, Fig. 4-7). 
Furthermore, it had to be excluded that the protein elution buffers evoked significant effects. Thus, 
equal amounts of Reb1 elution buffer and TAP300 (with regard to the normally applied volumes of 
the elution fractions) were included in transcriptions. Reactions were conducted with Pol I, II and III 
(KOAc-purified) in presence of additional 50mM KOAc and compared to a negative control. Visual 
evaluation of the transcription gel lead to the conclusion, that neither buffer significantly influenced 
transcription by either polymerase (Fig. 4-25). For Pol I and II, transcript singal intensities seemed to 
decrease slightly upon addition of either buffer in accordance with general salt-dependency of the 
two polymerases (Fig. 4-21). 
Concerning the possible dependency of the results on the amount of additional KOAc in the reaction, 
it could be shown that the quality of the statements did not change with minor effects on absolute 
numbers (data not shown). 
Finally, the question was addressed, whether the polymerase purification protocol influenced the 
results. In Fig. 4-31 and Fig. 4-25, results of identical transcription experiments are depicted conducted 
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with KCl- and KOAc-purified Pol I. In these experiments, the tailed template TER and reference were 
transcribed in presence of Fob1, Nsi1 or Reb1. Visual and mathematical comparison of the respective 
results showed that the observed effects did not depend on the polymerase purification method 
(calculations only shown for KCl polymerases). 
In summary, it could be demonstrated that the results obtained in the in vitro transcription assay 
were robust and reproducible. 
 
Fig. 4-25: Template, buffer, polymerase and RNA marker controls. (A) Transcription reactions were performed as 
described with 10nM of each tailed template and 1µl Pol I preparation (KOAc conditions). Either both or one of the 
templates TER or reference were present in the reactions. Nsi1 was used at 88nM concentration. After addition of Nsi1, the 
sample was allowed to equilibrate for 15min at RT before the reaction was started. Isolated RNAs were separated on a 5% 
denaturing PA gel. Exposition time of the dried gel was 1h. Cartoons of the templates indicate the identity and length of the 
RNAs. Transcript length calculations were based on calibration curves obtained from a set of RNA marker bands. Identical 
experiments were performed at 50mM KOAc and 150mM KOAc. The gel pictures represent the 50mMKOAc situation. (B) 
Description see (A), except not Nsi1 but Reb1 was used at 700nM concentration. (C) Description see (A), except not Nsi1 
but Fob1 was used at 276nM concentration. (D) Experiments were done as described in (A) with tailed templates TER and 
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reference. Instead of protein factors, equal amounts of the respective elution buffers were included in the reaction, with T 
standing for TAP300 buffer, R standing for Reb1 elution buffer and – indicating the negative control. 
 
 
4.6 Efficient Pol I termination is dependent on the presence and 
orientation of the cis-elements in the rDNA terminator in vitro 
 
 
4.6.1 The T-rich 1 element is required for efficient termination by Nsi1 
 
Previous results had demonstrated that Nsi1 was required for Pol I termination. Since the region 
spanning from the T-rich 1 element to the RFB contains several identified cis-elements, the question 
arose which of these elements actually influenced of Nsi1-dependent termination. Thus, a series of 
tailed templates was created containing various rDNA terminator cis-element combinations (Fig. 4-1, 
4.1.2). Transcription reactions were carried out with 10nM of each template, 88nM Nsi1, 1µl Pol I 
preparation and additional 50mM KOAc. The transcripts were separated on a 5% denaturing PA gel 
and visualized by exposure to an imaging plate for 1h. Calculations demonstrated that the least 
amount of run-off transcript (40%) was generated if the entire terminator region was present in the 
template (Fig. 4-26). Inversion or deletion of the Reb1 binding site led to complete alleviation of the 
effect. When the T-rich 1 sequence was missing, the abortive transcript was still visible, albeit 
termination efficiency dropped by factor two (80%). Equal results were obtained with respective 
constructs lacking the RFB. However, comparison of transcription with template TER and the 
template containing only the T-rich 1 element and the Reb1 BS resulted in a small difference in full-
length transcript formation of 10%. 
In summary, presence and correct orientation of the Reb1 binding site is necessary for Nsi1 
dependent termination of Pol I. The T-rich element is required for efficient termination. The RFB 
slightly stimulates the effect.  
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Fig. 4-26: Cis element analysis reveals that presence and orientation of the Reb1 BS are necessary for Nsi1-dependent Pol 
I termination and that the T-rich 1 element is required for efficient termination in vitro. Transcription reactions were 
performed in triplicate as described with 10nM of the respective tailed template and 1µl Pol I. Nsi1 was used at 88nM 
concentration. After addition of Nsi1, the sample was allowed to equilibrate for 15min at RT before the reaction was 
started. Isolated RNAs were separated on a 5% denaturing PA gel. Exposition time of the dried gel was 1h. Cartoons of the 
templates indicate the identity and length of the RNAs. Signals were normalized to the reference transcript and the ratios of 
the full length transcript signal intensities of the lanes of interest versus the negative control were calculated and plotted. 
 
 
4.6.2 Reb1-dependent termination requires the T-rich 1 element and the 
Reb1 binding site 
 
Reeder and co-workers observed that Reb1-dependent Pol I termination required the T-rich 1 
element and the Reb1 BS in vitro (Lang et al. 1994). To compare the results obtained with Nsi1 with 
the published data, identical experiments as described in 4.6.1 were performed with Reb1 instead of 
Nsi1 to elucidate the cis-element dependency of Reb1-dependent Pol I termination in vitro. As usual, 
Reb1 concentration was set to 700nM. With templates missing the T-rich 1 element or the Reb1 BS, 
no termination was detected, which is in agreement with the literature. Most efficient termination 
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(40% full length transcript) was achieved if all cis elements were present in the template (Fig. 4-27). 
With templates TER and T-rich Reb1 BS, strong signals of abortive transcripts were observed. 
However, deletion of the RFB led to a minor decrease in termination efficiency (< 5%). Transcription 
of templates with an inverted Reb1 binding site resulted in a minor terminaton effect (70% full length 
transcript) compared to the respective templates with the correctly oriented binding site. 
Interestingly, the length of the abortive transcripts changed with the orientation of the Reb1 binding 
site. Upon correct orientation, transcripts were mapping to the T-rich 1 site as observed before. If the 
binding site was inverted, the (very faintly visible) abortive transcripts extended to the Reb1 binding 
site. 
In summary the results demonstrated that the T-rich 1 element and the correctly oriented Reb1 BS 
were required for efficient Reb1-dependent Pol I termination. The percentage of terminated 
transcripts was reduced by roughly factor two if the Reb1 binding site was in inverted orientation. 
 
Fig. 4-27: Cis element analysis reveals that presence of the Reb1 BS and the T-rich 1 element are necessary for efficient 
Reb1-dependent Pol I termination in vitro. Description see Fig. 4-29, except that Reb1 was used at 700nM concentration 
instead of Nsi1.  
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4.7 Nsi1 and Fob1 exhibit cooperativity in Pol I transcription 
termination in vitro 
 
Ha and co-workers suggested a cooperative effect between Nsi1 and Fob1 (Ha et al. 2012, p.1). Thus 
it was tried to determine, if Nsi1 and Fob1 acted cooperatively in Pol I termination in vitro. 
Transcription conditions were chosen such that the termination effect exerted by Nsi1 was minimally 
visible (20nM). Then Fob1 was titrated to the reactions in three steps (27.6nM, 276nM, 1380nM). 
Note that the amount of Fob1 representing full complexion of the template was 276nM. Samples 
only containing Fob1 or Nsi1 or no additional factors served as controls. Transcription reactions were 
assembled as usual and either Fob1 or Nsi1 or both were added. Equilibration time was 15min at RT. 
The autoradiography of the denaturing PA gel is depicted in Fig. 4-28 A. As expected, presence of Nsi1 
resulted in a minimal fraction of terminated transcript (lane 2, green bar). Upon addition of rising 
amounts of Fob1 to samples containing Nsi1 (lanes 3, - 5, red bars) the signal intensity of the band 
representing the transcript terminated at the T-rich 1 site increased visibly. Furthermore, the two 
characteristic abortive transcripts at RFB1 and RFB3 appeared due to the presence of Fob1. However, 
the signal intensity of those bands seemed to be altered due to the presence of Nsi1. In a first step, 
the fractions of remaining full length transcript compared to the negative control (lane1) were 
calculated and plotted for every lane as usual, reflecting the made observations.  
To address the question of cooperativity, diagrams with stacked columns were created from the 
dataset. First, the percentages of remaining run-off transcript obtained in the reactions with Fob1 
and Nsi1 were plotted (red columns) like in the regular diagram. Then, the amount of transcripts 
terminated by Nsi1 was calculated as the difference between 100% and the amount of full-length 
transcript gained in the Nsi1 control (lane 2, green columns). The fraction of transcripts terminated 
by Fob1 was calculated alike (blue columns). The values obtained for Nsi1 and Fob1 were plotted on 
top of the red columns. If the effects exerted by Fob1 and Nsi1 were simply additive, this sum should 
be 100%. However, the values differed from 100% depending on the amount of Fob1 up to roughly 
15%. This suggests a cooperative behaviour between Nsi1 and Fob1.  
The result was challenged in an identical experiment conducted with the tailed template T-rich1 TER 
missing the RFB. The rationale was to further investigate whether simply the presence of Fob1 and 
thus probably a direct interaction between Nsi1 and Fob1 was imposing the cooperative effect or if 
the RFB DNA sequence was needed as well. The results are depicted in (Fig. 4-28 B). Contrary to the 
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previous experiment with the complete TER template, the signal intensity of the band representing 
the Nsi1-dependent terminated transcript did not increase visibly upon titration of Fob1. This 
impression was verified when the remaining amounts of the full-length transcripts were calculated. 
In the stacked column diagram, the fractions added up to 100% thus showing the additivity of the 
effects observed in this experiment. The results lead to the conclusion that the cooperative effect of 
Nsi1 and Fob1 in Pol I transcription termination depended on both presence of Fob1 and the RFB, 
which was also in good agreement with the cis-element analysis (Fig. 4-26). 
 
Fig. 4-28: Nsi1 and Fob1 exhibit cooperativity in Pol I transcription termination in vitro. (A) Transcription reactions were 
performed in duplicate as described with 10nM of the tailed template TER and 1µl Pol I. Nsi1 was used at 20nM 
concentration. Fob1 was titrated in three steps (27.6nM, 276nM, 1380nM) After addition of Nsi1 and/or Fob1, the sample 
was allowed to equilibrate for 15min at RT before the reaction was started. Isolated RNAs were separated on a 5% 
denaturing PA gel. Exposition time of the dried gel was 1h. A cartoon of the template indicates the identity and length of 
the RNAs. Signals were normalized to the reference transcript and the ratios of the full length transcript signal intensities of 
the lanes of interest versus the negative control were calculated and plotted. Grey bar: negative control; green bar: Nsi1 
control, red bars: reactions with Nsi1 and Fob1; blue bars: Fob1 control titration. Red bars in the stacked diagram are 
identical to the red bars corresponding to lanes 3, 4 and 5. The percentages of terminated transcripts by Nsi1 (green bars) 
and Fob1 (blue bars) were calculated and plotted on top. (B) Explanation see (A) except that the tailed template T-rich 1 
Reb1 BS was used instead of TER. 
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Obviously, the next question was whether Reb1 and Fob1 also exhibited a cooperative effect in Pol I 
transcription termination in vitro. An identical transcription experiment was carried out as described 
above with the template containing the complete rDNA terminator. Reb1 was used at 8.7nM, the 
least concentration at which a terminated transcript had been observed in titration experiments. The 
results can be seen in Fig. 4-29. In the Reb1 control lane (2), a very faint band corresponding to the 
abortive transcript at T-rich 1 was detected. Upon titration of Fob1 to samples containing Reb1, this 
signal did not visibly intensify (lanes 3-5). Comparison of the Fob1 control (lanes 6-8) with the lanes 
of interest (3-5) showed no difference in the intensity of the abortive transcript at RFB1.  
First, the fractions of remaining full length transcript compared to the negative control (lane 1) were 
calculated and plotted for every lane as usual, confirming the observations. Then, diagrams with 
stacked columns were created from the dataset as outlined above. Contrary to the results obtained 
with Nsi1 on the same template, the signals added up to 100% thus indicating additivity of the 
effects. 
 
Fig. 4-29: Reb1 and Fob1 do not act cooperatively in Pol I transcription termination in vitro. (A) Description see Fig. 4-31 
A. Instead of Nsi1, Reb1 was used at a concentration of 8.7nM. The contrast was adjusted compared to the original image. 
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4.8 Pol I mutants partly show altered behaviour in the termination 
assay compared to the wild-type 
 
Since RNA Pol I subunits have been implicated to act in transcription termination, the question arose 
whether the termination effects observed with Nsi1, Reb1 and Fob1 in vitro could be traced back to a 
single subunit or a Pol I submodule. The analysis was based on previous reports indicating that 
subunit A12.2 was required for cleavage of the nascent RNA (Kuhn et al. 2007) and thus a key player 
in termination (Prescott et al. 2004). It was further demonstrated that deletion of A49 or the 
A49/A34.5 dimer resulted in reduced Pol I activity and hence in a growth phenotype (Huet et al. 
1975; Liljelund et al. 1992). A more recent study structurally related TFIIF to the A49/A34.5 dimer 
(Kuhn et al. 2007) hence proposing a role as a built-in Pol I elongation factor. Therefore Pol I mutants 
lacking subunits A12.2 and A49 were purified (4.2.2) and employed in the analysis. Additionally it was 
reported that deletion of A12.2 was synthetically lethal (Gerber et al. 2008), if serine residue 685 in 
subunit A190 was mutated to aspartate (A190 S685D). Accordingly, the analyses were extended to 
Pol I A190 phosphomutants. Four mutants were selected in which either serine 685 or all serines 
which were identified as phosphosites were mutated to alanine or aspartate (A190 S685A, A190 
S685D, A190 SallA, A190 SallD). Transcription experiments were carried out as usual with 10nM of 
the TER template complexed with either Nsi1 (88nM), Reb1 (700nM) or Fob1 (276nM) and 1µl of the 
respective polymerase fraction. The results are depicted in (Fig. 4-30).  
When Pol I ∆ A12 was transcribing the Nsi1-complexed template, an additional band was observed 
between the reference transcript and the transcript terminated at T-rich 1 compared to the wild-type 
situation (Fig. 4-30 A). According to a calibration curve derived from the RNA marker, it had a length of 
232nt. Compared to the template, this size corresponds to the region just upstream of the Reb1 
binding site. Furthermore, two transcript signals were obtained with Pol I ∆ A12 mapping to the RFB1 
and RFB 3 regions independently of the presence of an additional factor. The above observations 
were also made, if the Reb1-bound template was transcribed by Pol I ∆ A12 (Fig. 4-30 B). One way of 
interpretation includes the hypothesis that the mutant is less termination-competent but eventually 
pauses upon reaching Nsi1. It can be speculated whether a distinct DNA structure is formed at the 
Reb1 binding site and the RFB which imposes an elongation obstacle for this Pol I mutant by itself. It 
might be envisioned that a special DNA structure could be a prerequisite for the cooperative effect 
on Pol I termination observed with Nsi1 and Fob1.  
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Compared to the wild-type, no differences could be detected, if the Nsi1-complexed template was 
transcribed with Pol I ∆ A49 (Fig. 4-30 A). However, Reb1 or Fob1-dependent elongation blocking was 
roughly twice as efficient (Fig. 4-30 B, C). This observation would be generally in agreement with the 
role of A49/A34.5 as an elongation factor, albeit the question remains why results obtained with Nsi1 
differed. 
No major differences in termination efficiency were detected with Pol I A190 S685A and S685D in 
relation to the wild-type with Nsi1, Reb1 and Fob1 (Fig. 4-30 A, B, C). In contrast, for both the A190 
SallA and SallD mutant the remaining proportion of run-off transcript was slightly elevated (70%-80% 
read-through) upon transcription of Reb1-, Nsi1- and Fob1-bound templates. 
In summary, Pol I mutants partially show altered behaviour regarding transcription termination. 
However more thorough analyses of the observed effects and the respective polymerase mutants 
are necessary to draw mechanistic conclusions.  
 
Fig. 4-30: Pol I mutants partially show altered transcription termination efficiency compared to the wild-type. (A) 
Transcription reactions were performed in triplicate as described with 10nM of the tailed template TER and 1µl of the 
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respective polymerase preparation. Nsi1 was used at 88nM concentration. After addition of Nsi1, the sample was allowed 
to equilibrate for 15min at RT before the reaction was started. Isolated RNAs were separated on a 5% denaturing PA gel. 
Exposition time of the dried gel was 1h. A cartoon of the template indicates the identity and length of the RNAs. Signals 
were normalized to the reference transcript and the ratios of the full length transcript signal intensities of the lanes of 
interest versus the negative control were calculated and plotted. (B) Description see (A) except that Reb1 was used at 
700nM concentration instead of Nsi1. (C) Description see (A) except that Fob1 was used at 276nM concnentration instead 
of Nsi1. 
 
 
4.9 Pol I, II and III deal differently with elongation obstacles in vitro 
 
4.9.1 Only Pol I is significantly paused by Nsi1 and Reb1 
 
A major goal of this study was to compare Pol I, II and III regarding their ability to handle elongation 
obstacles or in other words, if the purified trans-acting factors were elongation barriers for all of the 
polymerases or not. Therefore, comparative transcription assays with Pol I, II and III were performed 
in presence of Nsi1, Reb1 of Fob1. The sample containing the tailed template TER (Fig. 4-1) was 
incubated with 88nM Nsi1, 700nM Reb1 or 276nM for 15min at RT. Then transcription was started 
by addition of the polymerase and performed as described (3.2.12). The isolated RNA was separated 
on a 5% denaturing PA gel which was then exposed to an imaging plate for 1h. The experiments were 
done in triplicate and conducted in presence of 50mM KOAc or 150mM KOAc to exclude salt-
dependency of observed effects. Size estimations of transcripts were based on calibration curves 
obtained with an RNA marker. 
With Nsi1, abortive transcripts mapping to the T-rich 1 region were detected upon transcription with 
Pol I and in significantly lower intensity with Pol III but not with Pol II (Fig. 4-31 A). Note that with Pol 
III, the full length transcript cannot be formed due to the T-rich 2 element which serves as a Pol III 
terminator. Quantification (3.2.12 D) of the signals of the full length transcripts confirmed previous 
results showing that compared to the negative control, in presence of Nsi1 only 50%-60% of the full 
length transcript was obtained when transcription was done with Pol I. With Pol II or III still 80%-90% 
of the amount run-off transcript were detected. Albeit more full length transcript seemed to be 
produced in an environment with higher ionic strength, the general tendency was the same in both 
setups. It can be speculated, if higher KOAc concentration lowers the strength of the Nsi1-DNA 
interaction and thus favours run-off transcription. 
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Fig. 4-31: Comparative transcription with Pol I, II and III using the tailed TER template complexed with Nsi1 or Reb1 
reveals significant differences between the polymerases. (A) Transcription reactions were performed as described with 
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10nM tailed template TER and 1µl of the respective polymerase preparation. Nsi1 was used at 88nM concentration. After 
addition of Nsi1, the sample was allowed to equilibrate for 15min at RT before the reaction was started. Isolated RNAs were 
separated on a 5% denaturing PA gel. Exposition time of the dried gel was 1h. Cartoons of the templates indicate the 
identity and length of the RNAs. Signals were normalized to the reference transcript and the ratios of the full length 
transcript signal intensities of the lanes of interest versus the negative control were calculated and plotted. Identical 
experiments were performed at 50mM KOAc and 150mM KOAc The gel pictures and diagrams represent the 50mMKOAc 
situation. (B) Description see (A), except not Nsi1 but Reb1 was used at 700nM concentration. (C) Description see (A), 
except not Nsi1 but Fob1 was used at 276nM concentration 
When Reb1 was included in the reactions, an abortive transcript mapping to the T-rich1 site was 
detected in Pol I transcription as previously shown (Fig. 4-31 B). This effect was not observed for Pol II 
or III. Quantification confirmed that upon addition of Reb1, only 30%-40% of full-length transcript 
were formed with Pol I. Contrary, the amount of RNA generated by Pol II or III was only minimally 
impaired. For Pol II, this was unexpected since it was proposed that Pol II transcription is terminated 
by Reb1 (Lang et al. 1998). The results did not qualitatively depend on the amount of salt in the 
reaction. Quantification for Pol III could not be performed due to insufficient signal intensity in the 
50mM KOAc setup. 
The effect of Fob1 could be investigated only for Pol I and Pol II as the RFB is located 3’ downstream 
of the T-rich 2 element which terminates Pol III. Nonetheless a respective experiment with Pol III was 
carried out to determine if Fob1 interfered with Pol III transcription independently of its designated 
binding sites. However Fob1 did not impose an elongation obstacle for Pol III. Upon transcription of 
the Fob1-complexed TER template with Pol I, the two previously shown bands mapping to RFB1 and 
RFB3 could be observed (Fig. 4-31 C). As in earlier experiments, the signal correlated to RFB1 was 
stronger than the one at RFB3. Taken into consideration that in body labeling conditions, more α-32P-
CTP is incorporated in longer RNAs, still more transcripts seem to be aborted at RFB1. However, 
calculation of a remaining full-length transcript proportion of 80% revealed that Fob1 was only a 
minor roadblock for Pol I. Transcription with Pol II resulted in an additional, faintly visible transcript 
in the range of RFB1, though quantification yielded the same result as for Pol I. 
In summary, it was shown that Nsi1, Reb1 and Fob1 specifically imposed elongation barriers of 
different strength for Pol I in vitro. Contrary, Pol II and Pol III transcription was not pronouncedly 
impaired by the presence of the mentioned factors in the way of the elongating polymerase. The 
effects were reproducible and only quantitatively dependent on the amount of KOAc present in the 
reaction. 
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4.9.2 LexA affects Pol II and III elongation but not Pol I 
 
We further wanted to elucidate, whether the results how Pol I, II and III deal with proteins which 
bind to the 35S rDNA terminator during transcription was transferable to other elongation barriers. 
Therefore, it was an interesting option to extend this analysis to the strong DNA-binding bacterial 
protein LexA. Therefore, in vitro transcriptions were done with the tailed template containing three 
bacterial SOS boxes and therefore three binding sites for LexA (Fig. 4-2). The template (22nM) was 
fully complexed with LexA (1.6µM) as determined in gel shift analyses (Fig. 4-15). After addition of 
LexA, the sample was allowed to equilibrate at RT for 15min and then transcription was started by 
addition of the respective polymerase. Experiments were carried out in triplicate comparatively with 
Pol I, II and III as described. The isolated RNAs were separated on a 5% denaturing PA gel which was 
exposed to an imaging plate for 1h after drying. The amount of full length transcript was reduced 
visibly when Pol II was transcribing the complexed template and an additional smaller RNA was 
detected (Fig. 4-32). According to a calibration curve created with an RNA marker, the small fragment 
had a length of 188nt, which maps closely to the first SOS box (240nt-220nt) of the template.  
 
Fig. 4-32: LexA is an elongation obstacle for Pol II and III but not for Pol I. Transcription reactions were performed as 
described with 22nM tailed template 3x LexA and 1µl of the respective polymerase preparation. LexA was used at 1.7µM 
concentration. After addition of LexA, the sample was allowed to equilibrate for 15min at RT before the reaction was 
started. Isolated RNAs were separated on a 5% denaturing PA gel. Exposition time of the dried gel was 1h. Cartoons of the 
templates indicate the identity and length of the RNAs. Signals were normalized to the reference transcript and the ratios of 
the full length transcript signal intensities of the lanes of interest versus the negative control were calculated and plotted. 
Calculation of the proportion of the remaining run-off transcript resulted in 50% for Pol II. Pol I was 
not affected and for Pol III a minor effect was observed, though no abortive transcript was visible. 
Unfortunately, the interesting comparison to T7 RNA polymerase could not be done as the 
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polymerase does not tolerate the ionic strength in the reaction and not all yeast polymerases work in 
the T7 polymerase buffer. As the tailed template assay does not answer the question of transcript 
release, no distinction can be made whether the observed effects are termination or polymerase 
pausing. Our results for Pol I are in good agreement with the literature, since recent in vivo 
experiments showed that LexA does not impose a transcriptional barrier for Pol I (Reiter et al. 2012). 
 
 
4.9.3 TTF-I affects elongation of all three yeast RNA polymerases 
 
We further characterized the three RNA polymerases by focusing on the question whether the well-
studied Pol I termination factor TTF-I of higher eukaryotes would be an elongation obstacle and 
which polymerases would be affected. Respective transcription experiments used tailed templates 
incorporating a part of the mouse rDNA terminator which includes 5 TTF-I binding sites (5x TTF-I, Fig. 
4-2). Additionally, a similar template with the inverted sequence was available (5x TTF-I inv) to 
investigate whether observed effects were direction-dependent. An N-terminal truncation variant of 
mouse TTF-I was used in the experiments (TTF-I ∆N348) which was a kind gift from Attila Nemeth 
(Németh et al. 2004, Fig. 4-33 B). Transcription experiments were only conducted with KOAc-purified 
polymerases with additional 150mM KOAc. Template concentration was 9.5nM and TTF-I ∆N348 was 
present at 7.6µM. After addition of TTF-I, the sample was equilibrated at RT for 15min and then 
transcription was started by addition of the respective polymerase. Experiments were carried out in 
duplicate comparatively with Pol I, II and III as described. The isolated RNAs were separated on a 5% 
denaturing PA gel which was exposed to an imaging plate for 1h after drying.  
TTF-I imposed a major roadblock for all three polymerases (Fig. 4-33 A) albeit it cannot be 
discriminated between termination and pausing concerning Pol II and III. With Pol I, no full length 
transcript of the 5x TTF-I template was formed in presence of TTF-I, corresponding to 100% 
termination. Instead, two major bands mapping to the first and second TTF-I binding site were 
observed. Interestingly, if transcription was performed with a 5x TTF-I template containing the yeast 
rDNA promoter and an initiation-competent fraction containing Pol I (PA600, (Tschochne & Milkereit 
1997)), all transcripts were terminated at the first binding site in presence of TTF-I (data not shown). 
Pol II was able to fully transcribe a fraction of the complexed template, but singals of transcripts in 
the range of the first three binding sites were detected. For Pol III it was impossible to transcribe the 
template completely due to a large T-rich region located shortly downstream of the second TTF-I 
binding site which acted as a terminator.  
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Fig. 4-33: TTF-I is a major roadblock for all three RNA polymerases. (A) Transcription reactions were performed as 
described with 9.5nM tailed template 5x TTF-I and 1µl of the respective polymerase preparation. TTF-I was used at 7.6µM 
concentration. After addition of TTF-I, the sample was allowed to equilibrate for 15min at RT before the reaction was 
started. Isolated RNAs were separated on a 5% denaturing PA gel. Exposition time of the dried gel was 1h. Cartoons of the 
templates indicate the identity and length of the RNAs. Signals were normalized to the reference transcript and the ratios of 
the full length transcript signal intensities of the lanes of interest versus the negative control were calculated and plotted. 
(B) TTF-I ∆N348 from Attila Nemeth was analysed on a 10% SDS gel. (C) Description see (A) except the template was 5x TTF-
I inv. 
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However, a fraction of transcripts was elongated until the first binding site only. Size estimations 
were based on a calibration curve obtained with an RNA marker. Calculation of the proportion of the 
remaining run-off transcript resulted in 40% for Pol II and 60% for Pol III. Compared to all other 
investigated factors, only TTF-I represented an insuperable roadblock for one of the polymerases, in 
this case Pol I. Furthermore, in vitro transcription experiments with the tailed template 5x TTF-I inv 
demonstrated that the observed effects were dependent on the orientation of the binding sites with 
regard to the elongating polymerase (Fig. 4-33 C). The results for Pol I are in good agreement with 
published (Evers et al. 1995) and unpublished (Gernot Längst, personal communication) data. 
 
 
4.10 Transcription of chromatin templates in vitro 
 
In the cell, transcription occurs in the context of chromatin, a complex assembly of nucleic acids and 
proteins. The most abundant structural unit of chromatin is the nucleosome. As outlined in (2.4), 
studies on how Pol I, II and III deal with a nucleosomal template in vitro are hard to compare. Thus 
we wanted to study Pol I, II and III elongation on a nucleosomal template comparatively to learn 
more about the respective polymerase-inherent capability to overcome a nucleosomal barrier.  
 
4.10.1 Establishment of nucleosomal templates 
 
The reconstitution of the DNA-nucleosome complex in vitro is called chromatin assembly. 
Nucleosomes were assembled on tailed templates containing one or multiple 601 nucleosome 
positioning sequences (Lowary & Widom 1998) via salt dialysis in vitro (Kleiman & Huang 1972; 
Woodcock 1977; Wilhelm et al. 1978; Gadski & Chae 1976; Peterson 2008; Lee & Narlikar 2001). Due 
to the strong affinity of the 601 sequence to the histones, the nucleosome position is exactly 
determined. Hence this technique yields a homogeneous population of chromatin templates. As 
every template behaves differently in chromatin assembly, a titration series of assemblies with 
different histone:DNA ratios was conducted first. Samples contained 5µg of the tailed template with 
one 601 binding sequence, 10mg BSA and varying amounts of chicken histones in a total volume of 
50µl high salt buffer. (Table 3-8). Purified chicken core histones H2A, H2B, H3 and H4 were a kind gift 
of the Längst lab (NEELIN & BUTLER 1959) (Fig. 4-34). The assembly was carried out as described 
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(3.2.8) and dialysis from 2M NaCl to 200mM was done over night at RT. Chromatin and free DNA 
were separated on a native 6% PA gel and the DNA was visualized with ethidium bromide (Fig. 4-34). 
Note that during tailed template preparation the vector backbone remained in the solution and thus 
two bands were visible in the negative control. The analysis revealed that upon rising histone 
concentrations first the 1x 601 template was occupied by a nucleosome followed by the vector 
backbone. This coincides with the strong affinity of the 601 sequence in comparison to random DNA. 
However once all 601 sites were occupied by nucleosomes, random nucleosome formation on the 
backbone started. Thus, the additional vector DNA served as a buffer against assembly of more than 
one nucleosome on the tailed template. For in vitro transcription, a mixture of assemblies with a 
ratio of 0.6:1 and 0.8:1 was used, which exhibited full template occupancy but not yet random 
assembly. 
 
Fig. 4-34: Nucleosomes are assembled on templates containing 601 positioning sequences via salt dialysis. Chromatin was 
assembled via salt dialysis from 2M to 200mM over night. Assembly reactions contained 5µg 1x 601 tailed template DNA, 
10mg BSA and varying amounts of histones in a total volume of 50µl. Purified histones from chicken erythrocytes were a 
kind gift of the Längst lab. 10% of the assembly reactions were separated on a native 6% PA gel and the DNA was visualized 
with ethidium bromide. Equal amounts of the mixture of 0.6:1 and 0.8:1 chromatin and naked template DNA were digested 
with BsiWI for 1h at 37°C. Samples were Proteinase K treated as described and EtOH precipitated. The pellet was 
redissolved and completely applied on a 1% agarose gel. DNA was visualized with SYBR Safe. Samples omitting BsiWI which 
were equally treated served as controls. 
Due to the length of the standardly used elongated version of the 1x 601 template, formation of 
additional nucleosomes up- and downstream of the 601 sequence could not be excluded. A 
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downstream nucleosome would not compromise the later analyses as putative effects should be 
induced by the first nucleosome with known positioning. In contrast, a nucleosome positioned 
randomly upstream of the 601 sequence would make soild data analysis impossible. However, the 
short template version did not provide enough space to accommodate a second nucleosome 
upstream of the 601 sequence. Comparison of results obtained with the short (data not shown) and 
long (Fig. 4-35) version of the 1x 601 template (4.1.2) in identical in vitro transcription assays showed 
no significant differences in elongation behavior (4.10.2). This suggested that no additional 
nucleosome had been positioned upstream of the 601 sequence on the elongated template. 
The amount of template which had actually been assembled was further determined by a restriction 
endonuclease protection assay. Therefore, equal amounts of naked DNA and chromatin were 
digested with BsiWI which has a recognition site in the 601 sequence close to the dyad axis of the 
nucleosome. Afterwards, the samples were Proteinase K digested and EtOH precipitated. As a 
control, naked DNA and chromatin samples were treated equally without adding the enzyme. The 
extracted DNA was then analyzed on a 1% agarose gel (Fig. 4-34). While the naked DNA had been 
digested upon addition of BsiWI, the chromatinized template DNA had been fully protected by the 
nucleosome. This result confirmed the previous assumption that the template DNA was fully 
assembled according to the sensitivity of the detection method. 
 
 
4.10.2 In vitro interaction of Pol I, II and III with a nucleosomal 
transcription barrier 
 
To determine how a single nucleosome would affect the elongation of Pol I, II and III, comparative in 
vitro transcription experiments were conducted as described (3.2.12). The reference template, 1x 
601 naked DNA and chromatin were present at a final concentration of 17nM. Controls included 
reactions with only one of the three templates (reference, 1x 601 naked or chromatin) to trace 
effects back to one template. Reactions were started with 1µl of the respective polymerase 
preparation. Isolated RNAs were separated on a denaturing PA gel which was exposed for 1h or over 
night. The results are depicted in Fig. 4-35. Pol II did not manage to produce a detectable full-length 
transcript from the chromatin template as judged after 1h exposure. Upon over night exposure of 
the gel, an abortive transcript could be detected with a length of 218nt, which corresponds to the 5’ 
end of the 601 sequence. A faint band between 400nt and 500nt (*) possibly could represent the full-
length transcript, however the signal intensity was too low for quantification. Thus a nucleosome 
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imposed a very strong barrier for Pol II in vitro, which is in good agreement with the literature (see 
2.4). In contrast, Pol I (60% readthrough) and Pol III (50%) elongation were only compromised.  
 
             
Fig. 4-35: A single nucleosome is a very strong barrier for Pol II and an elongation obstacle for Pol I and Pol III in vitro. 
Transcription reactions were performed in triplicate as described with 17nM of the tailed template 601 and the reference 
template. Reactions were started with 1µl of the respective polymerase preparation. Chromatinized 1x 601 template was 
used at 17nM. Isolated RNAs were separated on a 5% denaturing PA gel. Exposition time of the dried gel was 1h or over 
night to visualize the abortive transcript, respectively. A cartoon of the template indicates the identity and length of the 
RNAs. Signals were normalized to the reference transcript and the ratios of the full length transcript signal intensities of the 
lanes of interest versus the negative control were calculated and plotted. The red asterisk marks the possible run-off 
transcript produced by Pol II. 
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4.10.3 Subunit A49 significantly contributes to Pol I’s ability to transcribe 
a nucleosomal template 
 
Since Pol I was able to transcribe a nucleosomal template, the next question was whether this ability 
could be traced back to one or more subunits. Therefore, a subset of the already discussed Pol I 
mutants (4.2, 4.8) was tested in the in vitro transcription assay. Reactions were conducted as 
outlined above with 1µl of the respective polymerase preparation. Wild-type Pol I and the 
phosphomutant Pol I A190 S685A transcribed the chromatin template with 60% efficiency compared 
to naked DNA (Fig. 4-36 A). The fraction of full length transcript dropped to 45% when the chromatin 
template was transcribed by Pol I A190 S685D. However, the Pol I mutants lacking either subunits 
A12.2 or A49 generated only about 30% full length transcript in comparison to naked DNA. These 
results were in good accordance with the proposed role of subunit A49 as an elongation factor.  
To formally demonstrate that the observed effect was due to the subunit A49, transcription 
experiments were conducted with equal amounts of wild-type Pol I, Pol I ∆A49 and different 
mixtures of Pol I ∆A49 and recombinant A49/A34.5 (4.3.7). All polymerases were preincubated on ice 
for 15min. Final concentration of the polymerases in the transcription reaction was roughly 7.5nM 
and A49 /A43.5 was titrated in four steps (7.5nM, 15nM, 75nM, 150nM final concentration). 
Interestingly, compared to the results above, the amount of full length transcript obtained with both 
wild-type Pol I and Pol I ∆ A49 was lower than in previous experiments (45% and 10%) (Fig. 4-36 A). 
One possible explanation would be that the 15min incubation negatively influenced the 
integrity/activity/processivity of the polymerases. Nonetheless, upon titration of A49/A34.5 to Pol I 
∆ A49, wild-type read-through levels were reached. Note that in this experiment an abortive 
transcript was observed with Pol I ∆A49 which mapped to the 5’ end of the 601 sequence. No 
polymerase activity was detected if transcription was carried out only in presence of recombinant 
A49/A34.5. Thus this suggests that subunit A49 plays a crucial role in transcription of nucleosomal 
templates by Pol I in vitro. 
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Fig. 4-36: Pol I subunits A49 and A12.2 significantly contribute to Pol I’s ability to transcribe a nucleosomal template. (A) 
Transcription reactions were performed in triplicate as described with 17nM of the tailed template 601 and the reference 
template. Reactions were started with 1µl of the respective polymerase preparation. Chromatinized 1x 601 template was 
182  CHAPTER IV – RESULTS 
__________________________________________________________________________________ 
used at 17nM. Isolated RNAs were separated on a 5% denaturing PA gel. Exposition time of the dried gel was 1h. A cartoon 
of the template indicates the identity and length of the RNAs. Signals were normalized to the reference transcript and the 
ratios of the full length transcript signal intensities of the lanes of interest versus the negative control were calculated and 
plotted. (B) Description of the transcription reactions an calculations see (A). Pol I ∆ A49 (150nM) was incubated with 
recombinant A49/A34.5 (3µM) for 15min on ice. Final A49/34.5 concentrations in the transcription reactions were 7.5nM, 
15nM, 75nM and 150nM with the final Pol I WT and ∆ A49 concentration being 7.5nM. 
 
 
4.10.4 TFIIF does not enable Pol II transcription through a nucleosome 
 
After the confirmation that the A49/A34.5 dimer played a crucial role in transcription of chromatin 
templates by Pol I, it was logical to test its partial structural paralog TFIIF in this regard. Previously, 
Izban & Luse had reported that TFIIF exhibits no stimulatory effect on Pol II transcription of a 
nucleosomal template in vitro (Izban & Luse 1992). Transcription experiments were done as outlined 
for the titration of A49/A34.5 in (4.10.3). Reactions contained equal amounts of Pol II or mixtures of 
Pol II and purified TFIIF (500mM KCl condition, 4.3.6) respectively. As a negative control, transcription 
reactions were carried out with TFIIF alone. Pol II and the Pol II-TFIIF mixtures were incubated on ice 
for 15min prior to transcription to form the Pol II-TFIIF complex as shown in 4.3.6 C. The final Pol II 
concentration in the assay was 18nM and TFIIF was titrated in four steps (18nM, 25nM, 62.5nM, 
125nM final concentration). All reactions were processed standardly and the extracted RNAs were 
separated on a 5% denaturing PA gel (Fig. 4-37 A). It was immediately obvious, that Pol II was not able 
to transcribe the chromatin template in the presence of TFIIF. Interestingly, the signal intensities of 
transcripts derived from naked DNA increased with rising amounts of TFIIF (Fig. 4-37 A). This is in 
accordance with published results indicating that TFIIF acts as a Pol II elongation factor on naked DNA 
by stimulation of the elongation rate and by decreasing elongation pausing (Flores et al. 1989; Price 
et al. 1989; Bengal et al. 1991; Izban & Luse 1992; Tan et al. 1994). Thus we propose that our TFIIF 
preparation is active. 
It could not be excluded that only minor amounts of the Pol II-TFIIF complex were formed upon 
incubation. However in Fig. 4-18 it was shown that Pol II was co-purified with TFIIF at 200mM KCl. Thus 
a fraction was available containing a certain amount of ex vivo purified Pol II-TFIIF complex. Albeit 
the percentage of Pol II-TFIIF complex in this preparation was unknown, it was demonstrated that 
the preparation exhibited polymerase activity (Fig. 4-18). Hence this fraction was used side-by-side 
with Pol II to transcribe the nucleosomal and naked template 1x 601 DNA (Fig. 4-37 B). Also in this 
experiment, no full length transcript originating from the chromatin template could be observed, 
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leading to the conclusion that Pol II-TFIIF was not able to transcribe a nucleosomal template, which 
confirmed previously published results (Izban & Luse 1992). 
 
 
Fig. 4-37: TFIIF does not enable Pol II transcription through a nucleosome. (A) Transcription reactions were performed as 
described with 17nM of the tailed template 601 and the reference template. Reactions were started with 1µl of the 
respective polymerase preparation. Chromatinized 1x 601 template was used at 17nM. For the titration, Pol II was 
incubated with TFIIF purified at 500mM KCl for 15min on ice. Final TFIIF concentrations in the transcription were 18.8nM, 
25nM, 62.5nM and 125nM. Isolated RNAs were separated on a 5% denaturing PA gel. Exposition time of the dried gel was 
1h. A cartoon of the template indicates the identity and length of the RNAs. Signals were normalized to the reference 
transcript and the signal intensities of the 1x 601 full length transcripts in the lanes without chromatin were calculated and 
plotted. 
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5.1 Validation of the in vitro transcription system 
 
Several factors were described to interact with the transcribing RNA Pol I at the terminator region. 
Two of these factors are Nsi1 and Fob1. We developed a novel approach to purify Nsi1 and Fob1 
recombinantly from SF21 insect cells (3.2.9). The preparations were sufficiently pure to address their 
function in DNA binding and in in vitro transcription (4.3). The Fob1 fraction was purified close to 
homogeneity according to gel filtration. Interestingly, Fob1 eluted from the column as an apparent 
tetramer (4.3.3). Gel filtration analysis of Nsi1 was unsuccessful since it did not elute from the 
column. The trans-acting factors Reb1 and LexA were purified according to the published protocols 
or slight variations thereof (Morrow et al. 1990, Griesenbeck J.). LacI purification followed the 
protocol for LexA preparation (4.3.5). Gel filtration analysis revealed that the protein samples were 
purified close to homogeneity. Furthermore, multimerization of the factors was observed as they 
eluted from the column as an apparent pentamer (Reb1, 4.3.1), tetramer (LacI, 4.3.5) or monomer 
(LexA, 4.3.4). This is in good agreement with the literature for LexA and LacI (Bell & Lewis 2000; 
Butala et al. 2009). However, it is unknown, whether Reb1 forms multimers in vivo and if this has any 
implications in its designated function as a Pol I termination factor. 
Specific binding of Reb1, Fob1 and LexA to their designated recognition sites according to the 
literature could be verified in vitro (Kobayashi 2003; Butala et al. 2009; Morrow et al. 1989). We 
could demonstrate that Nsi1 binds to the terminator-proximal Reb1 BS in vitro albeit optimal 
conditions could not be determined to this end (4.3.2). Note that association of Nsi1 with a template 
containing the complete terminator region seemed to have slightly altered binding behaviour 
compared to a template lacking the RFB. 
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Further, we report a one-step method for purification of all three yeast RNA polymerases based on 
immunoprecipiation. Judged based on the sensitivity of mass spectrometric analysis, polymerase 
fractions were not cross-contaminated with each other and devoid of transcription factors (4.2.2, 
4.2.3). 
In vitro transcription reactions were performed with tailed templates. This method was first 
described by the Chamberlin group (Dedrick & Chamberlin 1985; Kane & Chamberlin 1985; Kadesch 
& Chamberlin 1982). However our approach generates templates with an equal tail length of 20nt. In 
contrast, use of terminal nucleotide transferase as described before yields a mixture of different tail 
lengths and hence a set of templates with different initiation efficiencies. It was proposed that tailed 
templates can be only transcribed once. This is based on the observation that upon transcription of a 
tailed template an RNA-DNA hybrid is formed and the template strand gets displaced (Dedrick & 
Chamberlin 1985; Kane & Chamberlin 1985; Kadesch & Chamberlin 1982). Single stranded DNA was 
not reported as a template for RNA polymerases so far. It is obvious that tailed template 
transcription hence does not resemble the in vivo situation with a protruding transcription bubble. 
Thus the possibility exists that effects observed in such a system differ from the in vivo situation. In 
this regard, confirmation of the in vitro results in an in vivo approach is crucial. However, as will be 
explained below, our in vitro data match with our previously reported in vivo results (Reiter et al. 
2012). 
 
 
5.2 Nsi1 is a bona fide Pol I transcription termination factor 
 
Currently, two models for yeast Pol I transcription termination are being discussed. A simple 
explanation for the Pol I termination mechanism was postulated by the Reeder group (“pause and 
release”). Extensive in vitro studies (Lang et al. 1994) support a hypothesis according to which Pol I is 
stalled by the presence of Reb1 at its cognate binding site. Termination subsequently occurs due to 
the presence of the T-rich 1 stretch upstream of the pausing site which promotes release of both 
transcript and Pol I by destabilization of the ternary elongation complex. However, Reb1 was not 
found to be associated with its binding site in the 35S terminator region in vivo above background 
levels (Kawauchi et al. 2008; Goetze et al. 2010; Reiter et al. 2012). Furthermore, depletion of Reb1 
steady-state levels to roughly 25% did not result in significant termination defects (Kawauchi et al. 
2008). In yeast strains deficient in the RNase III-like endonuclease Rnt1 which is necessary for 35S 
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rRNA 3’ end formation, acculumation of Pol I transcripts extending to the T-rich 1 region and beyond 
was observed (Prescott et al. 2004; Reeder et al. 1999). The same was observed for cells expressing 
catalytically inactive mutants of the 5’->3’ exonuclease Rat1 and the helicase Sen1 (Kawauchi et al. 
2008). Furthermore, Pol I occupancy downstream of T1 increases in the before mentioned strains. 
Thus, a second model which shows similarity to the “torpedo” mechanism suggested for Pol II 
transcription termination was proposed by the Tollervey and Proudfoot groups based on 
transcription run-on (TRO) and ChIP analyses (Kawauchi et al. 2008; Braglia et al. 2011; El Hage et al. 
2008). This model links transcription termination with 35S pre-rRNA processing. In a first step, Rnt1 
cleaves the nascent 35S-pre-rRNA and hence provides an entry site for Rat1 which trails the 
elongating polymerase and degrades the transcript. In this model Reb1 also serves as a pausing 
element for Pol I allowing Rat1 to catch up with it. When Rat1 has reached Pol I, Sen1 unwinds the 
RNA-DNA hybrid and thus the ternary complex is destroyed.  
In a publication by our group (Reiter et al. 2012), Nsi1, a Reb1 homologue, was introduced as a novel 
Pol I termination factor. In vivo association of Nsi1 with the terminator region was shown by ChIP 
(chromatin immunoprecipitation) and ChEC (chromatin endogeneous cleavage) analyses. Our data 
suggest that recombinant Nsi1 also binds to the Reb1 binding site of the Pol I terminator in vitro. This 
is in good agreement with the bioinformatical prediction of a consensus Nsi1 binding site 
(CCGGGTAA) which is identical to the 5’ part of the Reb1 BS (Gordân et al. 2010). Although no 
binding constants were calculated, the in vitro binding affinity of Nsi1 seemed to be higher than that 
of Reb1. This is not explanatory for the observation that Nsi1 but not Reb1 is associated with the 
terminator-proximal Reb1 BS but matches with it (Reiter et al. 2012). Note that according to genome-
wide analysis (Ghaemmaghami et al. 2003), Reb1 is believed to be present in roughly 7500 molecules 
per cell whereas Nsi1 is less abundant (~400 molecules). Additionally, it was shown that Reb1 but not 
Nsi1 is tightly associated with the promoter-proximal Reb1 binding site in vivo (Kawauchi et al. 2008; 
Goetze et al. 2010; Reiter et al. 2012). Analysis of mutant Reb1 binding sites with decreased (mut1) 
and increased (mut2) Reb1 binding affinities (Lang & Reeder 1993; Reeder et al. 1999) led to 
diminished or enhanced Pol I termination. If the terminator-proximal Reb1 BS was replaced my mut1 
or mut2 in a yeast strain harbouring the rDNA terminator in the ITS1, Nsi1 binding was impaired 
(mut1) or enhanced (mut2) and the growth defect reduced (mut1) or enhanced (mut2) (Reiter et al. 
2012). Thus the reason for recognition site selectivity of Reb1 and Nsi1 requires further investigation 
and may be mediated by other trans-acting factors like Fob1. 
Additionally, we showed that Pol I elongation through an Nsi1-complexed template containing the 
complete terminator sequence was impaired in vitro (roughly 40% readthrough, 4.5.1). However, 
Reb1 imposed a stronger roadblock to Pol I (roughly 30% readthrough) which is matching with the 
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results from the Reeder group (Lang et al. 1994). Preliminary analyses of promoter-dependent Pol I 
transcription termination with recombinant CF, Rrn3 and yeast-purified Pol I confirm the results 
regarding Nsi1-mediated transcription termination obtained with tailed templates. Furthermore, not 
only pausing but also transcript release could be demonstrated upon transcription of immobilized 
Nsi1-bound templates (H. Tschochner, unpublished data).  
Introduction of the terminator region in the ITS1 of the 35S rDNA leads to significant growth 
reduction of the respective yeast strain and this effect could be traced back to binding of Nsi1 (Reiter 
et al. 2012). However, the question remains, which terminator cis elements influence Nsi1-mediated 
termination. We could demonstrate that presence of the Reb1 BS alone was sufficient to induce Pol I 
pausing and/or release in vitro (4.6.1). Furthermore, the T-rich 1 element significantly enhanced this 
effect and presence of the RFB seemed to exhibit slightly stimulatory activity. In accordance, in vivo, 
integration of the terminator-proximal Reb1 BS into the ITS1 was sufficient to induce a growth 
defect, which was enhanced by the presence of the T-rich 1 element and the RFB (Merkl P. et al., 
manuscript in preparation, Pérez-Fernández, unpublished data). Additionally, the Nsi1-mediated 
polymerase pausing was dependent on the orientation of the Reb1 BS pointing towards a specific 
interaction between Nsi1 and the polymerase in contrast to simple elongation blocking. These 
observations are in good agreement with previous results demonstrating that Nsi1-mediated growth 
reduction in a yeast strain where the rDNA terminator was integrated in the ITS1 was dependent on 
the orientation of the Reb1 BS (Merkl P. et al., manuscript in preparation, Reiter et al. 2012).  
In a study by Ha and coworkers (Ha et al. 2012), cooperativity between Fob1 and Nsi1 was suggested. 
This hypothesis is based on the finding that depletion of Fob1 seems to result in reduced Nsi1 
recruitment to the Reb1 BS in the terminator region. Furthermore, interactions between Nsi1 and 
Fob1 were demonstrated based on yeast two-hybrid screens (Mohanty & Bastia 2004; Uetz et al. 
2000). Our in vitro data further strengthen the view of cooperativity between Nsi1 and Fob1 since 
upon a constant level of Nsi1, titration of Fob1 increased Pol I termination at the T-rich 1 element 
(4.7). On the other hand, cooperativity between Reb1 and Fob1 could not be shown in vitro.  
It was suggested that co-transcriptional 35S pre-rRNA processing is a prerequisite for correct 
termination in vivo (Kawauchi et al. 2008; Braglia et al. 2011; El Hage et al. 2008). In this regard, 
cleavage of the nascent RNA by Rnt1 would provide an entry site for Rat1. However, Reiter and co-
workers showed that efficient termination in vivo also occurred in absence of the Rnt1 cleavage site 
(Reiter et al. 2012). It was further proposed that a failsafe termination mechanism exists in case of 
absence of Rnt1 or its cleavage site (Braglia et al. 2011). In this model, the T-rich stretch marks a 
second cleavage site for an unknown endonuclease which provides an alternative entry site for Rat1. 
This hypothesis is in contrast to earlier reports indicating that the T-rich region is necessary for RNA 
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release (Lang & Reeder 1995). This failsafe mechanism was postulated based on hybrid selection 
transcription run-on (hsTRO) analysis in WT and ∆Rnt1 strains. hsTRO is a technique with which 3’ 
end formation can be detected. However, proof of 3’ end formation does not answer the question 
whether the 3’ end results from a cleavage event or polymerization cessation and release. To confirm 
this hypothesis, detection of 5’ end formation will be crucial. Furthermore, spatial requirements 
question the failsafe termination mechanism. The T-rich 1 stretch is located 16bp upstream of the 
Reb1 BS where Pol I is stalled due to binding of Reb1. Given the fact that Pol II is supposed to cover 
25bp of DNA (Gnatt et al. 2001) it is hard to imagine how an endonuclease could get access to the T-
rich stretch. In this regard, we were able to show that Pol I transcription is terminated in vitro in 
absence of both Rnt1 and the Rnt1 cleavage site only by Nsi1 or Reb1 binding to the template DNA. 
On the other hand, it can be imagined that RNA cleavage occurs not due to the presence of an 
unknown endonuclease, but is in intrinsic feature of Pol I. This explanation would facilitate 
termination in presence or absence of a T-rich stretch. In fact, it was reported previously, that 
subunit A12.2 is involved in transcription termination and RNA cleavage thus making it a possible 
candidate (Kuhn et al. 2007; Prescott et al. 2004). However, deletion of subunit A12.2 did not 
influence transcription termination at the T-rich 1 element (Braglia et al. 2011). According to our in 
vitro results, termination efficiencies of WT Pol I and Pol I ∆A12 are similar in the presence of Nsi1 
(4.8). In respective experiments conducted with Reb1, Pol I ∆A12 exhibited a slightly reduced 
termination efficiency. Similarly, Nsi1-mediated Pol I termination was not influenced by the absence 
of subunit A49, whereas the Reb1-bound template imposed a stronger barrier for Pol I ∆A49 (4.8). 
Furthermore, the transcriptional roadblock induced by Fob1 was enhanced for Pol I ∆A49. In 
summary, these results argue for a putative interplay of subunits A12.2 and A49 with Reb1 and 
interaction of A49 with Fob1, although the physiological relevance and the implication for the 
termination mechanism remains to be clarified.  
Concerning the Pol I A190 phosphomutants, no major changes in run-off transcript levels were 
observed with the S685A/D mutants compared to the WT when templates complexed with Reb1, 
Nsi1 or Fob1 were transcribed (4.8). Contrary, comparison of the SallA/D mutants with the WT 
revealed an elevated full-length transcript formation upon transcription of Nsi1 and Reb1 bound 
templates (4.8). Since both mutants with alanine or aspartate substitutions exhibit the same 
phenotype, we cannot draw meaningful conclusions from this set of experiments. However, 
phosphorylation of serine residues in A190 apart from S685 might affect transcription termination 
efficiency of Pol I. 
Taken together, our in vitro data further strengthen the pause-and-release model originally proposed 
by the Reeder group. In accordance with our previous study (Reiter et al. 2012) we speculate that 
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Nsi1 fulfills the pausing and/or release function originally assigned to Reb1 in vivo. Our results are 
supported by in vivo studies conducted in our lab demonstrating that Pol I occupancy at the Reb1 BS 
and the RFB increase upon deletion of Nsi1 and are further elevated in a ∆nsi1 ∆fob1 strain (J. Pérez-
Fernández, unpublished data). Nonetheless, a Reb1 function in Nsi1 recruitment, Nsi1 binding 
stabilization, or interaction with Pol I might be envisioned and will be the subject of further 
investigations. Concerning the torpedo termination model, it is possible that Rat1-mediated 
transcript degradation supports Pol I transcription termination. However, Nsi1 binding to the 
terminator-proximal Reb1 BS is sufficient to terminate at least a fraction of the transcribing Pol I in 
vitro. Nonetheless, our results do not exclude and comment on coupling of co-transcriptional 35S 
pre-rRNA processing to transcription termination. Furthermore, the physiological relevance of the 
apparent leakiness of Pol I transcription termination and hence the role of Nsi1 in rDNA integrity 
maintenance as suggested by Ha and coworkers (Ha et al. 2012) has to be investigated thoroughly. 
Comparison of yeast Pol I termination to the RNA polymerase termination mechanisms proposed for 
T7 phage, bacteria and archaea reveals interesting similarities. According to our current knowledge, 
T7 and archaeal transcription are terminated by the presence of a T-rich stretch, albeit without any 
additional trans-acting factors (2.1.2, 2.1.3, 2.1.4). The described factor-independent termination 
mechanism in bacteria also requires a T-rich region. However, it is suggested that furthermore GC-
rich inverted repeats which form an RNA hairpin structure contribute to bacterial RNAP termination. 
In this regard, bacterial and eukarotic Pol III seem to share related pathways according to most 
recent publications (Nielsen et al. 2013). For T7 RNAP, bacterial RNAP, yeast or mammalian Pol I, 
involvement of an RNA secondary structure in the termination process was not demonstrated so far. 
Note that the stem-loop structure in the pre-35S rRNA downstream of the 25S is an Rnt1 cleavage 
site and thus can not contribute to termination in the same allosteric mechanistic way as proposed 
for Pol III. 
Concerning putative evolutionary relatedness, the second, Rho-dependent termination mechanism 
of bacterial RNAP (2.1.3) exhibits similarities to the torpedo termination model for eukaryotic Pol II 
(and Pol I). Whereas in Rho helicase and RNase activity are unified, eukaryotes apparently require 
two different factors (Rat1 and Sen1 in yeast). The concept of DNA binding factor-mediated 
polymerase stalling was solely introduced for eukaryotic RNA Pol I and may be implied in PAS-
dependent Pol II termination (CPF, CF, 2.3.3). Clearly, Reb1 and/or Nsi1 function in polymerase 
pausing which is administrated by TTF-I in mammals. Release activity was shown to be executed by 
PTRF (Pol I and transcript release factor) in mouse in vitro, however its role and physiological 
relevance is questioned since PTRF null mice are viable. In yeast, transcript release was suggested to 
be mediated by the T-rich 1 element independently of Reb1 (Jeong et al. 1995; Lang & Reeder 1995) 
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(see also 5.3). Contrary, our most recent preliminary results indicate that Nsi1 alone is sufficient for 
transcript release in vitro (H. Tschochner, unpublished data). 
Interestingly, S. cerevisiae differs from its close relative S. pombe regarding the molecular 
organization of Pol I termination and replication fork blocking. It was shown that the fission yeast 
Reb1 functions both as an rDNA termination factor and has replication fork barrier blocking ability 
(Zhao et al. 1997; Sánchez-Gorostiaga et al. 2004). This is similar to the role of TTF-I in higher 
eukaryotes which also exhibits termination and replication fork blocking activity (Gerber et al. 1997; 
López-Estraño et al. 1998), whereas S. cerevisiae in contrast seems to depend on the cooperation of 
at least two separate factors, Nsi1 and Fob1. 
A recent report suggested that Nsi1 plays role in rDNA silencing and showed Nsi1 interactions with 
the RENT complex subunits Net1 and Sir2 (Ha et al. 2012). It remains to be clarified whether the 
function of Nsi1 in Pol I transcription termination and rDNA silencing are linked to each other and 
how this connection is reflected mechanistically. It can be speculated that the apparent leakiness of 
Pol I termination fulfills a physiological role regarding maintaining an open copy conformation or in 
rDNA integrity in general. 
 
 
5.3 Comparative in vitro transcription reveals differences between 
Pol I, II and III  
 
We demonstrated that the yeast RNA polymerases deal differently with elongation obstacles. All 
three physiological factors implicated in transcription termination Nsi1, Reb1 and Fob1 only 
influenced Pol I transcription significantly whereas Pol II and III elongation was minimally or not 
impaired (4.9.1). Interestingly, Reb1 exhibits a general negative effect on transcript signal intensities 
independent of the used polymerase. Since our transcription system is independent of initiation and 
reaction conditions are equal, the observed effects can be traced back to the polymerases. An easy 
explanation is provided by the hypothesis that Pol I has the lowest processivity and is hence easily 
stalled, whereas Pol II and III evict the factors from the DNA. However, if this assumption is true, Pol I 
should be most susceptible to all roadblocks. However, we showed that the strong DNA binding 
protein LexA was nearly no obstacle for Pol I but most significantly impaired Pol II traversal (4.9.2). 
Accordingly, incorporation of a cluster of three SOS boxes in the ITS1 of the 35S rDNA and concurrent 
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expression of LexA under the GAL promoter does not lead to a reduced growth phenotype although 
LexA is associated with its binding sites in vivo (Reiter et al. 2012). Thus, general differences in 
processivity can not explain our results. 
Furthermore, the functional homolog to Reb1 and/or Nsi1 in mammals, TTF-I, provides a barrier for 
all three RNA polymerases albeit Pol I is again most severely affected (4.9.3). Selective blocking of 
yeast Pol I by yeast and mouse Pol I transcription termination factors might be explained due to 
evolutionary conservation in the actual termination mechanisms. Assuming that this hypothesis is 
true and given the fact that a torpedo termination mechanism for Pol I was not identified in 
mammals so far, this might be another hint supporting the pause-and-release termination model in 
yeast. Nonetheless, this is solely speculative since there are substantial differences in Pol I 
transcription termination between yeast and mammals as outlined in the introduction. Postulating 
full occupancy of the respective binding sites based on EMSA observations, the mammalian Pol I 
terminator seems to be more potent than its yeast counterpart however a direct comparison is not 
valid due to the different terminator architecture. It can be speculated whether the apparent 
leakiness of Pol I termination in yeast is an experimental artifact or whether it even fulfills a 
physiological role as outlined in 5.2. 
Early studies by Reeder and co-workers suggested that LacI acts as an elongation obstacle for yeast 
RNA Pol I in vitro (Jeong et al. 1995). They further proposed that the blocking ability of LacI was 
independent of the surrounding DNA sequence and the orientation of the recognition site. However 
it was further reported that transcript release from LacI-stalled Pol I ternary complexes was 
enhanced by the presence of the T-rich 1 element but also worked without a specific surrounding 
DNA environment (Tschochne & Milkereit 1997). In vivo experiments to study the influence of LacI on 
Pol I elongation using a yeast strain with a LacI binding site in the rDNA ITS1 (Reiter A, 2012), as well 
as in vitro transcription analyses (data not shown), remained unconclusive.  
The next obvious consideration is whether the difference in subunit composition evokes the diverse 
susceptibility to elongation obstacles. All three polymerases share a core comprised of 10 subunits of 
which 5 are identical in Pol I, II and III. Two further subunits, AC40 and AC19 are shared by Pol I and 
III. The two largest subunits which comprise the catalytically active center are homologous to each 
other, albeit are differing in molecular weight. Further, Pol I subunits A12.2, A43 and A14 have 
(partial) structural and functional homologs in Pol II and III (Vannini & Cramer 2012). To this end, all 
three polymerases are structurally related. However, only Pol I and III contain a specific subcomplex 
consisting of A49/A34.5 or C53/C37. Subunits Tfg1 and Tfg2 of the initiation and elongation factor 
TFIIF were identified as the respective homologs to the Pol I/III specific subcomplex (2.2.2). This 
would provide an explanation for the results obtained with LexA as an elongation obstacle. Addition 
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of TFIIF to reactions executed with Pol II and/or use of Pol I/III mutants lacking A49/A34.5 or C53/C37 
should allow to clarify this hypothesis. Additionally, Pol III contains three subunits lacking in both Pol I 
and II (C82, C34, C31) of which C82 and C34 are related to TFIIE subunits. This could be part of an 
answer to the question why Pol III is nearly not affected by any of the trans-acting DNA binding 
factors during elongation. 
In summary, we could show that under equal reaction conditions Pol I, II and III exhibit striking 
differences when encountering elongation barriers in vitro. Hypotheses to explain the observations 
with the different polymerase subunit composition remain speculative. Thorough polymerase 
mutant analysis and inclusion of the predicted structural and functional subunit homologs will be 
necessary to draw solid conclusions. However our results indicate fundamental inherent differences 
of Pol I, II and III in spite of their structural relatedness. 
 
 
5.4 Pol I, II and III deal differently with a chromatin template 
 
It is a long-standing question in the field how elongating RNA polymerases cope with a nucleosomal 
barrier. Many and mostly in vitro studies have been conducted as outlined in the introduction (2.4), 
however focusing usually on one RNA polymerase. With the established in vitro transcription system 
it was possible to compare the three yeast RNA polymerases side-by side regarding their ability to 
transcribe a nucleosomal template. To this end, mononucleosomal templates assembled via salt 
dialysis on the strong 601 positioning sequence (Lowary & Widom 1998) were incorporated in the 
analysis. We could demonstrate that Pol II is not able to overcome the nucleosomal barrier, whereas 
Pol I and III showed substantial levels of readthrough (4.10.2). Our observations regarding Pol II are in 
good agreement with the literature in which the nucleosome is described as a strong elongation 
barrier in vitro (Bondarenko et al. 2006; Hodges et al. 2009). Since the strength of the barrier 
depends on the magnitude of the actual histone-DNA interactions, it is coherent that we did not 
observe run-off transcripts with a template containing the very strong 601 sequence. Additionally, it 
was reported that Pol II is stalled after transcribing about 20-30nt of the nucleosome-covered DNA (Li 
et al. 2005). This is in good agreement with our observation of an abortive transcript mapping to the 
5’ end of the 601 sequence.  
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Regarding Pol I, our data are partly challenging a recent publication by the Zomerdijk group focusing 
on chromatin transcription by human Pol I in vitro (Birch et al. 2009). In this paper, FACT is proposed 
as an elongation factor for Pol I which facilitates chromatin transcription. An equal role for FACT had 
been shown earlier for Pol II transcription elongation. Most strikingly, we observe a Pol I read-
through efficiency of roughly 60% on a nucleosomal template. Contrary, Birch and co-workers report 
an efficiency of 10% with a Pol I fraction already containing the histone chaperone FACT. Based on 
the sensitivity of mass spectrometry, we can rule out cross-contamination of our Pol I preparation 
with the yeast FACT subunits Spt16 and Pob3. Additionally, transcription experiments were 
performed by Birch and co-workers with a polymerase fraction incubated with an antibody 
selectively recognizing one FACT subunit hence mimicking a “core” Pol I state. This resulted in a 
further reduction of full length transcript formation to roughly 2.5% which led to the conclusion that 
FACT is a Pol I elongation factor. Nonetheless, it cannot be ruled out that binding of the antibody to 
the proposed FACT-Pol I complex masks Pol I surfaces which are necessary for elongation and thus 
decreases elongation efficiency. We further conducted respective in vitro transcription experiments 
with Pol I on nucleosomal templates in presence of purified yeast FACT. To exclude the possibility 
that an affinity tag was compromising putative FACT activity, two different purifications with both 
possible baits Spt16-TAP and Pob3-TAP were used. However, no stimulation of Pol I readthrough 
levels could be demonstrated (data not shown). A previous report further suggested that FACT was 
not associated with ex vivo purified 35S rDNA chromatin (Hamperl 2012) based on mass 
spectrometric analysis. Additionally, FACT could not be detected co-precipitating with Pol I but with 
Pol II after formaldehyde crosslink (Hierlmeier et al. 2013). 
Taken together, in our hands Pol I is able to cope with a nucleosomal template on its own in vitro. 
The discrepancy of our results with the literature obviously could be explained by different Pol I 
elongation mechanisms in human and yeast. Thus, a role of FACT in Pol I transcription through 
nucleosomal templates can not be excluded but requires more investigation. 
We were further able to demonstrate that Pol I A190 S685D, Pol I ∆A12.2 and Pol I ∆A49 were 
impaired in transcription of the nucleosomal template (4.10.3). For Pol I ∆A49, the WT readthrough 
efficiency was restored upon pre-incubation with recombinant A49/A34.5. Therefore, we conclude 
that the A49/A34.5 dimer plays a crucial role in Pol I transcription elongation of nucleosomal 
templates. Our observations are in agreement with the literature which suggests that A12.2 and the 
A49/A34.5 dimer are necessary for proper Pol I elongation (Kuhn et al. 2007; Geiger et al. 2010). 
Although the synthetic lethality of Pol I ∆A12.2 with the S to D substitution of serine 685 in A190 was 
reported (Gerber et al. 2008), it remains unclear how both mutations affect elongation fidelity 
exactly. 
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TFIIF subunits Tfg1 and Tfg2 were identified as partial structural homologs to A49 and A34.5. Thus, 
we asked the question, whether TFIIF would help Pol II to overcome the nucleosomal barrier like it 
was shown for A49/A34.5 and Pol I. Concerning the question of TFIIF fidelity, we were able to 
demonstrate that presence of TFIIF enhanced run-off transcript levels of naked DNA by roughly 20%, 
therefore suggesting that our TFIIF preparation is active (4.10.4). Additionally, we have good 
evidence that incubation of Pol II with TFIIF leads to complex formation in vitro. In spite of this, we 
were not able to demonstrate stimulatory activity of TFIIF for Pol II traversal of a nucleosomal 
template. The same observation was made, if an ex vivo purified Pol II-TFIIF complex was used. In 
summary, this suggests that TFIIF by itself does not provide Pol II with the capability to overcome the 
nucleosomal barrier in vitro, which is accordance with previously published data (Izban & Luse 1992). 
Regarding Pol III, our experiments indicate an intrinsic ability to overcome nucleosomal barriers in 
vitro. This observation is in accordance with the literature (Studitsky et al. 1997). Although, no 
chromatin remodeling activity or histone tail modification changing activities were needed for 
transcription through a single nucleosome as proposed for a nucleosomal array in vitro (Englander et 
al. 1993; Ura et al. 1997; Tse et al. 1998; Ng et al. 2002; Arimbasseri & Bhargava 2008). 
 
 
5.5 Outlook 
 
Concerning yeast Pol I transcription termination, it will be crucial to verify the results in a promoter-
dependent in vitro transcription assay using immobilized templates. This will provide information 
about the release activity of Reb1 and Nsi1. Furthermore, our knowledge of the actual termination 
mechanism will remain limited unless the mode of interaction between Reb1, Nsi1 and Fob1 
including the spatial organization is not elucidated. For unification or refusal of the current 
termination models, it will be important to unravel whether Rat1-mediated transcript degradation is 
a prerequisite for termination in vivo. Additionally, further in vivo experiments have to validate the 
physiological relevance of our observations, although our preliminary data support our in vitro 
results (J. Perez Fernandez, unpublished data).  
Regarding the chromatin transcription abilities of Pol I, II and III, work with polymerase mutants will 
be important to draw mechanistic conclusions of the observed phenotypes. Furthermore, 
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incorporation of other known Pol II elongation factors and/or histone remodelers will possibly reveal 
one of more candidates that facilitate Pol II traversal on a nucleosomal template in vitro. 
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     CHAPTER VIII – ABBREVIATIONS 
°C   temperature in degrees celcius 
AA   acrylamide 
Amp   Ampicillin 
APS  ammonium persulfate 
ATP   adenosine triphosphate 
BisAA   bisacrylamide 
BSA   bovine serum albumine 
C-/N-terminal   carboxy/aminoterminal 
CBP Calmodulin binding protein 
CE core element 
CF  core factor 
CIP calf intestinal phosphatase 
CTP  cytosine  triphosphate 
DMSO dimethylsulfoxide 
DNA   deoxyribonucleic acid 
dNTP   deoxynucleoside triphosphate 
E. coli   Escherichia coli 
EDTA  ethylene diamine tetra acetate 
EtOH  ethanol 
FCS fetal calf serum 
Fig.   figure 
g   gram(s) 
g   gravitational force 
GTP   Guanosine triphosphate 
HCl   hydrochloric acid 
HEPES  4-(2-hydroxyethyl-)-piperazine-1-ethane sulfonic acid 
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HOAc  acetic acid 
IPTG isopropyl β-D-1-thiogalactopyranoside 
kb, bp, nt kilobase, basepair, nucleotide 
kDa   kilo Dalton 
kV   kilovolts 
l   liter(s) 
LB   lysogeny broth 
M   molar 
M. musculus   Mus musculus 
MALDI  Matrix assisted laser desorption ionization 
MeOH  methanol 
MES 2-(N-morpholino)ethanesulfonic acid 
miRNA  micro RNA 
MOPS 3-(N-morpholino)propanesulfonic acid 
mRNA   messenger RNA 
MW   molecular weight 
N2(l)   liquid nitrogen 
NaOAc  sodium acetate 
NaOH   sodium hydroxide 
Ni-NTA   Ni(II)-nitrilotriacetic acid 
nm   nanometer(s) 
NTP  nucleoside triphosphate 
OD600   optical density at 600nm wavelength 
ORF   open reading frame 
p.a.   pro analysi 
PA600   a crude chromatographic fraction enriched in RNA 
Pol I 
PAGE  polyacrylamide gel electrophoresis 
PCR polymerase chain reaction 
pH  negative decadic logarithm of the H+ ion 
concentration 
PI(s)   protease inhibitors 
PIP   RNA  Pol I promoter 
PMSF   phenylmethylsulfonylflouride 
ProtA Protein A 
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ProtK   Proteinase K 
PVDF polyvinylidene fluoride 
rDNA  ribosomal DNA 
RNA   ribonucleic acid 
rRNA  ribosomal RNA 
RT room temperature 
S  sedimentation coefficient 
s, min, h second, minute, hour 
S. cerevisiae  Saccharomyces cerevisiae 
SDS  sodium dodecyl sulfate 
snoRNA   small nucleolar RNA 
snRNA   small nuclear RNA 
TAP tandem affinity purification 
Taq   thermostable DNA polymerase from Thermus 
aquaticus 
TCA   trichloroacetic acid 
TEMED   tetramethylethylenediamine 
TEV Tobacco etch virus protease 
TM melting temperature 
TOF time of flight 
U   enzymatic unit 
UAF   upstream activating factor 
UE   upstream factor 
UTP   uridine triphosphate 
WT  wildtype 
X-GAL 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
β-ME  β-mercaptoethanol 
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